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Abstract
The future of medical imaging is linked to Artificial Intelligence (AI). The manual
analysis of medical images is nowadays an arduous, error-prone and often unaffordable
task for humans, which has caught the attention of the Machine Learning (ML) com-
munity. Magnetic Resonance Imaging (MRI), which constitutes the standard imaging
technique for the diagnosis of many lethal diseases, provides us with a wide variety of
rich representations of the morphology and behavior of lesions completely inaccessible
without a risky invasive intervention. Nevertheless, harnessing the powerful but often
latent information contained in MRI acquisitions is a very complicated task, which
requires computational intelligent analysis techniques.
Central nervous system tumors are one of the most critical diseases studied through
MRI. Specifically, glioblastoma represents a major challenge, as it remains a lethal
cancer that, to date, lacks a satisfactory therapy. Of the entire set of characteristics
that make glioblastoma so aggressive, a particular aspect that has been widely studied
is its vascular heterogeneity. The strong vascular proliferation of glioblastomas, as well
as their robust angiogenesis and extensive microvasculature heterogeneity have been
claimed responsible for the high lethality of the neoplasm. Therefore, the study of
these hallmarks is crucial to better understand the tumor’s aggressiveness and design
new effective therapies that improve patient prognosis.
This thesis focuses on the research and development of the Hemodynamic Tissue
Signature (HTS) method: an unsupervised ML approach to describe the vascular hete-
rogeneity of glioblastomas by means of perfusion MRI analysis. The HTS builds on the
concept of habitats. A habitat is defined as a sub-region of the lesion with a particular
MRI profile describing a specific physiological behavior. The HTS method delineates
four habitats within the glioblastoma: the High Angiogenic Tumor (HAT) habitat, as
the most perfused region of the enhancing tumor; the Low Angiogenic Tumor (LAT)
habitat, as the region of the enhancing tumor with a lower angiogenic profile; the
potentially Infiltrated Peripheral Edema (IPE) habitat, as the non-enhancing region
adjacent to the tumor with elevated perfusion indexes; and the Vasogenic Peripheral
Edema (VPE) habitat, as the remaining edema of the lesion with the lowest perfusion
profile. The research and development of the HTS method has generated a number of
contributions to this thesis.
First, in order to verify that unsupervised learning methods are reliable to extract
MRI patterns to describe the heterogeneity of a lesion, a comparison among several
structured and non-structured unsupervised learning methods was conducted for the
task of high grade glioma segmentation. Additionally a generic postprocessing stage
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was also developed to automatically map each label of an unsupervised segmentation
to a healthy or pathological tissue of the brain.
Second, a Bayesian unsupervised learning algorithm from the family of Spatially
Varying Finite Mixture Models (SVFMMs) is proposed. The algorithm, named Non
Local Spatially Varying Finite Mixture Model (NLSVFMM), successfully integrates a
continuous Gauss-Markov Random Field (MRF) prior density weighted by the probabi-
listic Non Local Means (NLM) weighting function, to codify the idea that neighboring
pixels tend to belong to the same semantic object. The proposed prior simultaneously
enforces local smoothness on the segmentations, while preserves the edges and the
structure between classes.
Third, the HTS method to describe the vascular heterogeneity of glioblastomas
through the aforementioned habitats is presented. The HTS method has been applied
to real cases, both in a local cohort of patients from a single-center, and in an in-
ternational retrospective cohort of more than 180 patients from 7 European centers.
A comprehensive evaluation of the method was conducted to measure the prognostic
potential of the HTS habitats, as well as their stratification capabilities to identify
populations with different prognosis. Statistically significant associations were found
between most of HTS habitats and Overall Survival (OS) of patients, as well as signi-
ficant differences were observed in survival rates of sub-populations divided according
to HTS derived measurements.
Finally, the methods and technology developed in this thesis have been integrated
into an online public open-access platform for its academic use. The ONCOhabitats
platform is hosted at https://www.oncohabitats.upv.es, and provides two main ser-
vices: 1) glioblastoma tissue segmentation, and 2) vascular heterogeneity assessment
of glioblastomas by means of the HTS method. Both services, in addition to prepro-
cessed images and segmentation maps, automatically generate a radiological report,
summarizing the findings of the study. ONCOhabitats not only offers the scientific and
medical community access to leading-edge algorithms for the analysis of these tumors,
but gives access to its computational cluster capable to process about 300 cases per
day.
The results of this thesis have been published in ten scientific contributions, inclu-
ding top-ranked journals and conferences in the areas of Medical Informatics, Statistics
and Probability, Radiology & Nuclear Medicine, Machine Learning and Data Mining
and Biomedical Engineering. An industrial patent registered in Spain (ES201431289A),
Europe (EP3190542A1) and EEUU (US20170287133A1) was also issued, summarizing
the efforts of this thesis to generate tangible assets besides the academic revenue obtai-
ned from research publications. Finally, the methods, technologies and original ideas
conceived in this thesis led to the foundation of ONCOANALYTICS CDX, a company
framed into the business model of companion diagnostics for pharmaceutical com-
pounds, thought as a vehicle to facilitate the industrialization of the ONCOhabitats
technology.
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Resumen
El futuro de la imagen me´dica esta´ ligado a la Inteligencia Artificial (IA). El ana´lisis
manual de ima´genes me´dicas es hoy en d´ıa una tarea ardua, propensa a errores y a
menudo inasequible para los humanos, que ha llamado la atencio´n de la comunidad
de Aprendizaje Automa´tico (AA). La Imagen por Resonancia Magne´tica (IRM), que
constituye la te´cnica de imagen esta´ndar para el diagno´stico de muchas enfermedades
letales, nos proporciona una amplia y rica variedad de representaciones de la morfo-
log´ıa y el comportamiento de lesiones completamente inaccesibles sin una intervencio´n
invasiva arriesgada. Sin embargo, explotar la potente pero a menudo latente informa-
cio´n contenida en las adquisiciones de IRM es una tarea muy complicada, que requiere
te´cnicas de ana´lisis computacional inteligente.
Los tumores del sistema nervioso central son una de las enfermedades ma´s cr´ıticas
estudiadas a trave´s de IRM. Espec´ıficamente, el glioblastoma representa un gran des-
af´ıo, ya que, hasta la fecha, continua siendo un ca´ncer letal que carece de una terapia
satisfactoria. De todo el conjunto de caracter´ısticas que hacen del glioblastoma un
tumor tan agresivo, un aspecto particular que ha sido ampliamente estudiado es su
heterogeneidad vascular. La fuerte proliferacio´n vascular de los glioblastomas, as´ı co-
mo su robusta angioge´nesis y la extensa heterogeneidad de su microvasculatura han
sido consideradas responsables de la alta letalidad de esta neoplasia. Por lo tanto,
el estudio de estos factores es crucial para entender mejor la agresividad del tumor y
disen˜ar nuevas terapias efectivas que mejoren el prono´stico del paciente.
Esta tesis se centra en la investigacio´n y desarrollo del me´todo Hemodynamic Tissue
Signature (HTS): un me´todo de aprendizaje no supervisado para describir la hetero-
geneidad vascular de los glioblastomas mediante el ana´lisis de perfusio´n por IRM. El
me´todo HTS se basa en el concepto de ha´bitats. Un ha´bitat se define como una subre-
gio´n de la lesio´n con un perfil particular de IRM, que describe un comportamiento
fisiolo´gico concreto. El me´todo HTS delinea cuatro ha´bitats dentro del glioblastoma:
el ha´bitat High Angiogenic Tumor (HAT), como la regio´n ma´s perfundida del tumor
con captacio´n de contraste; el ha´bitat Low Angiogenic Tumor (LAT), como la regio´n
del tumor con captacio´n de contraste con un perfil angioge´nico ma´s bajo; el ha´bitat In-
filtrated Peripheral Edema (IPE), como la regio´n edematosa sin captacio´n de contraste
adyacente al tumor con ı´ndices de perfusio´n elevados; y el ha´bitat Vasogenic Peripheral
Edema (VPE), como el edema restante de la lesio´n con el perfil de perfusio´n ma´s bajo.
La investigacio´n y desarrollo del me´todo HTS ha originado una serie de contribuciones
enmarcadas en esta tesis.
En primer lugar, para verificar que los me´todos de aprendizaje no supervisados son
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fiables a la hora de extraer patrones de IRM para describir la heterogeneidad de una
lesio´n, se realizo´ una comparacio´n entre varios me´todos de aprendizaje estructurado
y no estructurado no supervisados en la tarea de segmentacio´n de gliomas de grado
alto. Adicionalmente, se desarrollo´ un me´todo gene´rico de postproceso para mapear
automa´ticamente cada etiqueta de una segmentacio´n no supervisada a un tejido sano
o patolo´gico del cerebro.
En segundo lugar, se ha propuesto un algoritmo de aprendizaje Bayesiano no super-
visado dentro de la familia de los Spatially Varying Finite Mixture Models (SVFMMs).
El algoritmo, llamado Non Local Spatially Varying Finite Mixture Model (NLSVFMM),
integra con e´xito un Gauss-Markov Random Field (MRF) continuo ponderado por la
funcio´n probabil´ıstica Non Local Means (NLM) como densidad a priori del modelo,
para codificar la idea de que los p´ıxeles vecinos tienden a pertenecer al mismo objeto
sema´ntico. La probabilidad a priori propuesta refuerza simulta´neamente la suavidad
local en las segmentaciones, a la vez que preserva los bordes y la estructura entre clases.
En tercer lugar, se presenta el me´todo HTS para describir la heterogeneidad vas-
cular de los glioblastomas mediante los ha´bitats mencionados. El me´todo HTS se ha
aplicado a casos reales, tanto en una cohorte local de pacientes de un solo centro, como
en una cohorte retrospectiva internacional de ma´s de 180 pacientes de 7 centros euro-
peos. Se llevo´ a cabo una evaluacio´n exhaustiva del me´todo para medir el potencial
prono´stico de los ha´bitats, as´ı como las capacidades de estratificacio´n de los mismos
para identificar poblaciones con prono´sticos diferentes. Se encontraron asociaciones
estad´ısticamente significativas entre la mayor´ıa de los ha´bitats HTS y la supervivencia
global de los pacientes, as´ı como diferencias significativas en las tasas de supervivencia
de subpoblaciones divididas segu´n mediciones derivadas del HTS.
Finalmente, los me´todos y la tecnolog´ıa desarrollados en esta tesis se han inte-
grado en una plataforma web online de acceso pu´blico para su uso acade´mico. La
plataforma ONCOhabitats se aloja en https://www.oncohabitats.upv.es, y ofrece dos
servicios principales: 1) segmentacio´n de tejidos de glioblastoma, y 2) evaluacio´n de
la heterogeneidad vascular de los glioblastomas mediante el me´todo HTS. Ambos ser-
vicios, adema´s de las ima´genes preprocesadas y los mapas de segmentacio´n, generan
automa´ticamente un informe radiolo´gico resumiendo los hallazgos del estudio. ON-
COhabitats no so´lo ofrece a la comunidad cient´ıfica y me´dica acceso a algoritmos del
estado del arte para el ana´lisis de estos tumores, sino que tambie´n permite acceder a
su clu´ster computacional, capaz de procesar cerca de 300 casos al d´ıa.
Los resultados de esta tesis han sido publicados en diez contribuciones cient´ıficas,
incluyendo revistas y conferencias de primer nivel en las a´reas de Informa´tica Me´dica,
Estad´ıstica y Probabilidad, Radiolog´ıa y Medicina Nuclear, Aprendizaje Automa´tico y
Miner´ıa de Datos e Ingenier´ıa Biome´dica. Tambie´n se emitio´ una patente industrial re-
gistrada en Espan˜a (ES201431289A), Europa (EP3190542A1) y EEUU (US20170287133A1),
que representa los esfuerzos de esta tesis para generar activos tangibles adema´s de los
me´ritos acade´micos obtenidos de las publicaciones de investigacio´n. Finalmente, los
me´todos, tecnolog´ıas e ideas originales concebidas en esta tesis dieron lugar a la crea-
cio´n de ONCOANALYTICS CDX, una empresa enmarcada en el modelo de negocio de
los companion diagnostics de compuestos farmace´uticos, pensado como veh´ıculo para
facilitar la industrializacio´n de la tecnolog´ıa ONCOhabitats.
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El futur de la imatge me`dica esta` lligat a la Intel·lige`ncia Artificial (IA). L’ana`lisi
manual d’imatges me`diques e´s hui dia una tasca a`rdua, propensa a errors i sovint
inassequible per als humans, que ha cridat l’atencio´ de la comunitat d’Aprenentat-
ge Automa`tic (AA). La Imatge per Ressona`ncia Magne`tica (IRM), que constitueix la
te`cnica d’imatge esta`ndard per al diagno`stic de moltes malalties letals, ens proporciona
una a`mplia i rica varietat de representacions de la morfologia i el comportament de le-
sions completament inaccessibles sense una intervencio´ invasiva arriscada. Tanmateix,
explotar la potent pero` sovint latent informacio´ continguda a les adquisicions de IRM
esdeve´ una tasca molt complicada, que requereix te`cniques d’ana`lisi computacional
intel·ligent.
Els tumors del sistema nervio´s central so´n una de les malalties me´s cr´ıtiques estu-
diades a trave´s de IRM. Espec´ıficament, el glioblastoma representa un gran repte, ja
que, fins hui, continua siguent un ca`ncer letal que manca d’una tera`pia satisfacto`ria.
Dintre del conjunt de caracter´ıstiques que fan del glioblastoma un tumor tan agres-
siu, un aspecte particular que ha sigut a`mpliament estudiat e´s la seua heterogene¨ıtat
vascular. La forta proliferacio´ vascular dels glioblastomes, aix´ı com la seua robusta an-
gioge`nesi i l’extensa heterogene¨ıtat de la seua microvasculatura han sigut considerades
responsables de l’alta letalitat d’aquesta neopla`sia. Per tant, l’estudi d’aquests factors
esdeve´ crucial per entendre millor l’agressivitat del tumor i dissenyar noves tera`pies
efectives que milloren el prono`stic del pacient.
Aquesta tesi es centra en la recerca i desenvolupament del me`tode Hemodynamic
Tissue Signature (HTS): un me`tode d’aprenentatge no supervisat per descriure l’he-
terogene¨ıtat vascular dels glioblastomas mitjanc¸ant l’ana`lisi de perfusio´ per IRM. El
me`tode HTS es basa en el concepte d’ha`bitats. Un ha`bitat es defineix com una subre-
gio´ de la lesio´ amb un perfil particular d’IRM, que descriu un comportament fisiolo`gic
concret. El me`tode HTS delinea quatre ha`bitats dins del glioblastoma: l’ha`bitat High
Angiogenic Tumor (HAT), com la regio´ me´s perfosa del tumor amb captacio´ de con-
trast; l’ha`bitat Low Angiogenic Tumor (LAT), com la regio´ del tumor amb captacio´
de contrast amb un perfil angioge`nic me´s baix; l’ha`bitat Infiltrated Peripheral Ede-
ma (IPE), com la regio´ edematosa sense captacio´ de contrast adjacent al tumor amb
ı´ndexs de perfusio´ elevats, i l’ha`bitat Vasogenic Peripheral Edema (VPE), com l’edema
restant de la lesio´ amb el perfil de perfusio´ me´s baix. La recerca i desenvolupament
del me`tode HTS ha originat una se`rie de contribucions emmarcades a aquesta tesi.
En primer lloc, per verificar que els me`todes d’aprenentatge no supervisats so´n
fiables a l’hora d’extraure patrons d’IRM per descriure l’heterogene¨ıtat d’una lesio´,
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es va realitzar una comparacio´ entre diversos me`todes d’aprenentatge estructurat i no
estructurat no supervisats en la tasca de segmentacio´ de gliomes de grau alt. Addi-
cionalment, es va desenvolupar un me`tode gene`ric de post-processament per mapejar
automa`ticament cada etiqueta d’una segmentacio´ no supervisada a un teixit sa o pa-
tolo`gic del cervell.
En segon lloc, s’ha proposat un algorisme d’aprenentatge Bayesia` no supervisat
dintre de la famı´lia dels Spatially Varying Finite Mixture Models (SVFMMs). L’al-
gorisme, anomenat Non Local Spatially Varying Finite Mixture Model (NLSVFMM),
integra amb e`xit un Gauss-Markov Random Field (MRF) continu ponderat per la fun-
cio´ probabil´ıstica Non Local Means (NLM) com a densitat a priori del model, per a
codificar la idea que els p´ıxels ve¨ıns tendeixen a perta`nyer al mateix objecte sema`ntic.
La probabilitat a priori proposada reforc¸a simulta`niament la suavitat local en les seg-
mentacions, alhora que preserva les vores i l’estructura entre classes.
En tercer lloc, es presenta el me`tode HTS per descriure l’heterogene¨ıtat vascular
dels glioblastomas mitjanc¸ant els ha`bitats esmentats. El me`tode HTS s’ha aplicat a
casos reals, tant en una cohort local de pacients d’un sol centre, com en una cohort
retrospectiva internacional de me´s de 180 pacients de 7 centres europeus. Es va dur
a terme una avaluacio´ exhaustiva del me`tode per mesurar el potencial prono`stic dels
ha`bitats, aix´ı com les capacitats d’estratificacio´ dels mateixos per identificar poblaci-
ons amb prono`stics diferents. Es van trobar associacions estad´ısticament significatives
entre la majoria dels ha`bitats HTS i la supervive`ncia global dels pacients, aix´ı com di-
fere`ncies significatives en les taxes de supervive`ncia de sub-poblacions dividides segons
mesuraments derivats de l’HTS.
Finalment, els me`todes i la tecnologia desenvolupats en aquesta tesi s’han integrat
en una plataforma web online d’acce´s pu´blic per al seu u´s acade`mic. La plataforma
ONCOhabitats s’allotja en https://www.oncohabitats.upv.es, i ofereix dos serveis prin-
cipals: 1) segmentacio´ dels teixits del glioblastoma, i 2) avaluacio´ de l’heterogene¨ıtat
vascular dels glioblastomes mitjanc¸ant el me`tode HTS. Ambdo´s serveis, a me´s de les
imatges preprocessades i els mapes de segmentacio´, generen automa`ticament un infor-
me radiolo`gic resumint els descobriments de l’estudi. ONCOhabitats no sols ofereix
a la comunitat cient´ıfica i me`dica acce´s a algorismes de l’estat de l’art per l’ana`lisi
d’aquests tumors, sino´ que tambe´ permet accedir al seu clu´ster computacional, capac¸
de processar prop de 300 casos al dia.
Els resultats d’aquesta tesi han sigut publicats en deu contribucions cient´ıfiques,
incloent revistes i confere`ncies de primer nivell a les a`rees d’Informa`tica Me`dica,
Estad´ıstica i Probabilitat, Radiologia i Medicina Nuclear, Aprenentatge Automa`tic
i Mineria de Dades i Enginyeria Biome`dica. Tambe´ es va emetre una patent in-
dustrial registrada a Espanya (ES201431289A), Europa (EP3190542A1) i els EUA
(US20170287133A1), que representa els esforc¸os d’aquesta tesi per generar actius tan-
gibles a me´s dels me`rits acade`mics obtinguts de les publicacions d’investigacio´. Final-
ment, els me`todes, tecnologies i idees originals concebudes en aquesta tesi van donar
lloc a la creacio´ d’ONCOANALYTICS CDX, una empresa emmarcada en el model de
negoci dels companion diagnostics de compostos farmace`utics, pensat com a vehicle
per facilitar la industrialitzacio´ de la tecnologia ONCOhabitats.
viii
Glossary
Mathematical notation
X Random variable
x Particular realization of the random variable X
p (X) Marginal probability density function of the random variable X
p (X,Y ) Joint probability density function of two random variables X and Y
p (X|Y ) Conditional probability density function of the random variable X conditioned to Y
Θ Vector of parameters of a probability density function
Θˆ Optimal vector of parameters under some optimization criteria
Θ˜ Initial guess of a vector of parameters
p (X; Θ) Probability density function of the random variable X subject to Θ
L (Θ;X) Likelihood function of random variable X given parameter vector Θ
x Column vector x
xT Transpose of x
E [p(X)] Expectation of probability density function p (X)
Ep(Y ) [p(X)] Conditional expectation of probability density function p (X) subject to p (Y )
RD D-dimensional space of real numbers
∂x
∂t Partial derivative of variable x with respect to variable t
Mi Set of neighbors of the ith observation
⊗ Convolution product
δ (·) Dirac delta function
‖ · ‖ Euclidean norm
{·} Set of elements
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Acronyms
AI Artificial Intelligence
AIF Arterial Input Function
ANN Artificial Neural Network
ANTs Advanced Normalization Tools
ASL Arterial Spin Labeling
BDSLab Biomedical Data Science Laboratory
BRATS BRAin Tumor Segmentation
CAE Convolutional AutoEnconder
CBF Cerebral Blood Flow
CBICA Center for Biomedical Image Computing and Analytics
CBV Cerebral Blood Volume
cdf cumulative distribution function
CDSS Clinical Decision Support System
CDx Companion Diagnostic
CNN Convolutional Neural Network
CSF Cerebro-Spinal Fluid
CRF Conditional Random Field
DCAGMRF Directional Class-Adaptive Gauss-Markov Random Field
DCE Dynamic Contrast Enhanced
DCM Dirichlet Compound Multinomial
DL Deep Learning
DSC Dynamic Susceptibility Contrast
DTI Diffusion Tensor Imaging
DWI Diffusion Weighted Imaging
EGFR Epidermal Growth Factor Receptor
EM Expectation-Maximization
ET Enhancing Tumor
FLAIR Fluid Attenuation Inversion Recovery
FMM Finite Mixture Model
x
FSE Fast Spin Echo
GBCA Gadolinium-Based Contrast Agent
GM Grey Matter
GMM Gaussian Mixture Model
HAC Hierarchical Agglomerative Clustering
HAT High Angiogenic Tumor
HMRF Hidden Markov Random Field
HR Hazard Ratio
HTS Hemodynamic Tissue Signature
HUPLF Hospital Universitario y Polite´cnico La Fe
ICBM International Consortium of Brain Mapping
i.i.d. independent and identically distributed
IPE Infiltrated Peripheral Edema
LAT Low Angiogenic Tumor
MAP Maximum A Posteriori
MICCAI Medical Image Computing and Computer Assisted Intervention
ML Machine Learning
MLE Maximum Likelihood Estimation
MLP Multi-Layer Perceptron
MNI Montreal Neurological Institute
MPRAGE Magnetization-Prepared Rapid Acquisition with Gradient Echo
MR Magnetic Resonance
MRF Markov Random Field
MRI Magnetic Resonance Imaging
MRSI Magnetic Resonance Spectroscopy Imaging
MTT Mean Transit Time
NLM Non Local Means
NLSVFMM Non Local Spatially Varying Finite Mixture Model
NMR Nuclear Magnetic Resonance
OS Overall Survival
xi
Glossary
PCA Principal Component Analysis
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Chapter 1
Introduction
1.1 Motivation
Medical imaging has widely proven to be an essential tool for modern medicine. The
ability to non-invasively visualize in-vivo representations of the interior of the hu-
man body constituted an unprecedented breakthrough in the diagnosis, prognosis and
follow-up processes of the diseases (McRobbie et al, 2007). The first medical image
acquisition dates back to 1895 with the discovery of X-rays (Ro¨ntgen, 1898), however it
was not until the end of the 20th century that medical imaging took a qualitative leap
with the development of the MRI (Damadian, 1971; Lauterbur, 1973, 1974; Mansfield,
1977). Over the years, medical imaging has evolved rapidly, reaching sophisticated
techniques capable of quantifying large amounts of information of the anatomy and
functionality of human tissues. Consequently, the analysis of such complex information
has become a specialized discipline that requires advanced computational techniques
to make the most of the knowledge contained therein.
In this context, ML emerges as a solid candidate for medical image analysis. ML
is an application of AI that provides systems the ability to learn and identify complex
patterns in multi-dimensional data, and perform specific tasks without being explicitly
programmed. The beginnings of ML in medical imaging dates back to the middle of
the 20th century with the birth of the expert systems (Russell and Norvig, 2016).
From that moment on, an unstoppable proliferation of ML systems for multitude of
clinical problems took place, reaching its first hype cycle peak at the end of 20th
century. Today, with the advent of the Deep Learning (DL) techniques, medical image
analysis is undergoing a new deep revolution that is settling the ML as an indisputable
instrument in the modern clinical practice.
However, ML has historically addressed medical problems from the perspective
of automatizing arduous complex tasks for humans. Tied to medical imaging, ML
has successfully addressed complicated problems such as identifying and delineating
abnormal tissues in multiple images or classifying and grading lesions from medical
acquisitions (Azuaje, 2019; Levine et al, 2019; Kann et al, 2019). Supervised learning,
which is a family of techniques under the ML umbrella, has led this approach with
unquestionable effectiveness. However, due to its learning nature, supervised learn-
ing is only able to address problems where humans already know the answer (Duda
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et al, 2000). This family of techniques builds models by means of learning the rela-
tions between tuples of 〈input data, desired output〉, which necessarily requires that
all algorithm’s possible outputs are explicitly known. This approach, without under-
estimating its unquestionable usefulness, reduces the ML to an instrument for solving
and automatizing tasks with already well-known targets, with the added value of high
accuracy, repeatability and reliability.
On the contrary, we would like ML to help us to discover new knowledge from
the medical data beyond what humans can devise. At this point unsupervised learn-
ing arises as a tailor-made solution to this purpose. Unsupervised learning, unlike
supervised learning, inspects unlabeled data for hidden patterns and inner relation-
ships that describe the latent structure of the data (Bishop, 2006). This alternative
approach has the intrinsic capability to discover new knowledge from the data in the
form of new hypothesis about the structure and arrangement of the information. In
this sense, unsupervised learning should assume a relevant role in medical imaging and
must drive ML to serve not only as a tool for automating complex processes, but also
as an instrument for exploring and extracting hidden knowledge from medical images.
A canonical example in which the convergence of medical imaging and ML must
be reoriented towards the discovery of new knowledge is the study of highly aggressive
heterogeneous tumors (Rudie et al, 2019; Tandel et al, 2019). Specifically, glioblastoma
tumor represents a major challenge, as it remains a lethal tumor that, to date, lacks a
satisfactory therapy, presenting one of the poorest prognosis among all human cancers,
with a median survival time of 12-15 months despite aggressive treatment (Jain, 2018).
Since the introduction of the Stupp treatment (Stupp et al, 2005) in 2005, there have
been no significant changes in the therapies that have led to an improvement in patient
prognosis. Therefore, the blockbuster model of “the same treatment for all” is consid-
ered to be depleted. In this regard, efforts today must be placed into the extraction
of new knowledge from medical data that allow us to move towards new personalized
more effective therapies.
One of the reasons believed to be behind this tumor’s malignancy is its highly het-
erogeneous nature (Soeda et al, 2015). Glioblastomas are malignant masses character-
ized by hyper-cellularity, pleomorphism, micro-vascular proliferation and high necrosis
mitotic activity (Gladson et al, 2010). Particularly, vascular heterogeneity has been
largely studied since it is considered crucial for glioblastoma propagation and survival
(Das and Marsden, 2013). Glioblastoma presents strong abnormal vascular prolifer-
ation, robust angiogenesis, and extensive micro-vasculature heterogeneity (Kargiotis
et al, 2006), which have been shown to have a direct effect on prognosis (Hardee and
Zagzag, 2012). Therefore, the early assessment of the heterogeneous vascular architec-
ture of the tumor is thought to provide important information to improve and design
new therapies.
However, measuring vascular heterogeneity from medical images is currently an
uncertain task. There is no a consensus nor an accepted method to assess it. Conse-
quently, there are no imaging protocols nor tools that includes such information in the
clinical routine, hence ignoring this valuable knowledge in the management of the dis-
ease. Likewise, there are no expert manual annotations nor medical imaging datasets
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from where supervised ML algorithms can learn models. Such an undefined problem
provides an excellent opportunity to apply unsupervised learning as an instrument for
exploring new knowledge about the vascular profile of the tumor.
This thesis confronts all the factors mentioned above. The thesis focuses on the
conjugation of unsupervised ML techniques on medical imaging data to non-invasively
measure and describe the vascular heterogeneity of glioblastomas. This premise has es-
tablished the main motivation and goals of this thesis, leading to the following research
questions and objectives.
1.2 Research questions and objectives
The application of unsupervised ML techniques to medical images for brain tumor anal-
ysis poses a number of challenges that need to be addressed. First of all, by definition,
unsupervised learning is a more open and undefined task than supervised learning.
Unlike the latter, unsupervised learning solutions generally lack of semantic meaning.
On the contrary, they usually consist of an interpretation of the data structure in terms
of subgroups that share similar patterns with each other. Therefore, these algorithms
require intelligent strategies, both during training and in the posterior analysis of the
solution, to guide them towards the extraction of useful, consistent and interpretable
knowledge.
Tied to the characterization of the vascular heterogeneity of glioblastomas, un-
supervised learning methods need to be guided to find hidden patterns in perfusion
medical images that are consistent with physiologically plausible hypotheses. In this
sense, these unsupervised methods must serve not only as a mere algorithms for the
characterization of the vascular profile of the tumor, but to tools to measure advanced
imaging biomarkers that could give clues about the underlying physiological process
taking place in the tumor.
Under a more technical point of view, learning patterns from imaging data also
poses important challenges that must take into a account. Imaging data presents
patterns of local regularity and spatial redundancy that suggest that they cannot be
assumed to be independent and identically distributed (i.i.d.). Robust image analysis
algorithms - both supervised and unsupervised learning - must consider this structured
nature of the images and must include mechanisms to take advantage from this latent
information.
As a consequence the next research questions are proposed in this thesis:
RQ1 Is unsupervised learning an adequate and reliable solution to extract valuable
knowledge from complex MRI data?
RQ2 Can we contribute to the unsupervised learning family with new structured pre-
diction algorithms to improve the extraction of knowledge from images?
RQ3 Can we contribute to a better understanding of the vascular heterogeneity of the
glioblastoma by means of an advanced analysis of MRI through unsupervised
learning methods?
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RQ4 Can useful measurements be obtained from the vascular heterogeneity description
of glioblastoma that provide meaningful information on relevant patient’s clinical
outcomes?
RQ5 Can the unsupervised learning method to describe the vascular heterogeneity of
glioblastomas be part of a medical imaging software for a complete analysis of
the tumor through MRI?
The research work conducted in this thesis aims to provide solutions to these ques-
tions by means of theoretical and empirically validated scientific methods applied to
the study of the vascular heterogeneity of glioblastomas by MRI. To this end the
following objectives were defined:
O1 Review of the state-of-the-art in unsupervised learning algorithms, especially fo-
cused on image oriented algorithms and paying special attention to those applied
to the analysis of brain tumor MRI images.
O2 Evaluate the feasibility of unsupervised learning algorithms to analyze and ex-
tract knowledge from MRI data.
O3 Develop a new unsupervised learning algorithm to exploit the structured na-
ture of the images and take advantage from the spatial redundancy and local
information contained therein.
O4 Develop a methodology based on image processing and unsupervised learning
algorithms to detect and describe the vascular heterogeneity of glioblastoma
through MRI.
O5 Validate the vascular heterogeneity assessment method on real clinical routine
MRI, by exploring associations between the proposed heterogeneity description
and relevant clinical outcomes of the patient.
O6 Implement a reliable tool capable of providing an advanced state-of-the-art anal-
yses for glioblastoma MRI studies, including the methods to describe the vascular
heterogeneity profile of the tumor.
The proposed objectives enclose the main goal of this thesis: the study of unsu-
pervised ML techniques for medical imaging data to non-invasively describe the vascu-
lar heterogeneity of glioblastomas. Such goal can also be decomposed in two strands
depending on the research scope: the technical goal, which aims to consolidate the
unsupervised learning as a reliable tool for the future of medical image analysis; and
the clinical goal, which intends to non-invasively describe the vascular heterogeneity of
glioblastoma trough MRI to improve tumor understanding and clinical decision mak-
ing. In this sense, the following scientific contributions support the achievement of the
proposed objectives.
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1.3 Thesis contributions
This section presents the main contributions of this thesis. First, a summary of the
most relevant aspects of each contribution is presented. Next, the scientific publications
in high impact journals and conferences are listed. Finally, the technological and
software results, as well as clinical studies, industrial patents and transfer actions are
compiled.
1.3.1 Main contributions
C1 - Comparative study of unsupervised learning algorithms for glioblas-
toma segmentation
In this study, a comparison of unsupervised learning algorithms, including struc-
tured and non-structured methods was performed for the task of high grade
glioma segmentation. The study describes the statistical model underlying each
algorithm and also proposes a general post-processing stage to identify which
classes of an unsupervised segmentation correspond to pathological or healthy
tissues. An independent evaluation of the performance of the unsupervised learn-
ing algorithms was carried out in a public real dataset, which demonstrated the
capability of unsupervised learning to extract relevant knowledge from MRI data.
This work was published in the journal contribution P1 (Juan-Albarrac´ın et al,
2015b) and presented in the conference P2 (Juan-Albarrac´ın et al, 2015a).
C2 - An unsupervised learning algorithm for structured prediction
A new variant of the Spatially Varying Finite Mixture Models (SVFMMs) family
is proposed in this thesis. The algorithm, named Non Local Spatially Varying
Finite Mixture Model (NLSVFMM), successfully merges the SVFMMs with the
Non Local Means (NLM) framework, proposing a continuous Markov Random
Field (MRF) that simultaneously enforces smooth constraints in homogeneous re-
gions of the image while preserves the edges and structures without degradation.
This approximation improves the existing approaches in terms of complexity of
the model, as the NLM weighting function does not introduce additional param-
eters into the model to be estimated. Moreover, it outperforms current methods
in terms of performance in a segmentation task of real world images. This work
was published in the journal contribution P3 (Juan-Albarrac´ın et al, 2019b).
C3 - A method for the vascular heterogeneity assessment of glioblastoma
The Hemodynamic Tissue Signature (HTS) method analyzes the perfusion MRI
of a glioblastoma using an unsupervised learning approach to delineate four
habitats within the lesion that exhibit different hemodynamic activity. The
habitats describe the High Angiogenic Tumor (HAT) and Low Angiogenic Tu-
mor (LAT) regions of the glioblastoma, and the potentially Infiltrated Periph-
eral Edema (IPE) and Vasogenic Peripheral Edema (VPE) of the lesion. Such
approximation establishes a conceptual frame for the description of the tumor
heterogeneity by means of the detection of clinically relevant sub-regions, a.k.a
habitats, with differentiated imaging biomarkers. The preliminar results of this
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work were first presented in the conference contribution P4 (Juan-Albarrac´ın
et al, 2016) and it was finally published in the journal contribution P5 (Juan-
Albarrac´ın et al, 2018).
C4 - Preliminary validation of the vascular heterogeneity assessment method
on a local cohort of glioblastomas
A preliminary validation study was performed to assess the association of the
HTS habitats with relevant clinical outcomes. Specifically, measurements on the
distributions of the hemodynamic biomarkers confined at each HTS habitat were
explored for potential correlations and predictive capabilities with the overall sur-
vival of the patients. Additionally, a technical study was conducted to measure
the degree of dissimilarity between these distributions, in order to confirm the
physiological differences of the hemodynamic activity of the habitats. Results
on a real cohort from a local hospital were published in the journal articles P5
(Juan-Albarrac´ın et al, 2018) and P6 (Fuster-Garcia et al, 2018).
C5 - International retrospective multicenter clinical study for validating
the vascular heterogeneity assessment method
The relevant findings obtained in the experiments for the preliminary validation
of the aforementioned vascular heterogeneity assessment method led us to initiate
an international multi-center validation study of the technology. This constituted
the first clinical study in which the Universitat Polite`cnica de Vale`ncia (UPV) was
sponsor. The clinical study was formally registered in the ClinicalTrial.gov plat-
form from the U.S. National Library of Medicine with identifier NCT03439332,
as seen in contribution CS. It consists of a multi-center observational retrospec-
tive study with data collected from 7 international hospitals, with a total of 305
patients enrolled since 1st of January of 2012 until February of 2018. Results
obtained with this large heterogeneous cohort of untreated glioblastomas were
published in the journal contribution P7 (A´lvarez Torres et al, 2019), consoli-
dating the previous findings about the predictive potential of the habitats.
C6 - An online open-access system for glioblastoma MRI analysis
This contribution consists of the development of a web-based system for the
analysis of glioblastomas by means of MRI. The system, named ONCOhabitats
(https://www.oncohabitats.upv.es), provides free access to all the methods de-
veloped and validated in this thesis, but also to other state-of-the-art algorithms
in the field of medical image analysis, to offer a complete solution for the study of
glioblastoma from raw unprocessed MRI. ONCOhabitats implements two main
services to describe the morphological and vascular heterogeneity of the glioblas-
toma, generating for each service an automated LATEX-based report summarizing
all the findings of the study. The details of the system were presented in the
journal contribution P8 and conference contribution P9, and the software was
registered in the technological catalogue of the UPV, as shown in contributions
S1 and S2.
C7 - An industrial patent for generating multi-parametric nosological im-
ages
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In addition to the scientific and academic contributions, the methods, tech-
nologies and original ideas conceived in this thesis were protected under the
international patent mentioned in contribution PT. The patent issued “Method
and system for generating multi-parametric nosological images” was registered in
Spain (ES201431289A), with the added value of being evaluated with previous
exam; was extended to the European (EP3190542A1) territory and United States
(US20170287133A1) through the Patent Cooperation Treaty (PCT) programme.
The patent protects a method to produce nosological images from multiple med-
ical image acquisitions, with the aim of facilitating the diagnosis and treatment
of diseases. In this sense, this thesis has contributed not only with advances in
knowledge in the fields of ML and medical imaging, but with a technological
asset of high value for the UPV, which opens the door to transfer actions for the
creation of new business opportunities.
C8 - Foundation of the ONCOANALYTICS CDX, S.L. company
The issuance of the patent led us to participate in two of the most cutting-edge
national programmes for the generation of business models and new start-ups
in the field of healthcare technologies. The author of this thesis, together with
the advisors, participated in the EIT Health Headstart Proof of Concept 2016
programmme, in which we were awarded the best Proof of Concept Spain for
a technology-based start-up; and in the CaixaImpulse acceleration programme
for facilitating entrepreneurship in biomedicine. Such mentoring activities fi-
nally led to the foundation of ONCOANALYTICS CDX, S.L. in 2018, with the
commercial name Texture CDx, as shown in contribution TR. The company was
framed into the business model of companion diagnostics for pharmaceutical com-
pounds, with the aim of using the aforementioned vascular heterogeneity assess-
ment technology to help in the stratification of patients affected by glioblastoma
during the clinical trial of a drug. ONCOANALYTICS CDX was established by
a multi-disciplinary team made up of computer scientists, physicists, oncologists,
biomedical engineers and financial experts, including 6 UPV graduates and 4
Phd, thus contributing to the generation of professional opportunities for highly
qualified personnel.
The work developed in this thesis has been framed in several national research
projects, one of which has obtained the A+ rating, i.e. the best rating available. This
has made it possible to raise public funds, new research projects and doctoral grants
that have consolidated the research line in the Biomedical Data Science Laboratory
(BDSLab) of the UPV.
1.3.2 Scientific publications
The scientific contributions of this thesis have been published in six scientific top-
ranked journals and five conference proceedings in the fields of Machine Learning,
Statistics and Probability, Radiology & Nuclear Medicine, Medical Imaging and Biomed-
ical Data Mining. The publications are listed as follows:
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P1 - Javier Juan-Albarrac´ın, Elies Fuster-Garcia, Jose´ V. Manjo´n, Montserrat Robles, F.
Aparici-Robles, L. Mart´ı-Bonmat´ı and Juan M. Garc´ıa-Go´mez. ‘Automated Glioblas-
toma Segmentation Based on a Multiparametric Structured Unsupervised Classifica-
tion’. PLoS One; 2015; 10(5):e0125143. May 2015. (Juan-Albarrac´ın et al, 2015b).
IF: 3.057 (JCR 2015): 11/63 Multi-disciplinary sciences (Q1).
P2 - Javier Juan-Albarrac´ın, Elies Fuster-Garcia and Juan M. Garc´ıa-Go´mez. ‘Hier-
archical Tissue-Guided Glioblastoma Segmentation based on DCA-SVFMM’. II Inter-
national Symposium on Clinical and Basic Investigation in Glioblastoma. GBM2015.
3(1):101. Toledo, Spain. September 2015. (Juan-Albarrac´ın et al, 2015a).
P3 - Javier Juan-Albarrac´ın, Elies Fuster-Garcia and Juan M. Garc´ıa-Go´mez. ’Non-
Local Spatially Varying Finite Mixture Models for Image Segmentation’. Statistics and
Computing; September 2019; Accepted for publication. (Juan-Albarrac´ın et al, 2019b).
IF: 2.383 (JCR 2018): 16/123 Statistics & Probability (Q1), 31/105 Computer Science,
Theory & Methods (Q2).
P4 - Javier Juan-Albarrac´ın, Elies Fuster-Garcia and Juan M. Garc´ıa-Go´mez. ‘An on-
line platform for the automatic reporting of multi-parametric tissue signatures: A case
study in Glioblastoma’. In: Crimi A., Menze B., Maier O., Reyes M., Winzeck S.,
Handels H. (eds) Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain
Injuries. BrainLes 2016. Lecture Notes in Computer Science, vol 10154. Springer,
Cham. Athens, Greece. October 2016. (Juan-Albarrac´ın et al, 2016).
P5 - Javier Juan-Albarrac´ın, Elies Fuster-Garcia, Alexandre Pe´rez-Girbe´s, F. Aparici-
Robles, A´ngel Alberich-Bayarri, Antonio Revert-Ventura, L. Mart´ı-Bonmat´ı and Juan
M. Garc´ıa-Go´mez. ‘Glioblastoma: Vascular Habitats Detected at Preoperative Dy-
namic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Predict Sur-
vival’. Radiology; 2018; 287(3):944-954. Jun 2018. (Juan-Albarrac´ın et al, 2018).
IF: 7.608 (JCR 2018): 4/129 Radiology, Nuclear Medicine & Magnetic Resonance
Imaging (Q1).
P6 - Elies Fuster-Garcia, Javier Juan-Albarrac´ın, Germa´n A. Garc´ıa-Ferrando, L. Mart´ı-
Bonmat´ı, F. Aparici-Robles and Juan M. Garc´ıa-Go´mez. ‘Improving the estimation of
prognosis for glioblastoma patients by MR based hemodynamic tissue signatures’. NMR
in Biomedicine; 2018; 31(12):e4006. December 2018. (Fuster-Garcia et al, 2018).
IF: 3.414 (JCR 2018): 5/41 Spectroscopy (Q1), 30/129 Radiology, Nuclear Medicine
& Magnetic Resonance Imaging (Q1), 22/73 Biophysics (Q2).
P7 - Mar´ıa Del Mar A´lvarez-Torres and Javier Juan-Albarrac´ın and Elies Fuster-Garcia
and Fuensanta Bellv´ıs-Bataller and David Lorente and Gaspar Reyne´s and Jaime Font
de Mora and Fernando Aparici-Robles and Carlos Botella and Jose Mun˜oz-Langa and
Raquel Faubel and Sabina Asensio-Cuesta and Germa´n A. Garc´ıa-Ferrando and Ed-
uard Chelebian and Cristina Auger and Jose Pineda and Alex Rovira and Laura Oleaga
and Enrique Molla`-Olmos and Antonio J. Revert and Luaba Tshibanda and Giro-
lamo Crisi and Kyrre E. Emblem and Didier Martin and Paulina Due-Tønnessen and
Torstein R. Meling and Silvano Filice and Carlos Sa´ez and Juan M Garc´ıa-Go´mez.
‘Robust association between vascular habitats and patient prognosis in glioblastoma: an
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international retrospective multicenter study’. Journal of Magnetic Resonance Imaging;
2019; 31(12):e4006. October 2019. (A´lvarez Torres et al, 2019).
IF: 3.732 (JCR 2018): 26/129 Radiology, Nuclear Medicine & Magnetic Resonance
Imaging (Q1).
P8 - Javier Juan-Albarrac´ın, Elies Fuster-Garcia, Germa´n A. Garc´ıa-Ferrando and Juan
M. Garc´ıa-Go´mez. ‘ONCOhabitats: A system for glioblastoma heterogeneity assess-
ment through MRI’. International Journal of Medical Informatics; 2019; 128():53-61.
August 2019. (Juan-Albarrac´ın et al, 2019a).
IF: 2.731 (JCR 2018): 57/155 Computer Science and Information Systems (Q2), 28/98
Healthcare Sciences & Services (Q2), 11/26 Medical Informatics (Q2).
P9 - Javier Juan-Albarrac´ın, Elies Fuster-Garcia and Juan M. Garc´ıa-Go´mez. ‘MT-
Simaging: multiparametric image analysis services for vascular characterization of
glioblastoma’. The European Society of Magnetic Resonance in Medicine and Biology
Congress. ESMRMB 2017. 30 (Suppl 1): S501–S692. Barcelona, Spain. October 2017.
(Juan-Albarrac´ın et al, 2017).
P10 - Javier Juan-Albarrac´ın, Elies Fuster-Garcia and Mar´ıa del Mar A´lvarez-Torres and
Eduard Chelebian and Juan M. Garc´ıa-Go´mez. ‘ONCOhabitats glioma segmentation
model’. In: Crimi A., Menze B., Maier O., Reyes M., Winzeck S., Handels H. (eds)
Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries. Brain-
Les 2019. Lecture Notes in Computer Science, vol 10154. Springer, Cham. Shenzhen,
China. October 2019. (Juan-Albarrac´ın et al, 2019c).
P11 - Juan Ortiz-Pla, Elies Fuster-Garcia, Javier Juan-Albarrac´ın and Juan M. Garc´ıa-
Go´mez. ‘GBM Modeling with Proliferation and Migration Phenotypes: A Proposal
of Initialization for Real Cases’. In: Tsaftaris S., Gooya A., Frangi A., Prince J.
(eds) Simulation and Synthesis in Medical Imaging. SASHIMI 2016. Lecture Notes
in Computer Science, vol 9968. Springer, Cham. Athens, Greece. October 2016.
(Ortiz-Pla et al, 2016).
1.3.3 Software
The research conducted in this thesis has led to the creation of ONCOhabitats platform
(https://www.oncohabitats.upv.es). ONCOhabitats is an online professional system
for glioblastoma analysis using MRI, which encapsulates all the original methods and
algorithms developed in this thesis, and several state-of-the-art algorithms for medical
image analysis. Preliminary versions of some methods of ONCOhabitats were first
registered in the technological catalogue of the UPV under the acronym CURIAM
BT+, while the final updated complete version of the ONCOhabitats system has been
recently registered as an asset of high value for the technological offer of the UPV.
S1 - Javier Juan-Albarrac´ın, Elies Fuster-Garcia, Juan M. Garc´ıa-Go´mez, Carlos Sa´ez,
Montserrat Robles and Miguel Esparza. ‘R-16874-2014 - Caracterizacio´n de firmas
biolo´gicas de glioblastomas (CURIAM BT+)’. CARTA Registry of the Universitat
Polite`cnica de Vale`ncia. 28/02/2014.
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S2 - Javier Juan-Albarrac´ın, Elies Fuster-Garcia, Juan M. Garc´ıa-Go´mez. ‘R-XXXXX-
2019 - Deteccio´n de ha´bitats para evaluacio´n de heterogeneidad biolo´gica de glioblas-
tomas (ONCOhabitats)’. CARTA Registry of the Universitat Polite`cnica de Vale`ncia.
In process.
1.3.4 Clinical studies
The aforementioned ONCOhabitats platform is currently enrolled in an international
multicenter observational restrospective clinical study registered at ClinicalTrials.gov
from the U.S. National Library of Medicine. The aim of the study is to validate the
prognostic capabilities of the HTS habitats for patients affected with glioblastoma. To
this end, the primary and secondary outcomes fixed for the clinical study are: the
“correlation between overall survival and progression-free survival (in days) of patients
undergoing standard-of-care treatment and the tumor vascular heterogeneity described
by the four habitats obtained by the HTS biomarker”. The clinical study involves data
collected from 7 international hospitals, with a total of 305 patients recruited since 1st
of January of 2012 until February of 2018.
CS - Multicenter Retrospective Observational Clinical Study NCT03439332. ‘Multicen-
tre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of
the Patient With Glioblastoma (ONCOhabitats)’. https://clinicaltrials.gov/ct2/show/
NCT03439332. Universitat Polite`cnica de Vale`ncia (UPV). 20/02/2018.
1.3.5 Patents
The know-how in medical image analysis generated by the author in this thesis was
protected under the international patent “Method and system for generating multi-
parametric nosological images”. The patent is currently registered in Spain (ES201431289A)
with previous exam, and was extended to Europe (EP3190542A1) and United States
(US20170287133A1) following the PCT procedure for patent internationalization. It
describes a procedure based on multi-parametric medical images to generate nosologi-
cal masks capable of describing the underlying physiological processes taking place in
the lesion. The patent materializes the interest that the scientific research conducted
in this thesis has originated in both the academic and business spheres. Moreover,
it represents the efforts of this thesis to generate tangible assets for a later phase of
business development.
PT - Javier Juan-Albarrac´ın, Elies Fuster-Garcia, Juan M. Garc´ıa-Go´mez, Miguel Esparza-
Manzano, Jose V. Manjo´n-Herrra, Monserrat Robles-Viejo, Carlos Sa´ez. ‘Method
and system for generating multi-parametric nosological images’. Asignee: Universi-
tat Polite`cnica de Vale`ncia (UPV).
ES201431289A: Oficina Espan˜ola de Patentes y Marcas. 05/09/2014. Legal status:
Active.
EP3190542A4: European Patent Office. PCT/ES2015/070584. 28/07/2015. Legal
status: Active.
US9990719B2: United States Patent and Trademark Office. PCT/ES2015/070584.
28/07/2015. Legal status: Active.
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1.3.6 Transference
The experience, knowledge and original ideas conceived in this thesis, together with
the issuance of the patent, aroused the author’s interest in taking a step beyond the
academic field. This led the author and the thesis advisors to the conceptualization of
a business plan to capitalize the results obtained in the thesis. In this sense, we partic-
ipated in the EIT Health Headstart Proof of Concept 2016 programmme, in which we
were awarded the best business plan for a biotech start-up; and in the CaixaImpulse
programme for facilitating entrepreneurship in biomedicine. The experience obtained
in these programmes in conjunction with the background of the advisors in generat-
ing spin-offs of the UPV, finally led to the foundation of ONCOANALYTICS CDX
company. ONCOANALYTICS CDX is formed by a multi-disciplinary team made up
of computer scientists, physicists, oncologists, biomedical engineers and financial ex-
perts, with a total of 6 UPV graduates and 4 Phd. Supported by the aforementioned
ONCOhabitats platform, the company is focused in developing image-based CDx for
glioblastoma, to facilitate patient stratification during the clinical trial of a drug.
PT - Javier Juan-Albarrac´ın, Elies Fuster-Garcia, Juan M. Garc´ıa-Go´mez, Germa´n A.
Garc´ıa-Ferrando, Carlos Vidal-Trujillo, Jose´ Mun˜oz-Langa, David Lorente-Estelle´s,
Ana Gonza´lez-Segura, Fuensanta Bellv´ıs-Bataller. ‘ONCOANALYTICS CDX S.L.’.
Commercial name: Texture CDx. CIF: B98981889. 01/03/2018.
1.4 Projects and partners
During the development of this thesis the author has actively participated in several
national, European and private research projects in collaboration with several hospitals
and clinical institutions. The projects related to this thesis are listed below:
CURIAM BT+ Caracterizacio´n de firmas biolo´gicas de glioblastomas mediante
modelos no-supervisados de prediccio´n estructurada basados en biomarcadores de im-
agen. Funded by the Spanish Ministry of Economy and Competitiveness (TIN2013-
43457-R, 2014-2016).
Objectives: This project aims to develop a computational medical imaging system
to obtain radiological profiles of the different areas of the tumor, to accurately measure
the vascular properties of the glioblastoma. Such profiles will also provide information
about the tumor grading and the expected survival of the patient.
Partners: Biomedical Data Science Laboratory (BDSLab)-ITACA group of the
Universitat Polite`cnica de Valencia (Valencia, Spain). Hospital Universitario y Polite´cnico
La Fe (HUPLF) (Valencia, Spain).
MTS4Up Biomarcadores dina´micos basados en firmas tisulares multiparame´tricas
para el seguimiento y evaluacio´n de la respuesta a tratamiento de pacientes con glioblas-
toma y ca´ncer de pro´stata. Funded by the Spanish National Research Agency (DPI2016-
80054-R, 2017-2018).
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Objectives: This project extends the TIN2013-43457-R project by improving the
technology to obtain radiological signatures of the glioblastoma incorporating diffusion
MRI to describe not only tumor vascularity, but also the cell density properties of the
tissues. Such improvements will allow an early evaluation of tumor progression and
an accurate assessment of the patient’s response to treatment. Finally, the technology
will also be evaluated on other pathologies such as prostate tumor to measure the
versatility of the methodology in other solid tumors.
Partners: Biomedical Data Science Laboratory (BDSLab)-ITACA group of the
Universitat Polite`cnica de Valencia (Valencia, Spain).
GLIO-MARKERS Estudio integrado de biomarcadores moleculares y de imagen
en pacientes con glioblastoma. Funded by the Universitat Polite`cnica de Vale`ncia and
Hospital Universitario y Polite´cnico La Fe (Prueba de Concepto 2015, UPV-FE-15-B,
2015-2016).
Objectives: This project aims to combine and integrate the analysis of glioblas-
toma biomarkers from three different physiological areas: blood circulating proteins,
immunohistologic biomarkers and MRI biomarkers. The purpose is to develop predic-
tive models for response to treatment assessment and measuring tumor progression, as
well as finding correlations between imaging biomarkers and circulating proteins.
Partners: Biomedical Data Science Laboratory (BDSLab)-ITACA group of the
Universitat Polite`cnica de Valencia (Valencia, Spain), Universitat Polite`cnica de Vale`ncia
(UPV) (Valencia, Spain).
DSSRADIOPLAN Inclusio´n de las tecnolog´ıas de firma tisular y modelos muti-
escala para el soporte a la planificacio´n de la radioterapia en el tratamiento del glioblas-
toma. Funded by the Universitat Polite`cnica de Vale`ncia and Hospital Universitario y
Polite´cnico La Fe (Prueba de Concepto 2016, UPV-FE-16-B, 2016-2017).
Objectives: The main purpose of this project is to plan and carry out the necessary
actions to evaluate the applicability and added value of the HTS technology to provide
clinical decision support in the management and planning of radiotherapy in patients
affected by glioblastoma.
Partners: Biomedical Data Science Laboratory (BDSLab)-ITACA group of the
Universitat Polite`cnica de Valencia (Valencia, Spain), Universitat Polite`cnica de Vale`ncia
(UPV) (Valencia, Spain).
MULTIBIOIM Multiparametric nosological images for supporting clinical decisions
in solid tumors. Funded by the EIT Health E.V. (Proof of Concept 2016, POC-2016-
SPAIN-07, 2016-2017).
Objectives: This project aims to develop a Proof of Concept (PoC) of the patented
procedure ES201431289A for generation of multiparametric tissue signatures based on
structural and functional MRI for solid tumors. This PoC aims to solve specific tech-
nical, strategical, legal, and commercial barriers to generate a reliable business model
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for the medical image analysis software market and convert a cutting-edge technology
into a clinically validable product.
Partners: BDSLab-ITACA group of the Universitat Polite`cnica de Valencia (Va-
lencia, Spain).
The projects on which the author was involved in previously and in parallel to the
development of this thesis are listed as follows:
DQV-MINECO Servicio de evaluacio´n y rating de la calidad de repositorios de
datos biome´dicos. Funded by the Spanish Ministry of Economy and Competitiveness
(Retos-Colaboracio´n 2013 programme, RTC-2014-1530-1, 2013-2016).
Objectives: This project aims to define a data quality evaluation and rating
service to assure the data value aimed to its reuse in clinical, strategic and scientific
decision making. It will be based on two software services. The first will evaluate nine
data quality dimensions. The second will generate a data quality rating positioning
the evaluated datasets according to several reuse knowledge extraction purposes.
Partners: VeraTech for Health S.L. (Valencia, Spain) and IBIME-ITACA group
of the Universitat Polite`cnica de Valencia, (Spain)
HELP4MOOD A Computational Distributed System to Support the Treatment of
Patients with Major Depression. Funded by the European Commission. VII Frame-
work Program (FP7-ICT-2009-4; 248765, 2011-2013).
Objectives: This project focuses on major depression disease. Patients with major
depression typically recover through antidepressant drugs, psychological therapy or
hospitalization. However, it has been shown that in many situations such recovery is
either slow or incomplete. Research shows that psychological therapies can be delivered
effectively without face to face contact at individual’s home by computerized cognitive
behavioral therapy. The project aims to advance the state-of-the-art in computerized
support for people with major depression by monitoring mood, thoughts, physical
activity and voice characteristics, by means of intelligent systems based on virtual
agent.
Partners: BDSLab-ITACA group of the Universitat Polite`cnica de Valencia, (Spain),
University of Edinburgh (United Kingdom), Fundacio´ I2CAT (Spain), Universitatea
Babes Bolyai (Romania), FVA SAS di Louis Ferrini (Italy), OBS Medical Ltd. (Italy),
Universitat Polite`cnica de Catalunya, (Spain), Heriot-Watt University (United King-
dom).
1.5 Thesis outline
The thesis is structured in eight chapters that thoroughly describe the research work
carried out during the thesis. The Chapter 1 has introduced the motivations, research
objectives and main contributions. Chapter 2 describes the thesis rationale, intro-
ducing the clinical problems addressed as well as the theoretical background needed to
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complement the description of the methods developed in the thesis. Chapter 3 presents
a preliminary study on the viability of the unsupervised learning paradigm to identify
and delineate pathological tissues in glioblastomas based on MRI patterns. Chapter 4
presents the mathematical development of a new unsupervised structured learning algo-
rithm for image segmentation, and a comparison of its performance against alternative
approaches. Chapter 5 introduces the HTS method: an unsupervised learning method
based on perfusion MRI to delineate vascular habitats within the glioblastoma to assess
its vascular heterogeneity. An study on the association of the vascular habitats and the
patient OS is presented. Chapter 6 describes the international multi-center validation
of the HTS method, under the framework of the observational retrospective clinical
study NCT03439332. The validation of the association of the vascular habitats and the
patient OS, as well as the stratification capabilities of the HTS habitats is presented.
Chapter 7 presents ONCOhabitats platform (https://www.oncohabitats.upv.es). ON-
COhabitats encapsulates all the work conducted in this thesis in a public open-access
platform, offering medical image analysis services to analyze both the morphological
and vascular heterogeneity of the glioblastoma. Finally, chapter 8 ends this disserta-
tion with the concluding remarks and recommendations to continue with the research
developed in this thesis.
Figure 1.1 outlines the thesis contributions structured among the thesis chapters,
along with the publications, research projects, transfer actions, patents and the soft-
ware developed during this study.
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Chapter 2
Rationale
This chapter describes the thesis rationale divided in five sections. First, the glioblas-
toma tumor is introduced, describing its epidemiology, etiology, biologic behavior,
morphological features, diagnosis and treatment. Second, MRI technique is disclosed,
illustrating their physical mechanisms, theoretical foundations and acquisition proto-
cols and sequences. Third a general review on the theoretical background probabil-
ity and statistical parameters estimation recommended for the understanding of the
methods developed in the thesis is provided. Fourth, an in-depth explanation of Finite
Mixture Model and Spatially Varying Finite Mixture Model and their parameter esti-
mation is presented to lay the foundation for many of the methods developed in this
thesis. Finally, a general review of the DL paradigm, as well as a revision of Artificial
Neural Networks, Convolutional Neural Networks and the back-propagation mechanics
is provided. This review is intended to establish a common basis to complement the
descriptions of background and methods explained in the following chapters.
2.1 Glioblastoma
The first recorded clinical report identifying glioblastoma as a tumor originating from
neuroglial cells dates back to 1863 by Virchow (2018). Since then, enormous progress
has been made in the understanding of this neoplasm thanks to an exhaustive multi-
disciplinary research in the clinical, pathological, radiological, molecular and genetic
aspects of the tumor. Such efforts have led nowadays to a detailed description of the
glioblastoma that has given us crucial, but still not sufficient, information to design
successful treatments for this disease.
Glioblastoma is a grade IV World Health Organization (WHO) deadly primary
brain tumor considered the most aggressive neoplasm of the central nervous system. It
is the most frequent and malignant astrocytoma in humans, accounting for more than
60% of all brain tumors in adults. Glioblastoma has a global incidence of 4.67 to 5.73
per 100000 people and presents a poor prognosis of 14-15 months despite aggressive
treatments. Although it can debute at any age, more than the 70% of the cases are
seen in patients between the ages of 45 and 70. Likewise, the incidence in males is
1.6 higher than in females and it is 2 times higher in Caucasians than in other races
(Tamimi and Juweid, 2017).
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Glioblastomas are infiltrative and deeply invasive heterogeneous masses character-
ized by hypercellularity, pleomorphism, microvascular proliferation and high necrosis
mitotic activity (Gladson et al, 2010). Typically, glioblastoma exhibits diffuse mar-
gins with co-existence of different tissues including active tumor, cysts, necrosis and
edema; all of them exhibiting a high variability related to the aggressiveness of the
neoplasm (Hardee and Zagzag, 2012). Strong vascular proliferation, robust angiogen-
esis, and extensive microvasculature heterogeneity are major pathological hallmarks
that differentiate glioblastomas from low-grade gliomas (Kargiotis et al, 2006).
Figure 2.1: Macroscopic example of glioblastoma. Image taken with kind permission from https:
//webpath.med.utah.edu/CNSHTML/CNS136.html
Figure 2.1 shows an example of a brain affected by glioblastoma. Note the deep
invasive ability of the tumor, evidenced by the tumor foci crossing the midline towards
the opposite hemisphere of the largest mass.
Heterogeneity has therefore been considered crucial to understand the aggressive-
ness of this tumor and its resistance to effective therapies. Glioblastoma heterogeneity
manifests itself at both macroscopic and microscopic levels. At the macroscopic level,
co-existance of an amalgam of blended malignant tissues including enhancing tumor,
non-enhancing tumor, hemorrhage, cyst, inflammation, necrosis or edema, results in
a chaotic mass highly complicated to manage clinically. At the microscopic level,
different glioblastoma molecular sub-types and genetic alterations have been discov-
ered in the past years. In 2010, Verhaak et al (2010) established a classification for
glioblastoma into four sub-types associated to mutations in EGFR, TP53, NF1 and
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PDGFRA/IDH1 genes: the classical, mesenchymal, neural and proneural sub-types.
The main characteristics of these tumor sub-types are summarized in Table 2.1.
Table 2.1: Summary of the most relevant characteristics of Verhaak glioblastoma subtypes classifica-
tion. * LOH: Loss of heterozygosity.
CLASSICAL MESENCHYMAL
• High EGFR (97%)
• Lack of TP53 mutations
• Chromosome 7 amplification with
LOH* chromosome 10
• CDKNA2 deletion (94%)
• High Notch and Sonic Hedgehog
markers
• Patients survive longest given ag-
gressive treatment
• Focal deletions at 17q11.2
• Mutated NF1 (70%)
• Mutated TP53
• Mutated PTEN
• Expression of CH13L1 marker
• Expression of MET marker
• Higher activity of astrocytic
markers (CD44 and MERTK)
• Increased NF-kB pathway
PRONEURAL NEURAL
• Altered PDGFRA
• Point mutations at IDH1 (93%)
• TP53 LOH (67%)
• Lesser chromosome 7 amplifica-
tion with LOH chromosome 10
• Focal amplifications at 4q12
(higher than other subtypes)
• Expression of oligodendrotytics
genes
• Neuron markers (NEFL,
GABRA1, SYT1, SLC12A5)
• Few (75%) has normal cells in
pathology slides
• Association with oligodendrocytic
and astrocytic differentiation but
mostly express neuron markers
In 2016, the WHO revisited the official classification for glioblastoma sub-types, dis-
tinguishing between two groups: the IDH-wildtype (90% of cases) and the IDH-mutant
(10% of cases), which are closely related to primary and secondary glioblastomas re-
spectively. Table 2.2 summarizes the most relevant aspects of the IDH-wildtype and
IDH-mutant glioblastomas.
The study of these transcriptional subtypes has yielded relevant findings such as sig-
nificant correlation with patient prognosis (Parsons et al, 2008). IDH-mutant glioblas-
tomas show a significant improvement in OS with a median survival of 31 months, with
respect to IDH-wildtype glioblastomas that present a median survival of 15 months
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Table 2.2: Summary of the most relevant aspects of IDH-wildtype and IDH-mutant glioblastomas.
IDH-wildtype glioblastomas IDH-mutant glioblastomas
Synonym Primary glioblastoma Secondary glioblastoma
Precursor lesion Not identifiable; develops Diffuse astrocytoma,
de novo Anaplastic astrocytoma
Proportion of glioblastomas ∼90% ∼10%
Median age at diagnosis ∼62 years ∼44 years
Male-to-female ratio 1.42 : 1 1.05 : 1
Mean length of clinical history 4 months 15 months
Median overall survival
Surgery + radiotherapy 9.9 months 24 months
Surgery + radiotherapy
+ chemotherapy
15 months 31 months
Location Supratentorial Preferentially frontal
Necrosis Extensive Limited
TERT promoter status 72% 26%
TP53 mutations 27% 81%
ATRX mutations Exceptional 71%
EGFR mutations 35% Exceptional
PTEN mutations 24% Exceptional
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Louis et al (2016). However, although tumor subtypes tend to correlate with relevant
clinical outcomes, the degree of correlation is often moderate and contradictory studies
constantly appear with confronted conclusions (Akagi et al, 2018). Moreover, survival
rates have shown no notable improvement since the last three decades (Stupp et al,
2005), so alternative approaches are required to study the glioblastoma heterogeneity
and its association with the tumor evolution.
In this sense, significant interest has been placed recently in the analysis of glioblas-
toma heterogeneity through medical imaging. The ability to discover non-invasive
markers associated with tumor sub-types, OS, Progression Free Survival (PFS) or re-
sponse to treatment has received much attention as it may help in improving clinical
decision making at an early stage of the disease. In this sense, MRI emerged as one of
the most reliable tool for quantifying in-vivo non-invasive imaging features capable to
accurately describe the heterogeneity of the glioblastoma.
2.2 Magnetic Resonance Imaging
Magnetic Resonance Imaging (MRI) is a medical imaging technique used to provide in-
vivo internal representations of the human body. This technique was developed in the
decade of 1970 by the professors Damadian (1971); Lauterbur (1973, 1974); Mansfield
(1977). Although Damadian’s work on the Nuclear Magnetic Resonance (NMR) relax-
ation of different tissues laid the groundwork for many further developments in MRI, it
was Paul Lauterbur who finally developed a reliable technique based on gradient mag-
nets to generate the first 2D and 3D Magnetic Resonance (MR) images of the interior
of the human body. A few years later Peter Mansfield developed a mathematical for-
mulation that dramatically accelerated the acquisition of MR images (seconds rather
than hours), making it a practical technique for the clinical routine. Paul Lauterbur
and Peter Mansfield finally awarded the Nobel prize in 2003 for their contributions
and advances in MRI.
MRI is based on the magnetic properties of the atomic nuclei, specifically on the
spin angular momentum of the hydrogen nucleus (H+). At a resting natural state, all
the hydrogen H+ nucleus in the human body spin randomly, thus canceling the angular
momentum each other and producing an overall zero spin magnetic momentum. Under
the influence of an external uniform magnetic field B0, the H
+ nuclei align their spin
with B0 in a parallel (low energy) or anti-parallel (high energy) state, producing an
overall spin magnetic momentum Mz, with z the direction of B0 (see figure 2.2). The
influence ofB0 also makes theH
+ nuclei to precess at a specific frequency (denominated
the Larmor frequency), which depends on the strength of B0 and the gyromagnetic
properties of the hydrogen nucleus.
The NMR phenomena is related to the excitation produced to the H+ nuclei by
the influence of an additional temporal magnetic field (radio-frequency pulse) with a
direction different from B0. When a radio-frequency pulse at the Larmor frequency
is triggered at B0, an energy exchange occurs with some H
+ nuclei, lifting them to
the high energy anti-parallel state. In addition, a synchronization of the precession of
all the H+ nuclei is induced, so that they all begin to precess in phase. This event
causes two magnetic effects in the system: 1) a decrease in the overall spin magnetic
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Figure 2.2: Diagram of the spin angular momentum of H+ nuclei at a resting natural state (left) and
under the influence of an uniform magnetic field B0 (right).
momentum Mz due to the lifted H
+ nuclei; and 2) the apparition of a spin magnetic
momentum Mxy transverse to the B0 field due to the phase coherence precession. Such
transverse magnetization Mxy generates a magnetic signal called the Nuclear Magnetic
Resonance Signal. Figure 2.3 shows a diagram of the effect produced by the radio-
frequency pulse on the spin angular momentum of the H+ nuclei.
Figure 2.3: Diagram of the effect produced by the radio-frequency pulse on the spin angular momen-
tum of the H+ nuclei. Some H+ nuclei lift their state to the anti-parallel high energy mode and a
precession synchronization is attained.
Once the radio-frequency pulse has ended, the system begins to relax, recovering
its initial state of equilibrium. The precession of the H+ nuclei begins to lose the
phase coherence due to the differences in the chemical context of each H+ nucleus.
Therefore, the transverse spin magnetic momentum Mxy begins to disappear, leading
to the so-called spin-spin relaxation or transverse T2 relaxation process. Likewise, the
previously lifted H+ nuclei return to their original low energy parallel state, restoring
the longitudinal magnetization Mz to its original value. This process is called the
spin-lattice relaxation or longitudinal T1 relaxation (see figure 2.4).
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Figure 2.4: Diagram of the relaxation process after the radio-frequency pulse ends. On top, the T1
spin-lattice relaxation, showing a recovery of the original Mz magnetization. On bottom, the T2
spin-spin relaxation, demonstrating the lose of the Mxy magnetization due to the phase de-coherence.
T1 and T2 relaxation times are significantly different between them, with T1 a
longer process than T2. Generally, T1 relaxation time ranges from 300 to 2000 ms while
T2 relaxation is about 30 to 150 ms. Moreover, it is difficult to determine the end of
the T1 and T2 relaxations exactly. Therefore, it is considered that the T1 relaxation is
completed once the signal recovers the 63% of the original Mz magnetization. Similarly,
the T2 relaxation is considered ended once the Mxy signal falls under the 37% of its
original value.
As stated above, the T1 and T2 relaxation is different for each H
+ nucleus de-
pending on its chemical context. Hence, different NMR signals are emitted during the
relaxation process, inducing dissimilar electric signals in the receiver coils of the MR
machine. Such disparities will in essence determine the intensities for each tissue in
the MR image. There are three different types of contrast in MR images: T1-weighted,
T2-weighted and Proton Density (PD) images; which are related to the so-called Rep-
etition Time (TR) and the Echo Time (TE) times. TR is the time between successive
radio-frequency pulses and affects the speed in which H+ nuclei realigns to the B0 field.
The TE refers to the time at which the electrical signal induced by the H+ nuclei is
measured in the magnetic coils and concerns the degree of dephase of the spins of the
H+ nuclei. Thus, the TR is closely connected to T1 relaxation effects, while TE is
more related to T2 relaxation events.
23
Chapter 2. Rationale
Figure 2.5 shows the relation between the TR, TE and the contrast produced on
the MR images.
Figure 2.5: Relation between the TR and TE and the intensity contrast produced in the MR images.
2.2.1 Anatomical MRI
So far we have seen that NMR relaxation process is different for each tissue depending
on its chemical context. This property allows to visually differentiate human tissues
via the measurement of their associated electric signals, generating images that depict
the anatomical structures of the region under study.
In the case of central nervous system tumors such as glioblastoma, several images
are typically acquired to best approach the lesion. These images intend to anatomically
describe the morphology of the lesion and its associated structures.
A common protocol for a MRI glioblastoma study should include the following
sequences:
T1-weighted : typically a volumetric 3D Fast Spin Echo (FSE) or Magnetization-
Prepared Rapid Acquisition with Gradient Echo (MPRAGE) sequence. The aim
of the sequence is the anatomical overview of the lesion, including the soft tissues
below the base of skull.
T1CE-weighted : typically a post-contrast volumetric 3D FSE or MPRAGE sequence.
It is a T1-weighted image acquired with administration of Gadolinium-Based
Contrast Agent (GBCA). Its main purpose is to assess vascular structures of
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the region under study. The list of approved contrast-agents for human use
is: gadoterate meglumine (Dotarem®), gadobutrol (Gadavist®), gadopentetate
dimeglumine (Magnevist®), gadobenate dimeglumine (MultiHance®), gadodi-
amide (Omniscan®), gadoversetamide (OptiMARK®), gadoteridol (ProHance®).
T2-weighted : typically a 2D axial FSE sequence. Its purpose is the evaluation of
basal cisterns, ventricular system and subdural spaces, evaluation of vasogenic
edema and good visualization of flow-voids in vessels.
FLAIR : typically a 2D axial Fluid Attenuation Inversion Recovery (FLAIR) T2-
weighted sequence. It is a special inversion recovery sequence with a long in-
version time. Its main characteristic is that it suppress the signal from the
cerebrospinal fluid so that it appears similar to a T2-weighted image but with
the cerebrospinal fluid dark instead of bright. Its purpose is the assessment of
white-matter tumor involvement and related vasogenic edema.
Figure 2.6 shows an example of the aforementioned MR images for a case affected
by glioblastoma.
Figure 2.6: Example of anatomical MR images typically acquired in a glioblastoma MR study. From
left to right: T1-weighted, T1CE-weighted, T2-weighted and FLAIR MRI.
2.2.2 Quantitative MRI
Quantitative Magnetic Resonance Imaging (qMRI) emerged in the 1980’s in the at-
tempt to measure the biological MR properties of the tissues (Tofts, 2004). Therefore,
its purpose is to turn the MRI into a scientific measurement instrument and not only
on an image acquisition system. This concept-shift is the essence of qMRI. qMRI
attempts to develop quantitative and reproducible techniques based on MR data, able
to measure biomarkers related to the underlying biological processes of the tissues
(Yankeelov et al, 2011). MRI Relaxometry (Deoni, 2010), Diffusion Weighted Imag-
ing (DWI) (Schaefer et al, 2000) and Perfusion Weighted Imaging (PWI) (Svolos et al,
2014) composes some of the most important techniques of qMRI.
Regarding glioblastoma tumors, one of the most relevant qMRI techniques is PWI.
As previously mentioned, glioblastoma tumors are characterized by a strong vascular
proliferation, robust angiogenesis, and extensive microvasculature heterogeneity. In
this sense, PWI allows the measurement of the kinetic properties of a paramagnetic
contrast agent, which is intravenously injected to the patient. PWI biomarkers are able
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to reveal the local vascular properties of the tissues and their hemodynamic behavior.
There are three main PWI techniques: Dynamic Susceptibility Contrast (DSC) perfu-
sion, Dynamic Contrast Enhanced (DCE) perfusion and Arterial Spin Labeling (ASL)
perfusion. For reasons of simplicity, and given that only DSC perfusion was used in the
development of this thesis, DCE and ASL perfusion quantification will not be covered
in this dissertation.
DSC perfusion MRI
DSC is the most frequently used technique for MRI perfusion of the brain. It relies on
the susceptibility-induced signal loss on T2∗-weighted sequences caused by the pass of a
GBCA bolus through a capillary bed. A rapid repeated image acquisition is performed
during the bolus injection, resulting into a series of images with the signal at each
voxel representing the susceptibility-induced signal loss of the corresponding tissue,
which is proportional to the amount of contrast present in the microvasculature. A
mathematical model is then fit to the intensity-time signals to derive various perfusion
parameters. The most commonly calculated parameters are relative Cerebral Blood
Volume (rCBV), relative Cerebral Blood Flow (rCBF) and Mean Transit Time (MTT).
Let S the susceptibility-induced signal loss observed at a given voxel. To quantify
the rCBV, rCBF and MTT parameters, a GBCA concentration-time conversion of S
must be performed. It is normally assumed that the tissue concentration of the contrast
agent is proportional to the change in T2∗ relaxation rate, i.e. ∆R2
∗, by means of:
∆R2∗ (t) = − 1
TE
log
(
S (t)
S0
)
= C (t) (2.1)
where t indicates the time, TE refers to the echo time of the DSC sequence and S0
refers to the intensity baseline of S.
Hence, DSC quantification allows to calculate the amount of GBCA tracer remain-
ing in the tissue at each time step at which the ∆R2∗ (t) is measured. This is described
by the so-called tissue impulse residue function, which is denoted as R (t). Therefore,
R (t) represents the fraction of the tracer still present in the tissue at time t after
an instantaneous infinitesimal injection (i.e. a Dirac-delta function) of tracer into a
tissue-feeding artery (Knutsson et al, 2010):
R (t) = 1−
∫ t
0
h (t) dt (2.2)
where h (t) is the distribution of the capillary transit time. By definition, it is con-
sidered that R (0) = 1, meaning that all the tracer is present in the tissue at t = 0,
and R (∞) = 0, meaning that the tracer lefts the tissue after a sufficiently long time
(assuming an intact blood–brain barrier with no extravasation).
In practice, however, the arterial tracer bolus arrives at the tissue with a delay
dependent on the circulatory path from the injection site to the tissue of interest.
Consequently, the measured ∆R2∗ (t) signal in the tissue does not reflect the response
to an instantaneous arterial input bolus, but to the convolution of a kernel given by
CBF · R (t) and the ∆R2∗ (t) signal in the tissue-feeding artery, i.e. the so-called
Arterial Input Function (AIF) (Rempp et al, 1994):
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C (t) = CBF ·R (t)⊗ AIF (t)
= CBF
∫ t
0
AIF (τ)R (t− τ) dτ (2.3)
where ⊗ stands for the convolution product and CBF is the Cerebral Blood Flow.
From equation 2.3 we can rapidly observe that knowing the AIF, the CBF can be
determined by deconvolution of the peak height of the CBF · R (t) signal, given that
R ∈ [0, 1].
Dozens of models has been proposed in the literature to successfully estimate the
CBF by deconvolution: fast truncated Singular Value Decomposition (SVD) fam-
ily (e.g. sSVD, cSVD, oSVD (Ostergaard et al, 1996; Wu et al, 2003; Zanderigo
et al, 2009)), nonlinear stochastic regularization (Zanderigo et al, 2009; Pillonetto and
De Nicolao, 2010), Fourier-Hunt frequency-domain deconvolution (Ostergaard et al,
1996; Chen et al, 2005), wavelet thresholding (Connelly et al, 2006), classical Tikhonov
regularization (Ostergaard et al, 1996; Zanderigo et al, 2009; Calamante et al, 2003),
maximum likelihood estimation (Vonken et al, 1999), maximum entropy deconvolu-
tion (Drabycz et al, 2005), Gaussian process deconvolution (Andersen et al, 2002), or
hierarchical Bayesian models (Schmid et al, 2007; Schmid, 2011).
In this thesis, the delay-insensitive oSVD method was employed to estimate the
CBF, as it has demonstrated to be robust to differences in tracer arrival times and to
AIF selection variability. Following this approach, the deconvolution problem can be
formulated as a matrix equation of the form c = Ab:

C (t0)
C (t1)
...
C (tN−1)
 = ∆t

AIF (t0) 0 . . . 0
AIF (t1) AIF (t0) . . . 0
...
...
. . .
...
AIF (tN−1) AIF (tN−2) . . . AIF (t0)


R (t0)
R (t1)
...
R (tN−1)
CBF
(2.4)
The above equation can be solved for b, with b = R (t) · CBF . By decomposing
A = U ·S ·V T , with U and V orthogonal matrices and S a non-negative square diagonal
matrix, the inverse of A can be expressed as A−1 = V ·W · UT where W = 1/S along
the diagonal only where values are higher than a threshold (truncation of the diagonal
for numerical stability reasons), and zero elsewhere. Therefore, we can estimate CBF
by solving for b and calculating its maximum value:
CBF = max
(
V ·W · UT · C) (2.5)
This procedure assumes that the AIF always arrive before the voxel signal C,
which in some situations may not be true (for example if the AIF is not the true AIF
of the corresponding tissue). In such situations, the computation of the CBF results
in an incorrect estimation, typically an underestimation of the CBF , due to a shifting
in the R (t) function.
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As proposed by Wu et al (2003) circular deconvolution can be employed to solve
this problem. By zero-padding the N point-time series AIF (t) and C (t) to length L,
with L ≥ 2N , time aliasing can be avoided. Thus, replacing also the matrix A by a
block-circulant matrix D of the form:
di,j =
{
ai,j, forj ≤ i
aL+i−j,0, otherwise
(2.6)
and solving using the equation 2.5, the CBF can be estimated safely also even if delay
effects exist in the AIF .
The MTT can be calculated by Zierler’s area-to-height relationship (Zierler Ken-
neth L., 1962), by the equation:
MTT =
∫∞
0
R (t) dt
max [R (t)]
=
∫ ∞
0
R (t) dt (2.7)
According to the central volume theorem (Meier and Zierler, 1954; Weisskoff et al,
1993), the CBV can be calculated following the relation:
CBV = CBF ·MTT (2.8)
Following this relation and combining equations 2.3 and 2.7, the CBV can also be
estimated by:
CBV =
∫∞
0
C (t) dt∫∞
0
AIF (t) dt
(2.9)
Leakage correction
Computational kinetic models for DSC quantification explicitly assume that the
GBCA remains in the intra-vascular space for the duration of the perfusion acquisition.
However, this assumption is typically not valid for glioblastomas, since they often
present blood-brain barrier breakdown. Therefore, GBCA extravasates to the extra-
vascular interstitial space producing a distortion in the ∆R2∗ (t) signal that leads to
an overestimation or underestimation of perfusion parameters if non leakage correction
is performed. GBCA leakage can be manifested in ∆R2∗ (t) signals in generally two
ways: the T2∗-dominant extravasation and the T1-dominant extravasation effects.
Numerous methods have been proposed in the literature to correct the leakage effect
in perfusion, and the deviation it produces in the estimation of the perfusion markers:
use of pre-dosing (Donahue et al, 2000), double-echo acquisitions (Vonken et al, 2000;
Uematsu et al, 2001) or parametric modeling (γ-variate fit of the ∆R2∗ (t) signals)
(Thompson Howard K. et al, 1964). The most common and reference technique is the
one proposed by Weisskoff et al (1994) and later elaborated by Boxerman et al (2006),
which corrects the leaky signal by estimating its deviation from a non-leaky reference
signal of the same patient.
Following Boxerman’s method, the ∆R2∗ (t) observed at a given voxel can be de-
termined as:
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∆R2∗ (t) ≈ K1∆R2∗ (t)−K2
∫ t
0
∆R2∗ (t′) dt′ (2.10)
where ∆R2∗ (t) stands for a whole-brain average signal in non-enhancing voxels, K1
is a scale-constant of the whole-brain average signal to fit the observed signal at the
corresponding voxel, and K2 is the term that reflects the effects of the leakage (both T1
and T2 dominant effects). Therefore, by simple manipulation (please refer to Boxerman
et al (2006) for more details), the leakage corrected signal can be determined as:
∆R2∗corr (t) = ∆R2
∗ (t) +K2
∫ t
0
∆R2∗ (t′) dt′ (2.11)
Both K1 and K2 can be determined by simple least squares fitting, and then cor-
rected ∆R2∗corr (t) signals can be computed to quantify CBV , CBF and MTT as
stated above. Figure 2.7 shows an example of the Boxerman’s correction of a T2∗- and
a T1-leaky curve.
Figure 2.7: Example of a T2∗ - and T1-leaky curves with their associated Boxerman’s corrected con-
centration curves.
Recirculation correction
DSC quantification involves the kinetic analysis of the first pass of a intravenously
injected GBCA. However, the ∆R2∗ (t) signal observed at each voxel primarily reflects
the first pass of the tracer, but also the second wave of GBCA that recirculates into
the tissue, after it has been shunted through the renal and coronary circulations and
back into the heart. This second wave, affects the ∆R2∗ (t), preventing the signal from
returning to its original baseline.
Hence, in order not to overestimate the perfusion parameters, typically the CBV ,
which is obtained from the integral or area under the ∆R2∗ (t) signal, the recirculation
phase must be corrected. One of the most popular methods is to use a γ-variate fitting.
The γ-variate function commonly employed to describe the first pass of the GBCA
is written as:
S (t) = K · (t− t0)α exp−(t−t0)/β (2.12)
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where K is a scaling factor, t0 is the bolus arrival time, and α and β determine the
shape and scale of the distribution.
Levenberg-Marquardt algorithm was employed in this thesis to perform the γ-
variate fitting of all the ∆R2∗ (t) signals of the DSC perfusions. Levenberg-Marquardt
algorithms searches for minimizing parameters in the form:
(
Kˆ, tˆ0, αˆ, βˆ
)
= arg min
K,t0,α,β
N∑
t=0
[∆R2∗ (t)− S (t|K, t0, α, β)]2 (2.13)
Figure 2.8 shows an example of a γ-variate fitting of a ∆R2∗ (t) signal.
Figure 2.8: Example of a γ-variate fitting of a ∆R2∗ (t) signal.
Contralateral white matter normalization
Finally, the rCBV and rCBF parameters are obtained by normalizing the CBV and
CBF quantities against the contralateral unaffected white matter value. This procedure
has shown to successfully standardize perfusion values among individuals, regardless of
their MRI protocol, hence allowing inter-patient multi-center studies (A´lvarez Torres
et al, 2019).
2.3 Probability theory
2.3.1 Basic concepts
In the following sections, the basic concepts of probability theory will be described to
facilitate the reading and understanding of subsequent chapters and contributions of
this thesis.
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Random variables
A random variable can be informally defined as a variable whose possible values are the
outcomes of a random phenomenon. Thus, random variables conceptually represent
an abstraction that allows addressing uncertainty in the measurement of quantities in
real world scenarios.
More formally, a random variable X : Ω → E is mathematically defined as a
measurable function from a possible set of outcomes Ω to a measurable space E.
Random variables can be of two types: discrete random variables, whose domain is
a countable number of distinct values (typically E = N); and continuous random
variables, whose domain takes an infinite number of values in a predefined interval
(typically E = R). Usually, random variables are denoted by uppercase letters, e.g.
X and their realizations by lowercase letters, e.g. x. Hence, for example, a random
variable that represents the volume of the brain in cubic centimeters in a population
could denoted as X, and the particular measurement of a patient within this population
could be denoted as x = 1273.6 cm3.
Random variables are usually governed by probability distributions that represent
the likelihood that any of the possible values that the variable can take would occur.
Such distributions constitute a fundamental principle to ML as they represent the
mathematical approximation to deal with the uncertainty in the process of learning
patterns from real data.
Probability distribution
A probability distribution is a mathematical function that describes the likelihood of
obtaining the possible values that a random variable can assume. Given a random
variable X, the probability that it takes the value x is denoted as:
p (X = x) (2.14)
where for the shake of simplicity we can assume p (X = x) ≡ p (x).
Probability distributions are generally divided into two classes depending on the
type of the random variable. For discrete random variables, the probability distribution
is known as probability mass function (pmf), denoted as f (x), and gives the probability
mass that the random variable X takes exactly the value x.
p (x) = f (x) → [0, 1] (2.15)
Since the probability mass is distributed among all the possible outcomes that the
discrete random variable can take, then:∑
x∈E
f (x) = 1 (2.16)
The cumulative distribution function (cdf), denoted as F (x), is defined as the prob-
ability that the random variable X takes values less than or equal to x, and takes the
form:
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F (x) = p (X ≤ x) =
∑
y≤x
y∈E
f (y) (2.17)
On the other hand, the probability distribution of a continuous random variable is
known as probability density function (pdf), denoted also as f (x). Since for continuous
random variables there is an infinite number of values in any interval, the pdf for
an exact specific value is not meaningful. Instead, the pdf for a continuous random
variable is commonly defined over an interval [a, b] in the form:
p (a ≤ X ≤ b) =
∫ b
a
f (x) dx → [0, 1] (2.18)
For the shake of simplicity, we can assume that for continuous random variables
p (x) refers to the pdf of x bounded to the infinitesimal interval [x, x+ dx]:
p (x) =
∫ x+dx
x
f (y) dy (2.19)
Likewise the discrete case, the probability density is distributed among all the
interval of possible values that the continuous random variable can take, which in the
most general case is [−∞,+∞], thus:∫ +∞
−∞
f (x) dx = 1 (2.20)
The cdf for a continuous random variable is finally defined as:
F (x) =
∫ x
−∞
f (y) dy (2.21)
The joint, marginal and conditional probability distributions
In many situations we will manage more than one random variable that operates on
the same probability space. In that situations, the joint, marginal and conditional
probability distributions arise to model uncertain events from different interrelated
events.
The joint probability distribution, denoted as p (x, y), is defined as the probability
distribution of two random variables operating in the same probability space whose
outcomes occur simultaneously. The conditional distribution, denoted as p (x|y), is
defined as the probability distribution of a random variable when another random
variable is known to have a particular value. Both distributions are closely related
through the product rule, which takes the form:
p (x, y) = p (x|y) p (y) = p (y|x) p (x) (2.22)
We can also relate these distributions with the marginal probability distribution
through the sum rule, i.e. by integrating out a random variable that takes all the values
in its subset. For discrete random variables the marginal probability distribution is
defined as:
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p (x) =
∑
y
p (x, y) =
∑
y
p (x|y) p (y) (2.23)
while for continuous random variables it is expressed as:
p (x) =
∫
y
p (x, y) dy =
∫
y
p (x|y) p (y) dy (2.24)
The Bayes’ theorem and Bayes decision rule
The Bayes’ theorem plays a central role in ML as it provides a relationship between
conditional and joint probability distributions of two random variables, which defines
the so-called minimum-risk decision rule (Duda et al, 2000; Bishop, 2006). Therefore,
the Bayes’ theorem allows to take optimal decisions for uncertain events based on prior
knowledge and conditions related to that events.
The Bayes’ theorem, also named Bayes’ rule or Bayes’ law, is defined as:
p (y|x) = p (x|y) p (y)
p (x)
(2.25)
Under the context of a pattern recognition classification problem, these distribu-
tions have specific interpretations related to the degree of belief they give to the occur-
rence of different events. In this sense, the Bayes’ formula can be informally expressed
as:
posterior =
likelihood× prior
evidence
(2.26)
where each term semantically means:
p (y|x) : posterior probability, that is the quantity that should be estimated and rep-
resents the degree of belief of observing the event (or class in a classification problem)
y, after taking into account the evidence x.
p (x|y) : likelihood distribution, it acts as a model of the random variable Y that
specifies the most probable outcome of X given a specific state of Y .
p (y) : prior distribution, it provides the degree of initial belief of observing the event
y of the random variable Y .
p (x) : evidence distribution, it acts as a normalization term that provides the total
degree of belief of the evidences X.
Note that the equation 2.25 can also be expressed in terms of joint probability
distributions in the form:
p (y|x) = p (x, y)∑
z
p (x, z)
(2.27)
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from where it can be observed that the denominator acts as a normalization constant
to ensure the conditional probability to sum 1.
Therefore, assuming Y to be a discrete random variable that models the differ-
ent classes of a pattern recognition classification problem, the Bayes’ minimum-risk
decision rule, sometimes also called minimum error-rate classifier, can be expressed as:
Decide y if p (y|x) > p (z|x) ∀z 6= y (2.28)
or more formally defined as:
yˆ = arg max
y
p (y|x) (2.29)
where yˆ refers to the optimal class for the decision problem.
Following the Bayes’ theorem, we can reformulate the equation 2.29 to:
yˆ = arg max
y
p (y|x)
= arg max
y
p (x|y) p (y)
p (x)
= arg max
y
p (x|y) p (y)
= arg max
y
p (x, y)
(2.30)
from where it can be observed that we can drop out the p (x) term as it is constant for
the maximization (which is only dependent on y).
The previous result directly leads to the definition of the two main families of mod-
els within the ML classification problem: the generative models and the discriminative
models. Generative models explicitly model the joint distribution p (x, y), which se-
mantically means that they learn a model to describe each class. By the opposite,
the discriminative models directly learn the posterior distribution p (y|x), which just
models the decision boundaries between the different classes of the problem, ignoring
the properties or characteristics of the classes.
Figure 2.9 illustrates both approaches, with the corresponding associated probabil-
ity distributions and learning goals for each model.
2.3.2 Probability distributions
The exponential family
The exponential family of probability distributions is an unified set of distributions
that can be expressed in the form:
p (x; Θ) = h (x) exp (η (Θ) · T (x)− A (Θ)) (2.31)
for some functions h (x), η (θ), T (x) and A (Θ); where Θ refers to the set of parameters
of the distribution.
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Figure 2.9: Summary of the goals and learning objectives of the generative and discriminative models
for a pattern recognition classification problem. Image taken with kind permission from https://
stanford.edu/∼shervine/teaching/cs-229/cheatsheet-supervised-learning.
The exponential family represents one of the most important families of distribu-
tions in statistics as it covers a wide range of distributions that naturally arise in many
natural phenomena. Among others, the most important probability distributions of
the exponential family are: the Normal, t-Student, Gamma, Multinomial and Dirichlet
distributions, which are employed in some contributions of this thesis.
The Normal distribution
The most important distribution of the exponential family, and in statistics in general,
is the Normal distribution. The Normal distribution, also called Gaussian distribution,
is a continuous symmetric probability distribution defined in the range [−∞,+∞], with
parameters Θ = {µ, σ2}, that takes the form:
p
(
x;µ, σ2
)
=
1√
2piσ2
exp
(
−(x− µ)
2
2σ2
)
(2.32)
where µ is referred as the mean and represents the central tendency or expected value
of the random variable governed by the distribution; and σ2 is referred as the variance
and represents the degree of divergence of the realizations of the random variable from
the central tendency.
The Normal distribution is also a fundamental distribution for probability theory
as it arises from the central limit theorem, which states that the summation of indepen-
dent random variables (properly normalized) tends to be normally distributed. This
theorem has important implications since it allows to employ statistical methods de-
signed for normal distributions to other problems involving non-normal distributions.
The generalization of the one-dimensional Normal distribution to the d-dimensional
multivariate case with d > 1 is defined as:
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p (x;µ,Σ) =
1
(2pi)n/2|Σ|1/2
exp
(
−1
2
(x− µ)T Σ−1 (x− µ)
)
(2.33)
where Σ refers to the covariance matrix, and models the variance of each independent
variable and the pair-wise covariance interactions between them.
The Normal distribution is typically denoted as N (µ, σ2) for the univariate case
and N (µ,Σ) for the multivariate case.
The t-Student distribution
The t-Student distribution is another continuous distribution of the exponential family
that arises from the estimation of the mean of a population that is normally distributed.
It is a symmetric zero-centered distribution, also defined in the range [−∞,+∞], with
parameters Θ = {ν}, that takes the form:
p (x; ν) =
Γ
(
ν+1
2
)
Γ
(
ν
2
)√
νpi
(
1 +
x2
ν
)− ν+1
2
(2.34)
with ν > 0 referring to the degrees of freedom of the distribution.
The t-Student distribution is very similar to the Normal distribution. In the limit
ν → +∞ the t-Student distribution exactly converges to a Normal typified distribution,
while for values of ν ∈ [1, 30] the distribution presents heavier and thicker tails, making
it a natural choice for robust data modeling in presence of outliers.
Figure 2.10: Comparison between probability density functions of a typified Normal distribution(
µ = 0, σ2 = 1
)
and different instances of t-Student distributions with parameters ν = {1, 2, 5, 10, 100}
The distribution can be generalized to a location-scale distribution (Bishop, 2006)
by compounding a Normal distribution of mean µ and unknown variance with an
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inverse Gamma distribution placed over the variance with parameters α = ν/2 and
β = νσ2/2. The resulting density has the form:
p
(
x;µ, σ2, ν
)
=
Γ
(
ν+1
2
)
Γ
(
ν
2
)√
νpiσ2
(
1 +
1
ν
(x− µ)2
σ2
)− ν+1
2
(2.35)
The generalization of the one-dimensional t-Student distribution to the d-dimensional
multivariate case is defined as:
p (x;µ,Σ, ν) =
Γ
(
ν+d
2
)
Γ
(
ν
2
)
(νpi)d/2 |Σ|1/2
(
1 +
1
ν
(x− µ)T Σ−1 (x− µ)
)− ν+d
2
(2.36)
where d refers to the dimensions of the random variable and Σ refers to the scale or
shape matrix, which in general is not equivalent to the covariance matrix of the Normal
distribution.
The t-Student distribution is typically denoted as St (ν), or St (µ, σ2, ν) and St (µ,Σ, ν)
for the location-scale univariate and multivariate versions respectively.
The Gamma distribution
The Gamma distribution is another continuous probability distribution of the exponen-
tial family, which is very common in the biomedical field as many biological phenomena
follow a Gamma distribution. It is a positive-only right-skewed distribution defined in
the range (0,+∞], with parameters Θ = {k, θ}, that takes the form:
p (x; k, θ) =
1
Γ (k) θk
xk−1 exp
(
−x
θ
)
(2.37)
where k is referred to as the shape parameter and θ is referred to as the scale parameter.
Such distribution is widely employed to model time-dependent biological phenom-
ena that have a natural minimum of 0, such as the MR signal decay produced by the
first pass of the bolus of a paramagnetic contrast agent intravenously injected to a
patient.
The generalization of the univariate Gamma distribution to the multivariate case
is the Wishart distribution. This distribution is defined for positive-definite (d× d)
matrices that represents the scatter matrix of two d-variate Normal-distributed random
variables, which falls far outside the scope of this thesis.
The Gamma distribution is typically denoted as G (k, θ).
The Multinomial distribution
The Multinomial distribution is a discrete probability distribution that models the
probability of observing each of K different outcomes in an experiment involving n
repeated trials. Therefore, the distribution governs a discrete random variable X,
whose realizations are vectors of the form x = (x1, . . . , xK), with xk ∈ {0, . . . , n}
representing the number of times the kth outcome has been observed after the n trials.
37
Chapter 2. Rationale
The Multinomial distribution has the parameters Θ = {p, n}, with p = (p1, . . . , pK),
representing the prior probability of observing each of the K possible outcomes before
the trials, and n indicating the number of trials. The pmf of the distribution takes the
form:
p (x; p, n) =
 n!x1!...xK !px11 . . . pxKK when
K∑
i=1
= n
0 otherwise
(2.38)
The Multinomial distribution is the generalization of several discrete distributions,
those ones taking specific values for k and n parameters. Thus, the Multinomial
distribution converts to the Bernoulli distribution when k = 2 and n = 1; to the
Binomial distribution when k = 2 and n > 1; and to the Categorical distribution
when k > 1 and n = 1.
The Multinomial distribution can also be expressed using the Gamma function as:
p (x; p) =
Γ
(∑
k
xk + 1
)
∏
k
Γ (xk + 1)
K∏
k=1
pxkk (2.39)
whose form is very similar to the Dirichlet distribution, which is its conjugate prior.
The Multinomial distribution is typically denoted as Mult (p, n).
The Dirichlet distribution
The Dirichlet distribution is a continuous probability distribution typically used in
Bayesian statistics as conjugate prior of the Multinomial distribution. It is the multi-
variate generalization of the Beta distribution, which is commonly used to model prior
knowledge about the probability of an event. Therefore, the Dirichlet distribution
governs a random variable X whose outcomes are the realizations of a Multinomial
distribution in the form x = (x1, . . . , xK), with xk ∈ [0, 1]. The distribution has the
parameters Θ = {α} and is defined as:
p (x;α) =
Γ
(∑
k
αk
)
∏
k
Γ (αk)
K∏
k=1
x
(αk−1)
k (2.40)
with α called the concentration parameter.
As stated above, the Dirichlet distribution is the conjugate prior of the Multinomial
distribution, which means that if a random variable X follows a Multinomial distri-
bution, and we assume a prior Dirichlet distribution over its parameter p, then the
posterior distribution of p is also Dirichlet distributed. Under the Bayesian statistics,
this relationship leads to a powerful mechanism to, given a new observation x, update
the parameter p in a pure algebraic manner, without recalculating the joint probability
distribution p (x,p), which normally remains intractable.
The Dirichlet distribution is typically denoted as Dir (α).
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2.3.3 Parameter estimation
Statistical inference is the process of deducing properties and making generalizations
about a population, by estimating the parameters of an underlying probability distri-
bution used to model observations taken from that population. Therefore, statistical
modeling typically consists of two steps: 1) choosing the distribution that best fits the
data, and 2) determining the parameters Θ of the distribution.
However, Θ is generally considered unobservable, as the whole population cannot
be observed either. Therefore, an estimation of the parameters Θˆ is usually calculated,
based on a random sample drawn from the population. The most typical analytical
methods of estimating the parameters of a probability distribution given its pdf (or
pmf) are: Maximum Likelihood Estimation (MLE), Maximum A Posteriori (MAP)
estimation and Bayesian inference, of which the first two are briefly described below
as they are extensively used in this thesis. On the other hand, numerical optimiza-
tion methods such as the Expectation-Maximization (EM) algorithm are also typically
employed to estimate the parameters of complex models that do not have closed-form
analytical solution. The EM algorithm is also discussed below as it is extensively used
in this thesis for several contributions.
Maximum Likelihood Estimation
The Maximum Likelihood Estimation (MLE) focuses on obtaining the best distribution
parameters Θˆ by maximizing the likelihood function L (Θ;x). This approach can be
semantically interpreted as “maximizing the probability of observing the random sample
X given a current guess about the parameters Θ of the model”.
Let X =
(
x1, . . . ,xN
)
a set of observations of a random variable. Formally, the
MLE estimate is defined as:
ΘˆMLE = arg max
Θ
L (Θ;X)
= arg max
Θ
p (X; Θ)
= arg max
Θ
∏
i
p
(
xi; Θ
) (2.41)
Differentiation is employed to maximize L (Θ;X), by setting the partial derivatives
of the function with respect to each parameter to zero. However, maximizing L (Θ;X)
is hard as it involves a product over all realizations of X. Typically, natural loga-
rithm is taken to simplify the expression in various senses: first, natural logarithm is
a monotonically increasing function so the maximum value of L (Θ;X) occurs at the
same point as the maximum value of logL (Θ;X); next, the logarithm of the prod-
uct converts to the sum of the logarithms, which is far easier to maximize than the
product since the derivative of a sum is the sum of derivatives; additionally, probabil-
ity distributions involving the exponential function take benefit from the logarithm to
simplify the expression to be maximized; finally, computing a sum of log-derivatives is
computationally more stable than calculating a product of probabilities, which quickly
tend to zero leading to numerical representation problems.
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Therefore, the log-likelihood is usually maximized in MLE, which is defined as:
ΘˆMLE = arg max
Θ
logL (Θ;X)
= arg max
Θ
log p (X; Θ)
= arg max
Θ
log
∏
i
p
(
xi; Θ
)
= arg max
Θ
∑
i
log p
(
xi; Θ
)
(2.42)
Maximum A Posteriori
Maximum A Posteriori (MAP) estimation is closely related to MLE in the sense that
both look for the parameters that equal to the mode of a distribution (the maximum
of the distribution). However, while MLE maximizes the likelihood (or log-likelihood)
distribution of the parameters Θ, MAP estimation maximizes the posterior distribution
of Θ with respect to the observations X. Therefore, in this case, MAP estimate can
be semantically interpreted as “maximizing the probability of a specific setting of the
Θ parameters of the model given the current observations of the random variable X”.
In this sense, MAP is also closely related to Bayesian estimation, since it considers Θ
parameters as a random variable that in turn is governed by some distribution with its
own parameters. Therefore, assuming Θ as a random variable and taking the Bayes’
rule:
p (Θ|X) = p (X|Θ) p (Θ)
p (X)
∝ p (X|Θ) p (Θ)
(2.43)
where we can ignore the normalizing constant as we are strictly speaking about nor-
malization, so proportionality is sufficient. Hence, the MAP estimate is defined as:
ΘˆMAP = arg max
Θ
logL (X|Θ)
= arg max
Θ
log p (Θ|X)
= arg max
Θ
log (p (X|Θ) p (Θ))
= arg max
Θ
log p (X|Θ) + log p (Θ)
= arg max
Θ
∑
i
log p
(
xi|Θ)+ log p (Θ)
(2.44)
from where it can be clearly observed that MAP is an augmentation of MLE that allows
to introduce a density p (Θ) over the parameters of the model, to inject initial beliefs
and/or prior knowledge about them. Moreover, it can also be quickly deduced that
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MLE is a particular case of MAP estimation when p (Θ) is assumed to be constant.
Thus, MAP can also be thought as a regularization/generalization of the MLE method.
As in MLE, differentiation is employed to maximize logL (X|Θ) and obtain closed-
form solutions for the estimation of the parameters of the model. At this point, con-
jugate priors, briefly introduced in section 2.3.2, become important when modeling
p (Θ), since assuming an adequate distribution for p (Θ) may be crucial to update the
parameters in a straightforward manner.
Expectation-Maximization algorithm
As stated above, MLE and MAP estimation consist in the maximization of the likeli-
hood and posterior functions respectively, by mathematical differentiation. However,
setting partial derivatives for the parameters of many complex models usually does
not find closed-form expressions, hence preventing direct analytical solutions.
A common way to deal with the complexity in optimizing parameters of models
that do not have closed form solution is to introduce a set of latent variables Z that
allow the model to be formulated in a more tractable way. Therefore, defining a joint
distribution p (X,Z; Θ) over the augmented space of observed and latent variables
allows to estimate the parameters of the model Θ in a more straightforward manner.
Then, once Θ is estimated, the distribution of the observed variables p (X; Θ) can be
obtained by marginalization. The EM algorithm takes advantage of such idea.
The EM algorithm, formalized in 1977 by Arthur Dempster, Nan Laird and Donald
Rubin (Dempster et al, 1977), provides an iterative numerical optimization framework
for the MLE and MAP estimate of models involving latent variables, when a closed-
form analytical solution is not possible. The algorithm relies on the introduction of
an informative latent variables that allow the model to be reformulated in such a way
that a closed-form solution for the estimation of the parameters can be found.
Of course, these latent variables Z are unknown quantities that prevent a direct
estimation of the model, so maximizing logL (Θ;X,Z) (for the MLE example case) is
not possible. However, some state of knowledge about the value of Z can be obtained
by computing its posterior distribution given the observations X and a guess about
the parameters of the model Θ˜, i.e. p
(
Z|X; Θ˜
)
. Therefore, instead of maximizing
logL (Θ;X,Z) the EM algorithm maximizes an auxiliary function, typically referred
as the Q-function, which is the expected value of logL (Θ;X,Z) under this posterior
distribution. That is:
ΘˆMLE = arg max
Θ
Q
(
Θ; Θ˜
)
= arg max
Θ
Ep(Z|X;Θ˜) [logL (Θ;X,Z)]
= arg max
Θ
∑
Z
p
(
Z|X; Θ˜
)
log p (X,Z; Θ)
= arg max
Θ
∑
i
p
(
zi|xi; Θ˜
)
log p
(
xi, zi; Θ
)
(2.45)
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This formulation quickly suggest an iterative scheme based on alternating between
computing the conditional expectations of the latent variables given the observations,
i.e. computing p
(
Z|X; Θ˜
)
, and updating the parameters of the model via the closed-
form solutions obtained thanks to the augmented formulation p (X,Z; Θ).
Therefore, the general scheme of the EM algorithm (for the MLE case) is:
Initialization: Choose an initial setting for Θ˜.
Expectation step: Evaluate the Q-function:
Q
(
Θ; Θ˜
)
= Ep(Z|X;Θ˜) [logL (Θ;X,Z)]
which actually means estimating the unknown quantity p
(
Z|X; Θ˜
)
Maximization step: Maximize the Q-function:
ΘˆMLE = arg max
Θ
Q
(
Θ; Θ˜
)
which consist of updating the parameters Θ of the model based on p
(
Z|X; Θ˜
)
Convergence: Stop if L
(
Θˆ;X
)
− L
(
Θ˜;X
)
≤ ; otherwise Θ˜ = Θˆ and go to
Expectation step.
Parameter estimation via EM algorithm is only guaranteed to converge to a local
maxima or to a saddle point of the function under maximization. Convergence to
the global maxima is not assured since the algorithm is only guaranteed to iteratively
increase the likelihood (or posterior) function after each iteration. Hence, optimizing
multi-modal functions can easily lead to local maximas, also conditioned by the ini-
tialization of Θ˜. An in-depth dissertation on the convergence properties of the EM was
made by professor Wu (1983).
In the following chapters, several applications of MLE and MAP parameter esti-
mation of complex models via EM will be presented.
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2.4 Mixture Models
So far we have seen that probability distributions give us a mathematical form to
describe the properties of a population represented by a random variable. However,
assuming that each observation is drawn from a single unimodal distribution leads to
a very simplistic scenario that generally does not apply in real-world situations. In
fact, real-world data typically present more complex patterns such as multi-modality,
sparsity, noise or presence of outliers. In this sense, models capable of capturing such
variability are required to describe the data in a more reliable sense.
In the following sections, three different families of mixture models grouped by
their structured or non-structured nature will be discussed.
2.4.1 Finite Mixture Model
Finite Mixture Models (FMMs) are probabilistic models that model a random variable
as a convex combination of pdfs. Therefore, FMM provides a statistical formal frame-
work to describe heterogeneous data trough a weighted sum of single distributions,
each one representing a sub-population within a dataset.
Let X =
(
x1, . . . ,xN
)
a set of observations of a random variable, where xi ∈ Rd.
A FMM of K components assumes a pdf over X in the form:
p (X; Θ) =
N∏
i=1
p
(
xi; Θ
)
=
N∏
i=1
K∑
j=1
pijφ
(
xi; Θj
) (2.46)
where Θ = {Θ1, . . . ,ΘK , pi1, . . . , piK} are the parameters of the model, with {Θj, pij}
the parameters of the jth component of the mixture modeled by the pdf φ (xi; Θj). The
parameters {pi1, . . . , piK} are typically called mixing coefficients and can be seen as the
prior probability of each component of the mixture describing the data. Therefore, it
follows that 0 ≤ pij ≤ 1 and:
K∑
j=1
pij = 1 (2.47)
Due to its mathematical tractability, Gaussian (or t-Student) distributions are typ-
ically employed to model the data, thus φ (xi; Θj) ∼ N (xi;µj,Σj). Figure 2.11 illus-
trates the pdf of a 3-component Gaussian Mixture Model (GMM) (in purple), with
their associated Normal distributions (blue, red and yellow).
A common way to estimate the parameters of a FMM could be via MLE. From
2.46 we can set:
43
Chapter 2. Rationale
Figure 2.11: Probability density functions of a 3-component GMM with their associated Normal
distributions.
ΘˆMLE = arg max
Θ
logL (Θ;X)
= arg max
Θ
log p (X; Θ)
= arg max
Θ
log
N∏
i=1
K∑
j=1
pijφ
(
xi; Θj
)
= arg max
Θ
N∑
i=1
log
K∑
j=1
pijφ
(
xi; Θj
)
(2.48)
from where we can immediately see that the maximization is very complex due to
the summation over K inside the logarithm. In fact, there is no closed-form analytical
solution for the MLE (nor MAP estimate) of a FMM. In this sense, alternative methods
are required to estimate the parameters of these models in a reliable but affordable
manner.
EM inference for FMM
As stated in chapter 2.3.3, a common way to deal with the complexity in optimizing
parameters of models that do not have closed form solution is to introduce a set of
latent variables Z that allow the model to be formulated in a more tractable way.
Under the FMM’s point of view, a latent variable Z is typically introduced indicat-
ing the component of the mixture to which the observation belongs to. Formally,
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let Z =
(
z1, . . . , zN
)
a random variable where zi ∈ {0, 1}K represents a binary K-
dimensional one-hot encoding variable, where zik = 1 indicates that the i
th observation
has originated by the kth component of the mixture, and hence zij = 0, ∀j 6= k. Under
this assumption, we can reformulate the FMM by defining a joint density over the
latent and observed variables in the form:
p (X,Z; Θ) =
N∏
i=1
K∏
j=1
(
pijφ
(
xi; Θj
))zij (2.49)
where we assume that Z follows a Multinomial unit-length distribution given by equa-
tion 2.38 with n = 1 (i.e. Categorical), i.e.:
zi ∼ CatK(pii) (2.50)
The MLE estimate of this augmented FMM can be expressed as:
ΘˆMLE = arg max
Θ
logL (Θ;X,Z)
= arg max
Θ
log p (X,Z; Θ)
= arg max
Θ
log
N∏
i=1
K∏
j=1
(
pijφ
(
xi; Θj
))zij
= arg max
Θ
N∑
i=1
K∑
j=1
log
(
pijφ
(
xi; Θj
))zij
= arg max
Θ
N∑
i=1
K∑
j=1
zij log
(
pijφ
(
xi; Θj
))
= arg max
Θ
N∑
i=1
K∑
j=1
zij
(
log pij + log φ
(
xi; Θj
))
(2.51)
which is far easier to optimize than the original FMM. In fact, closed-form solutions
can be found for all the parameters of the model depending on the form of φ (xi; Θj).
Optimizing pij requires considering the constraint that
∑
k pik = 1, which can be
easily achieved by using Lagrange multipliers. Therefore, setting the derivatives of
logL (Θ;X,Z) with respect pij and λ Lagrange multiplier yield:
1
pij
N∑
i=1
zij + λ = 0
K∑
k=1
pik − 1 = 0
(2.52)
Solving the system of equations and rearranging for pij provides:
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pij =
N∑
i=1
zij
N∑
i=1
K∑
k=1
zik
(2.53)
Note that the denominator of the above expression (2.53) is actually equal to N ,
since it is a summation of N one-hot encoding variables zi, which take a value 1 for
one of their components and 0 for the rest.
For the most typical case of FMM where φ (xi; Θj) ∼ N (xi;µj,Σj) (i.e. GMM),
means and covariance matrices must be optimized. Setting the derivatives of logL (Θ;X,Z)
with respect to the mean yields:
N∑
i=1
zijΣ
−1
j
(
xi − µj
)
= 0 (2.54)
where rearranging:
µj =
1
N∑
i=1
zij
N∑
i=1
zijx
i (2.55)
and solving for the covariance matrix yields:
N∑
i=1
zij
(
−1
2
Σ−1j +
1
2
(
xi − µj
)T
Σ−2j
(
xi − µj
))
= 0 (2.56)
where rearranging:
Σj =
1
N∑
i=1
zij
N∑
i=1
zij
(
xi − µj
) (
xi − µj
)T
(2.57)
Up to this point we have seen that assuming that we have both the observations
and latent variables {X,Z}, typically referred as the complete dataset, the MLE (and
also the MAP) estimate find closed-form solutions for the parameters of the FMM.
However, actually, we only have the observations X (i.e. the incomplete dataset), so,
as previously described in section 2.3.3, the only information we can get from the latent
variable Z is given by its posterior distribution conditioned to the observations X and
to a current estimate of the parameters of the model Θ˜, i.e. p
(
Z|X; Θ˜
)
. Following
the Bayes’ rule it is given by:
p
(
zij = 1|xi; Θ˜
)
= γij =
pijφ
(
xi; Θ˜j
)
∑
k
pikφ
(
xi; Θ˜k
) (2.58)
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Therefore, because it is not possible to compute the MLE of logL (Θ;X,Z) (due
to we only can observe X), we just can compute its expected value under the posterior
distribution p
(
Z|X; Θ˜
)
, which yields the so-called Q-function:
ΘˆMLE = arg max
Θ
Q
(
Θ; Θ˜
)
= arg max
Θ
Ep(Z|X;Θ˜) logL (Θ;X,Z)
= arg max
Θ
∑
Z
p
(
Z|X; Θ˜
)
log p (X,Z; Θ)
. . .
= arg max
Θ
N∑
i=1
K∑
j=1
γij
(
log pij + log φ
(
xi; Θj
))
(2.59)
which yields the same equation than 2.51 but substituting the latent variable zij by its
posterior quantity γij. Setting derivatives of this expression obviously gives the same
results as 2.53, 2.55 and 2.57, but replacing zij by γ
i
j.
This formulation hence suggest an iterative scheme for MLE or MAP estimate,
based on alternating between computing p
(
Z|X; Θ˜
)
, referred as the Expectation-step
or E -step; and updating the parameters of the model based on this distribution, re-
ferred as the Maximization-step or M -step. Therefore, the EM algorithm can be finally
summarized as:
Initialization: Choose an initial setting for Θ(0).
Expectation step: Estimate p
(
Z|X; Θ(t))
p
(
zij = 1|xi; Θ(t)
)
= γij
(t)
=
pi
(t)
j φ
(
xi; Θ
(t)
j
)
∑
k
pi
(t)
k φ
(
xi; Θ
(t)
k
)
Maximization step: Update the parameters of the model given p
(
Z|X; Θ(t))
Θˆ
(t+1)
MLE = arg max
Θ
Ep(Z|X;Θ(t)) logL (Θ;X,Z)
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where considering the GMM of the example:
pi
(t+1)
j =
N∑
i=1
γij
(t)
N∑
i=1
K∑
k=1
γik
(t)
µ
(t+1)
j =
1
N∑
i=1
γij
(t)
N∑
i=1
γij
(t)
xi
Σ
(t+1)
j =
1
N∑
i=1
γij
(t)
N∑
i=1
γij
(t)
(
xi − µ(t+1)j
)(
xi − µ(t+1)j
)T
Convergence: Stop if L (Θ(t+1);X) − L (Θ(t);X) ≤ ; otherwise t = t + 1 and
go to Expectation step.
2.4.2 Spatially Varying Finite Mixture Model
So far, we have seen that FMMs provide a rigorous statistical framework for modeling
heterogeneous data in a precise and formal manner. The optimization of the likelihood
function of a FMM provides a computationally feasible yet powerful solution to fit and
evaluate complex models to model random variables.
However, FMMs make an important assumption that can turn into a severe draw-
back when it comes to structured data, such as images. FMMs assume observations
X to be independent and identically distributed, hence implying no correlations be-
tween them. This assumption does not hold for imaging data in which observations,
i.e. pixels in 2D images or voxels in 3D volumes, are strictly arranged in a struc-
ture that inherently defines explicit correlations between them. Therefore, ignoring
the prior knowledge that adjacent observations are more likely to belong to the same
class wastes a highly useful information that allows images to be described in a more
concise, adequate and realistic manner.
The Spatially Varying Finite Mixture Model (SVFMM) is an extension of the FMM
for structured data, that aims to facilitate the modeling of the spatial correlations in-
herent in images. The SVFMM mainly differs from the FMM in the definition of the
mixing coefficients which, as we saw, can also be interpreted as the prior probabilities
of the components of the mixture. Specifically, the SVFMM assumes that each obser-
vation xi has its own different vector of mixing coefficients pii, denoted as contextual
mixing coefficients, rather than sharing a global vector for all observations. Addi-
tionally, the SVFMM assumes Π =
(
pi1, . . . , piN
)
to be a vector of random variables
rather than parameters, allowing a prior density to be defined to introduce statistical
correlations among them.
Let X =
(
x1, . . . ,xN
)
a set of observations of a random variable, where xi ∈ Rd.
A SVFMM of K components assumes a pdf over X in the form:
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p (X|Θ,Π) =
N∏
i=1
K∑
j=1
piijφ
(
xi; Θj
)
(2.60)
where Θ = {Θ1, . . . ,ΘK} and Π =
{
pi1, . . . , piN
}
are the parameters of the model. Note
that Θ and Π are actually treated as random variables, and that each observation xi
has its own associated vector of contextual mixing coefficients pii. Likewise FMM,
contextual mixing coefficients must also satisfy 0 ≤ piij ≤ 1 and:
K∑
j=1
piij = 1 (2.61)
A MAP estimate of the model is usually employed to introduce a proper density
over Π, typically in the form of a MRF, to establish dependencies between adjacent
contextual mixing coefficients. Therefore, the MAP estimate of the SVFMM is defined
as:
(
Θˆ, Πˆ
)
MAP
= arg max
(Θ,Π)
logL (X|Θ,Π)
= arg max
(Θ,Π)
log p (Θ,Π|X)
= arg max
(Θ,Π)
log
{
p (X|Θ,Π) p (Θ,Π)
p (X)
}
= arg max
(Θ,Π)
log {p (X|Θ,Π) p (Θ,Π)}
= arg max
(Θ,Π)
log p (X|Θ,Π) + log p (Θ,Π)
= arg max
(Θ,Π)
log p (X|Θ,Π) +:
const
log p (Θ) + log p (Π)
= arg max
(Θ,Π)
log p (X|Θ,Π) + log p (Π)
(2.62)
where we have assumed independence in p (Θ,Π) and also assumed a constant uniform
distribution for p (Θ) that gets rid out from the maximization.
Several densities for p (Π) has been proposed in the literature (Sanjay-Gopal and
Hebert, 1998; Woolrich et al, 2005; Blekas et al, 2005; Sfikas et al, 2008) to codify
the concept that neighboring observations tend to share the same component of the
mixture. A family of densities that has been widely used with successful results are
the Gauss-MRFs (Nikou et al, 2007). This family of priors encodes the general idea
that the estimator of the contextual mixing coefficients can be defined as the average
of its spatial neighbors:
pˆii =
1
|Mi|
∑
m∈Mi
pim (2.63)
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where Mi indicates the set of neighbors of the ith observation. In other words, this
prior assumes that differences between adjacent contextual mixing coefficients for a
given component j of the mixture are Gaussian distributed in the form:
piij − pimj ∼ N
(
0, β2
)
m ∈Mi (2.64)
This approach is somewhat na¨ıve and can be refined to capture variability among
different components of the mixture and spatial directions of the images. The Di-
rectional Class-Adaptive Gauss-Markov Random Field (DCAGMRF) prior, which lies
into the family of Simultaneous Auto-Regressive (SAR) models, has been used to reg-
ularize ill-posed inverse problems with successful results. The DCAGMRF takes the
form:
p (Π) =
N∏
i=1
K∏
j=1
D∏
d=1
∏
m∈Mid
1√
2piβ2j,d
exp
(
−
(
piij − pimj
)2
2β2j,d
)
(2.65)
where sub-index d refers to the different spatial adjacency directions (i.e. horizontals,
verticals or diagonals), and Mid indicates the set of neighbors of the ith observation
that lies in the dth spatial direction.
Merging 2.62 with 2.60 finally yields:
(
Θˆ, Πˆ
)
MAP
= arg max
(Θ,Π)
N∑
i=1
log
K∑
j=1
piijφ
(
xi|Θj
)
+ log p (Π) (2.66)
which again is analytically intractable, so numerical approximations should be em-
ployed.
EM inference for SVFMM
As in the FMM case, a binary K-dimensional one-hot encoding latent variable Z is
introduced to simplify the estimation of the model, by assuming knowledge about the
component of the mixture to which the observation belongs to. The formulation of the
SVFMM assuming the existence of the latent variables results in:
p (X,Z|Θ,Π) =
N∏
i=1
K∏
j=1
(
piijφ
(
xi; Θj
))zij (2.67)
The MAP estimate of the augmented SVFMM can be expressed as:
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(
Θˆ, Πˆ
)
MAP
= arg max
(Θ,Π)
logL (X,Z|Θ,Π)
= arg max
(Θ,Π)
log p (Θ,Π|X,Z)
. . .
= arg max
(Θ,Π)
log p (X,Z|Θ,Π) + log p (Π)
= arg max
(Θ,Π)
log
N∏
i=1
K∏
j=1
(
piijφ
(
xi; Θj
))zij + log p (Π)
. . .
= arg max
(Θ,Π)
N∑
i=1
K∑
j=1
zij
(
log piij + log φ
(
xi; Θj
))
+ log p (Π)
(2.68)
where again is far easier to optimize than 2.66 and from where we can quickly observe
that the maximization of Θ will be exactly the same as in the classic FMM. Only the
estimation of piij will be affected by the density p (Π) as expected.
Following the same reasoning than in classic FMM, the only information we can get
from the latent variable Z is given by its posterior density p
(
Z|X, Θ˜, Π˜
)
. Therefore,
the conditional expectation of logL (X,Z|Θ,Π) under this density is used as auxiliar
function for the optimization. Rearranging 2.65 into 2.68, substituting zij by their
posterior quantity γij and dropping constant terms that do not affect the maximization
yields the following Q-function:
Q
(
Θ,Π|Θ˜, Π˜
)
=
N∑
i=1
K∑
j=1
γij
(
log piij + log φ (x
i; Θj)
)− D∑
d=1
log
β2j,d
2
+
∑
m∈Mi
d
(piij−pimj )
2
2β2j,d
(2.69)
Optimizing piij from expression 2.69 must take into account several considerations.
First, note that piij appears in the term
∑
m∈Mid
(
piij − pimj
)2
once as the central indi-
vidual and D · |Mid| times as the neighbor of pimj individuals. Second, no closed-form
solution can be obtained when introducing the constraint
∑K
j=1 pi
i
j = 1 in the maxi-
mization. Instead, reparatory methods such as the quadratic programming algorithm
proposed in (Blekas et al, 2005), must be employed to project the solutions onto the
constraints to ensure probabilities sum up to 1.
Taking all this into consideration, the updates for piij are obtained as the roots of
the following second degree equation obtained by setting partial derivatives of 2.69
with respect piij (without restrictions):
(
piij
)2 D∑
d=1
|Mid|
β2j,d
− (piij) D∑
d=1
∑
m∈Mid
pimj
β2j,d
− γ
i
j
2
= 0 (2.70)
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which can easily demonstrated that always have a real non negative solution.
The DCAGMRF prior also introduces a new set of parameters β2j,d that govern the
variances of the Gauss-MRF. Setting derivatives of 2.69 with respect β2j,d yields:
β2j,d =
1
N
N∑
i=1
∑
m∈Mid
(
piij − pimj
)2
|Mid|
(2.71)
Therefore, the MAP EM algorithm for the SVFMM with the DCAGMRF prior can
be finally summarized as:
Initialization: Choose an initial setting for Θ(0) and Π(0).
Expectation step: Estimate p
(
Z|X,Θ(t),Π(t))
p
(
zij = 1|xi,Θ(t),Π(t)
)
= γij
(t)
=
piij
(t)
φ
(
xi; Θ
(t)
j
)
∑
k
piik
(t)
φ
(
xi; Θ
(t)
k
)
Maximization step: Update the parameters of the model given p
(
Z|X,Θ(t)Π(t))(
Θˆ, Πˆ
)(t+1)
MAP
= arg max
(Θ,Π)
Ep(Z|X,Θ(t),Π(t)) logL (X,Z|Θ,Π)
where considering the GMM example:
(
piij
(t+1)
)2 D∑
d=1
|Mid|
β2j,d
(t)
−
(
piij
(t+1)
) D∑
d=1
∑
m∈Mid
pimj
(t)
β2j,d
(t)
− γ
i
j
(t)
2
= 0 (∗)
µ
(t+1)
j =
1
N∑
i=1
γij
(t)
N∑
i=1
γij
(t)
xi
Σ
(t+1)
j =
1
N∑
i=1
γij
(t)
N∑
i=1
γij
(t)
(
xi − µ(t+1)j
)(
xi − µ(t+1)j
)T
β2j,d
(t+1)
=
1
N
N∑
i=1
∑
m∈Mid
(
piij
(t+1) − pimj (t+1)
)2
|Mid|
(*) Choose the real non-negative solution and project onto the constraints using
the quadratic programming algorithm (Blekas et al, 2005) to ensure
K∑
j=1
piij = 1
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Convergence: Stop if L (X|Θ(t+1),Π(t+1)) − L (X|Θ(t),Π(t)) ≤ ; otherwise t =
t+ 1 and go to Expectation step.
2.4.3 Dirichlet Compound Multinomial-Spatially Varying Fi-
nite Mixture Model
An important limitation of the SVFMM is that it does not inherently preserves the con-
dition of
∑
j pi
i
j = 1. Instead, reparatory projections must be employed to accomplish
with this constraint, thereby compromising the assumed Bayesian framework.
An interesting alternative is to consider that Π follows a Dirichlet Compound Multi-
nomial (DCM) distribution (Nikou et al, 2010). The DCM distribution is a hierarchical
discrete multivariate distribution, where an observation zi is drawn from a Multino-
mial distribution governed by a parameter vector pii, which in turn is drawn from a
Dirichlet distribution governed by parameter vector αi.
zi ∼ CatK
(
pii
)
pii ∼ DirK
(
αi
) (2.72)
Such scheme presents two important advantages for the SVFMM. First, the Dirich-
let distribution draws probability vectors that intrinsically satisfies the constraint∑
j pi
i
j = 1, so no reparatory corrections will be required. Next, the α
i parameters
of the Dirichlet distribution are not subject to any restriction (rather than αij ≥ 0)
so a Gauss-MRF can be imposed over them to introduce the spatial correlations and
local regularity in a more straightforward manner.
In this sense, the pdf of the zi variable given the parameters of the Categorical
distribution (Multinomial unit-length with n = 1) is:
p
(
zi|pii) = n!
K∏
j=1
(
zij
)
!
K∏
j=1
(
piij
)zij = K∏
j=1
(
piij
)zij (2.73)
The pdf of the pii variable given the parameters of the Dirichlet distribution is
p
(
pii|αi) = Γ
(
K∑
j=1
αij
)
K∏
j=1
Γ
(
αij
) K∏
j=1
piij
(αij−1) (2.74)
with Γ(·) the Gamma function. Integrating out both pdfs we obtain the following
density for the zi variables conditioned to αi:
p
(
zi|αi) = Γ
(
K∑
j=1
αij
)
Γ
(
K∑
j=1
αij + z
i
j
) K∏
j=1
Γ
(
αij + z
i
j
)
Γ
(
αij
) (2.75)
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Taking into account that Γ (x+ 1) = xΓ(x), the vector pii of label prior probabilities
can be finally computed as:
piij =
αij
K∑
j=1
αik
(2.76)
Therefore, the previously proposed DCAGMRF of equation 2.65 can be imposed
over the parameters of the Dirichlet distribution in the form:
p (A) =
N∏
i=1
K∏
j=1
D∏
d=1
∏
m∈Mid
1√
2piβ2j,d
exp
(
−
(
αij − αmj
)2
2β2j,d
)
(2.77)
Arranging this density into the SVFMM and substituting pii by its conditional
density under the Dirichlet process yields:
(
Θˆ, Aˆ
)
MAP
= arg max
(Θ,Π)
N∑
i=1
log
K∑
j=1
αij
K∑
k=1
αik
φ
(
xi|Θj
)
+ log p (A) (2.78)
which, as expected, is again analytically intractable.
EM inference for DCM-SVFMM
As in the previous cases, a binary K-dimensional one-hot encoding latent variable Z
is introduced to simplify the estimation of the model. The formulation of the DCM-
SVFMM assuming the existence of this latent variable results in:
p (X,Z|Θ, A) =
N∏
i=1
K∏
j=1
 αijK∑
k=1
αik
φ
(
xi; Θj
)

zij
(2.79)
The MAP estimate of the augmented DCM-SVFMM is expressed as:
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(
Θˆ, Aˆ
)
MAP
= arg max
(Θ,A)
logL (X,Z|Θ,Π)
= arg max
(Θ,A)
log p (Θ, A|X,Z)
. . .
= arg max
(Θ,A)
log p (X,Z|Θ, A) + log p (A)
= arg max
(Θ,A)
log
N∏
i=1
K∏
j=1
 αijK∑
k=1
αik
φ
(
xi; Θj
)

zij
+ log p (A)
. . .
= arg max
(Θ,A)
N∑
i=1
K∑
j=1
zij
log αijK∑
k=1
αik
+ log φ
(
xi; Θj
)
+ log p (A)
(2.80)
which, as usual, is easier to optimize than the original model.
The conditional expectation of logL (X,Z|Θ, A) under the posterior density p
(
Z|X, Θ˜, A˜
)
is again used as auxiliar function for the optimization, yielding the following Q-
function:
Q
(
Θ, A|Θ˜, A˜
)
=
N∑
i=1
K∑
j=1
γij
log αijK∑
k=1
αik
+ log φ (xi; Θj)
− D∑
d=1
log
β2j,d
2
+
∑
m∈Mi
d
(αij−αmj )
2
2β2j,d
(2.81)
As in the SVFMM case, the optimization of Θ is exactly equal than in classic
FMMs. The optimization of αij, however, does not require to introduce any constraint
to preserve the condition
∑
j pi
i
j = 1. Then, it is only necessary to consider that α
i
j
appears in the term
∑
m∈Mid
(
αij − αmj
)2
once as the central individual and D · |Mid|
times as the neighbor of αmj individuals.
Setting partial derivatives of 2.81 with respect αij yields the following third degree
equation:
(
αij
)3
+
(
αij
)2(
Ai−j −
Cij
Bij
)
− (αij)(Ai−jCijBij
)
− z
i
jA
i
−j
2Bij
= 0 (2.82)
where
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Ai−j =
K∑
k=1
k 6=j
αik
Bij =
D∑
d=1
|Mid|
β2j,d
Cij =
D∑
d=1
∑
m∈Mid
αmj
β2j,d
(2.83)
where, under polynomial theory, it can be demonstrated that there is always a real
non negative solution that satisfies αij ≥ 0. The Cardano’s or Vieta’s methods can be
employed to algebraically obtain the roots of the proposed third degree equation.
The optimization of β2j,d yields the same equation than 2.71 but expressed in terms
of α variables:
β2j,d =
1
N
N∑
i=1
∑
m∈Mid
(
αij − αmj
)2
|Mid|
(2.84)
Therefore, the MAP EM algorithm for the DCM-SVFMM with the DCAGMRF
prior can be finally summarized as:
Initialization: Choose an initial setting for Θ(0) and A(0).
Expectation step: Estimate p
(
Z|X,Θ(t), A(t))
p
(
zij = 1|xi,Θ(t), A(t)
)
= γij
(t)
=
piij
(t)
φ
(
xi; Θ
(t)
j
)
∑
k
piik
(t)
φ
(
xi; Θ
(t)
k
)
where
piij
(t)
=
αij
(t)
K∑
j=1
αik
(t)
Maximization step: Update the parameters of the model given p
(
Z|X,Θ(t)A(t))(
Θˆ, Aˆ
)(t+1)
MAP
= arg max
(Θ,A)
Ep(Z|X,Θ(t),A(t)) logL (X,Z|Θ, A)
where considering the GMM example:(
αij
(t+1)
)3
+
(
αij
(t+1)
)2(
Ai−j
(t) − Cij
(t)
Bij
(t)
)
−
(
αij
(t+1)
)(
Ai−j
(t)
Cij
(t)
Bij
(t)
)
− zijAi−j
(t)
2Bij
(t) = 0 (∗)
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µ
(t+1)
j =
1
N∑
i=1
γij
(t)
N∑
i=1
γij
(t)
xi
Σ
(t+1)
j =
1
N∑
i=1
γij
(t)
N∑
i=1
γij
(t)
(
xi − µ(t+1)j
)(
xi − µ(t+1)j
)T
β2j,d
(t+1)
=
1
N
N∑
i=1
∑
m∈Mid
(
αij
(t+1) − αmj (t+1)
)2
|Mid|
(*) Choose the real non-negative solution.
Convergence: Stop if L (X|Θ(t+1), A(t+1)) − L (X|Θ(t), A(t)) ≤ ; otherwise t =
t+ 1 and go to Expectation step.
2.5 Deep Learning
At the beginning of the 2000’s the ML started an important revolution with the birth
of the Deep Learning (DL) techniques (LeCun et al, 2015). Until that time, ML
was generally constituted by two disjoint and clearly differentiated stages: the feature
extraction step and the classification/regression step. The feature extraction step
was typically addressed manually, computing hand-crafted features from the raw data
guided by the expertise, knowledge and intuition of the researcher. These features were
then fed to the classifier/regressor, expecting to be discriminant informational inputs
to successfully solve the corresponding task. Therefore, a crucial step for the good
performance of classic ML methods typically relied in a powerful feature extraction
process.
The qualitative leap made by DL techniques concerns mainly the feature extraction
stage. Instead of computing hand-crafted features, DL models attempt to simultane-
ously learn a discriminant representation of the raw input data at the same time as
the classifier (regressor) is trained. This concept shift allows machines to learn the
optimal set of features appropriate for the task. Therefore, DL models not only learn
the decision boundaries (or regression model) of a discriminative classifier, but they
also learn a manifold to optimally project the data into it in such a way that the
classification task becomes as trivial as possible: the so-called representation learning.
Figure 2.12 depicts a general conceptual schema of the concept shift between classic
ML approach and the current DL paradigm.
DL addresses the representation learning problem by building concepts out of sim-
pler concepts. This kind of hierarchical learning perfectly fits into the nature of Artifi-
cial Neural Networks (ANNs). ANNs are ML models that process the input hierarchi-
cally by passing it through a nested set of layers, each of which learns a deeper level
of abstraction of the input. Therefore, concepts inside a ANN are built by concate-
nating the output of a layer, which represents a simpler abstract representation of the
input, and the input of the successive layer, which learns a more complex and richer
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Figure 2.12: Conceptual schema of the differences between classic ML and DL.
composite representation from those previous outputs. Figure 2.13 shows an example
of the hierarchical concept representation of images showing faces by a DL model.
Figure 2.13: Example of hierarchical features extracted during the learning process
of a DL model. Image taken with kind permission from https://devblogs.nvidia.com/
deep-learning-nutshell-core-concepts/hierarchical features/
The following sections briefly describe the basics and fundamental principles of
ANNs, and present the Convolutional Neural Networks (CNNs): the current state-of-
the-art classifier for most of the supervised visual computing related tasks.
2.5.1 Artificial Neural Networks
ANNs are connectionist computational models in which a number of processors, named
artificial neurons or perceptrons are interconnected in a manner inspired by the con-
nections between neurons in a human brain. ANNs were born in the mid-twentieth
century, in a combined effort of multiple researchers. In 1943 McCulloch and Pitts
(1943) created the first computational model of a biological neuron. Few years later
Hebb (2002) designed the first learning rule for ANNs based on the concept of neural
plasticity, whose premise was that if two neurons were active simultaneously, then the
strength of the connection between them should increase. In 1958, Rosenblatt (1958)
created the perceptron, which is the basis of the ANNs, and Ivakhnenko and Lapa
(1967) developed the first multi-layer ANN. In subsequent years, Kelley (1960) laid
the basis of the backpropagation algorithm, but it was not until the work of Rumelhart
et al (1986) where the first ANN was effectively trained using the backpropagation al-
gorithm by adjusting the weights of the network proportional to the gradient computed
from the error.
Today, ANNs are the most powerful and widely used ML algorithms, as they have
proven to largely outperform other approaches in many tasks such as visual object
recognition, object detection and segmentation and many other domains such as speech
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recognition, handwritten text recognition or financial time series prediction. The fol-
lowing sections provides an overview of the basics of ANNs to facilitate the reading
and understanding of subsequent chapters and contributions of this thesis.
The Perceptron
ANNs are composed by basic units called perceptrons or artificial neurons. The per-
ceptron (see Figure 2.14), in its most elementary form, is a simplified model of a bio-
logical neuron, approximated as a mathematical function for learning a binary linear
classifier. Let x = {x1, . . . , xD} a RD vector of features representing an observation.
Mathematically, a perceptron is defined as:
f (x) =
{
1 if
∑
iwixi + b > 0
0 otherwise
(2.85)
where wi represents a weight associated to the xi feature, and b stands for the bias of
the linear model. The Heaviside step activation function is employed in the most basic
perceptron algorithm, setting the output of the neuron to 1 (”activated”) if
∑
iwixi+b
is greater than a threshold (typically 0); or to 0 (”deactivated”) otherwise.
Figure 2.14: The perceptron.
Perceptrons are only able to solve linearly separable problems regardless of the
activation function employed. Therefore, they are only guaranteed to converge if the
training set is linearly separable. Otherwise, the perceptron will fail and no approxi-
mate solution is returned.
The Multi-Layer Perceptron
A Multi-Layer Perceptron (MLP) is a class of feedforward ANN composed of at least
three layers of interconnected perceptrons. Figure 2.15 shows an example of a simple
MLP with an input layer, a hidden layer and an output layer. Except of the input
layer, all the neurons in the other layers are perceptrons.
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Figure 2.15: A multi-layer perceptron.
The arrangement of multiple layers of perceptrons in combination with the non-
linear activation functions allow MLPs to solve non-linearly separable problems. In-
deed, it is demonstrated that MLPs are universal mathematical function approximators
through superposition of non-linearly activated perceptrons.
Activation functions
Activation functions are determinant for ANNs since they are fundamental to allow the
network to solve non-linear problems. An ANN of multiple layers, each one activated
by a linear function passed to the next layer, results in a final function that is a
combination of linear functions in a linear form, which by definition can be replaced
by a single linear function. In other words, no matter how many layers are stacked
in an ANN, if only linear activation functions are used, the network is still equivalent
to a single layer with linear activation, and therefore is only capable of solving linear
problems.
To mitigate this effect multitude of activation functions are proposed in the litera-
ture. The most important are summarized below:
Linear activation The most simple activation function. The output of the percep-
tron is proportional to the input. It is defined as:
f (x) = cx (2.86)
It allows a continuous output range, which is more powerful than a binary output,
however its derivative with respect to x is constant. This means that the gradient has
no relation to x and, therefore, regardless of the magnitude of the prediction error,
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the changes made by backpropagation are constant. Additionally, as said above, a
multi-layer ANN fully activated by linear functions is equivalent to a single-layer ANN
only capable of solving linear problems.
Heaviside step activation A binary activation function. The output of the per-
ceptron is ”activated” if
∑
iwixi + b is greater than a threshold, or is ”deactivated”
otherwise. It is typically defined as:
f (x) =
{
1 if
∑
iwixi + b > 0
0 otherwise
(2.87)
where ”activated” is typically represented by 1, and ”deactivated” fires the 0 value.
Likewise, the typical threshold employed to determine the output is the 0 value.
The Heaviside function outputs a binary discrete value, which presents some disad-
vantages. By definition it can only properly represent binary classification problems,
in which the ANN has only one output neuron. For multi-label problems where ANNs
have multiple output neurons firing Heaviside step activations, it is not possible to
correctly identify the corresponding class, hence preventing their training. Moreover,
continuous activation functions allow a smoother training process, less prone to fall
into bad local minima.
Sigmoid / Logistic activation One of the most historically used activation func-
tions. It represents the continuous soft approximation of the Heaviside step function.
It is mathematically defined as:
f (x) =
1
1 + exp (−x) (2.88)
Its non-linearity allows the network to learn complex decision boundaries by stack-
ing layers sequentially. Moreover, the gradient is related to the input, so it propagates
the magnitude of the error through the entire network. Finally, the output is contin-
uous and bounded to the [0, 1] range, allowing a smoother training process without
gradient explosion.
The main disadvantage of this activation function is that it originates the so-called
gradient vanishing problem. The gradient vanishing problem is related to the update
process of the wi weights of a network trained through gradient-based learning algo-
rithms such as backpropagation. In these algorithms, the weights of the network are
updated proportionally to the partial derivative of the error function with respect to
the weights. Depending on the nature of the activation function, it is possible for the
gradient to become extremely small, barely modifying the weights of the network, and
therefore slowing or even preventing the network from further training.
In the specific case of the sigmoid activation function, it can be seen that for x val-
ues above x = 2 and below x = −2, the slope of the function is almost near-horizontal.
Therefore, there is no effectively change in the gradient, resulting in the network re-
fusing to learn further. For small networks, this does not represent a big problem,
however, the more layers stacked in the network, the problem grows exponentially,
eventually collapsing the training of the model.
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Tahn activation A similar activation function than the sigmoid function. Indeed,
the tanh activation is a scaled version of the sigmoid function:
f (x) = tanh (x) =
2
1 + exp (−2x) − 1 = 2sigmoid (2x)− 1 (2.89)
It has similar properties than the sigmoid function. Its gradient is stronger than
the sigmoid but it also suffers from the vanishing gradient problem.
Softmax activation Typically an activation function only employed in the final
layer of a network to convert the activations into probabilities (posteriors). It is defined
as:
f (x) =
exp (xi)∑
j exp (xj)
(2.90)
The aim of this activation function is to normalize the outputs so that each neuron
triggers a value in the range [0, 1] and all of them add up to 1, giving the probability
of the input value being in a specific class.
ReLU activation First presented in 2009, the Rectified Linear Unit (ReLU) ac-
tivation function can be considered a milestone in DL. It is mathematically defined
as:
f (x) = max (0, x) (2.91)
This simple function provides a set of benefits that have made ReLU as the most
widely used activation function nowadays. First, ReLU is a non-linear function, so
it allows the network to model complex functions by stacking layers. Moreover, the
function is ranged between [0,+∞), hence allowing the gradient to not vanish as there
is no saturation in any range of the function. It also provides sparsity activation
since multiple neurons can fire 0 activation because of a negative input of the ReLU,
therefore becoming a lighter network.
However, ReLU activation suffers from the so-called dying ReLU problem. This
problem arises when a neuron continuously trigger negative values to the ReLU. In
these cases, the gradient become 0, preventing the neuron from responding to changes
in error, and updating its weights. If the problem affects multiple neurons in the
network, it could lead to a substantial part of the network passive.
Leaky-ReLU activation It consist of a simple modification of the ReLU function
to avoid the dying ReLU problem:
f (x) = max (αx, x) (2.92)
with α a parameter, typically adopting small values (α = 0.01), to allow a small positive
slope for the negative range of the function. Such modification allows the neuron to
prevent its paralysis, eventually reactivating it during the training process.
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Backpropagation algorithm
The backpropagation algorithm was originally introduced in the 1970s, but its impor-
tant was not fully recognized until the 1986 paper by Rumelhart et al (1986). Back-
propagation is an algorithm to efficiently train an ANN by adjusting its weights so that
the network output minimizes a given loss function. More formally, the backpropaga-
tion is an iterative optimization algorithm based on a gradient descent technique, to
update the weights of a network by computing the gradient of the loss function with
respect to each weight following the chain rule.
To illustrate the mechanics of the backpropagation algorithm, lets consider the sim-
ple ANN shown in figure 2.16 (example taken from https://www.anotsorandomwalk.
com/backpropagation-example-with-numbers-step-by-step/ with kind permission).
Figure 2.16: ANN example.
The following relations are established between the neurons of the network:
yh1 = w1x1 + w3x2 + w5x3 + b1
yh2 = w2x1 + w4x2 + w6x3 + b1
zh1 = f (y1h1)
zh2 = f (yh2)
yo1 = w7zh1 + w9zh2 + b2
yo2 = w8zh1 + w10zh2 + b2
zo1 = σ (yo1)
zo2 = σ (yo2)
where y· refers to the input of the corresponding neuron, and z· indicates the output
of the neuron after the activation function f (y) is applied, which in the example will
be the sigmoid function.
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Let assume the input values of the network x1 = 1, x2 = 4, x3 = 5 and the desired
target t1 = 0.1, t2 = 0.05. The forward pass of the network yields the following results:
yh1 = 0.1 (1) + 0.3 (4) + 0.5 (5) + 0.5 = 4.3
yh2 = 0.2 (1) + 0.4 (4) + 0.6 (5) + 0.5 = 5.3
zh1 = σ (4.3) = 0.9866
zh2 = σ (5.4) = 0.9950
yo1 = 0.7 (0.9866) + 0.9 (0.9950) + 0.5 = 2.0862
yo2 = 0.8 (0.9866) + 0.1 (0.9950) + 0.5 = 1.3888
zo1 = σ (2.0862) = 0.8896
zo2 = σ (1.3888) = 0.8004
Once the forward pass is completed, weights are updated by setting partial deriva-
tives of the error function E with respect to each weight, following the chain rule. As
an example, setting partial derivatives to update the weight w7 yield:
∂E
∂w7
=
∂E
∂zo1
· ∂zo1
∂yo1
· ∂yo1
∂w7
(2.93)
For the shake of simplicity lets consider E the sum of squared errors of the predic-
tions with respect to the targets:
E =
1
2
[
(zo1 − t1)2 + (zo2 − t2)2
]
(2.94)
Solving for the first term ∂E
∂zo1
of the partial derivatives in equation 2.93 yields:
∂E
∂zo1
= zo1 − t1 = 0.8896− 0.1 = 0.7896 (2.95)
The next term to solve is
∂zo1
∂yo1
, which only engages the activation function of the
neuron. The activation function chosen for the example is the sigmoid function, whose
derivative is x (1− x). Applying to the update process of the weights yields:
∂zo1
∂yo1
= zo1 (1− zo1) = 0.8896 (1− 0.8896) = 0.0982 (2.96)
Finally, the partial derivative
∂yo1
∂w7
involves the derivation of w7zh1 +w9zh2 +b2 with
respect w7, which is trivial:
∂yo1
∂w7
= zh1 = 0.9866 (2.97)
Therefore, the gradient of the error with respect to the weight w7 is:
∂E
∂w7
= 0.7896 · 0.0982 · 0.9866 = 0.0765 (2.98)
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Once the gradient of the loss function with respect to the corresponding weight is
known, the final update of the weight is typically performed by:
wˆ7 = w7 − η ∂E
∂w7
= 0.7− (0.01 · 0.0765) = 0.6992 (2.99)
with η referring to the learning rate typically set to small values (η = 0.01).
The updates of the remaining weights follow the same mechanics, with a slightly
more cumbersome computation due to the increase in the number of neurons intercon-
nected in deeper layers. The results are:
wˆ1 = w1 − η ∂E
∂w1
= 0.1000
wˆ2 = w2 − η ∂E
∂w2
= 0.2000
wˆ3 = w3 − η ∂E
∂w3
= 0.2999
wˆ4 = w4 − η ∂E
∂w4
= 0.4000
wˆ5 = w5 − η ∂E
∂w5
= 0.4999
wˆ6 = w6 − η ∂E
∂w6
= 0.6000
wˆ7 = w7 − η ∂E
∂w7
= 0.6992
wˆ8 = w8 − η ∂E
∂w8
= 0.7988
wˆ9 = w9 − η ∂E
∂w9
= 0.8992
wˆ10 = w10 − η ∂E
∂w10
= 0.0988
bˆ1 = b1 − η ∂E
∂b1
= 0.5000
bˆ2 = b2 − η ∂E
∂b2
= 0.4980
After weight updating, computing the output of the network in the iteration t = 1
yields:
z(1)o1 = 0.8892
z(1)o2 = 0.7997
Comparing the errors produced by the network in the first (t = 0) and second
iterations (t = 1):
E(0) = 0.5933
E(1) = 0.5925
which initially may not seem too much, but after repeating the process 100.000 times,
the error decreases to 0.0000351085, and the output of the network becomes:
z(100k)o1 = 0.1175 → (vs. t1 = 0.1)
z(100k)o1 = 0.0582 → (vs. t2 = 0.05)
concluding the training of the network. For an in-depth dissertation on ANNs, training
procedures, numerical optimizers and convergence properties of DL models please refer
to Bengio (2017).
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2.5.2 Convolutional Neural Networks
CNNs are a specialized type of ANNs inspired in the human visual cortex. In the 1950s,
experiments conducted by Dr. Hubel and Dr. Wiesel identified that sets of different
specific neurons in a cat’s visual cortex responded very quickly when observing images
with lines at specific angles, with light and dark patterns, or by observing movement in
a certain direction. These results laid the foundation for further research into animal’s
visual understanding.
Human visual cortex process the information by passing it from one cortical area to
another, where each cortical area is more specialized than the last one. For example,
the primary visual cortex focuses on preserving spatial location of visual information,
i.e. orientation of edges and lines. The secondary visual cortex feeds on the response of
the primary visual cortex and focuses on collecting spatial frequencies, size, colors and
shape of the object, while third visual cortex process the global motion and provides
a complete visual representation. CNNs adopts this philosophy and tries to act like a
computational visual cortex.
CNNs are a type of ANN mainly oriented for image processing, that arose in the at-
tempt to solve the limitations that classic MLPs have when dealing with images. First,
fully-connected ANNs do not scale well for images. Consider the example of a small
image of 100× 100 pixels. Each neuron of the second layer of a fully-connected ANN
has 10000 weights to learn. Therefore, assuming a simple MLP with a hidden layer
of 1000 neurons has 10M of weights only in the second layer, making it unaffordable
to optimize. Second, MLP also ignore the spatial information and local redundancy
inherent in images. In a MLP, the pixels of an image are independently connected
to the layers of the network, thus loosing the semantic meaning of the position and
its relation with their neighbors. This wastes a highly useful information that allows
images to be described in a more concise, adequate and realistic manner. Finally, clas-
sic MLPs are not translation-invariant. Since the input image is connected in a static
manner to the layers of the network, the patterns learned during the training process
are statically linked to the position in which they appeared. Therefore, same objects
appearing at different positions will change the weights associated to the corresponding
pixels, intrinsically learning the position in which they appeared.
CNNs, by the opposite, are non-fully connected ANNs, primarily made of a set
of stacked convolution layers, where each layer has a small set of shared weights that
intelligently adapt to the properties of images. They are by definition translation
invariant and context-sensitive, allowing for learning patterns related to objects of
interest appearing anywhere in the image.
The following sections overall introduce the main components and state-of-the-art
architectures for image segmentation with CNNs.
Convolution layer
A convolution layer is a special arrangement of neurons, typically in a 2D or 3D grid,
that acts as a bank of learnable filters (sometimes also called kernels). These filters
are used to perform a sliding dot product with an image to extract the set of optimal
features to solve the classification/regression task. The dot product operation, also
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named convolution, is defined as:
I ⊗K =
∑
i
Ii ·Ki (2.100)
where I and K are arrays of the same dimension, and i represents the index to traverse
such arrays. Figure 2.17 shows an example of a convolution between a kernel of size
3× 3 and a region of an image of the same size.
Figure 2.17: The convolution operation. Image taken with kind permission from https://
towardsdatascience.com/simple-introduction-to-convolutional-neural-networks-cdf8d3077bac.
Therefore, unlike the classic fully-connected layers of an ANN, a convolution layer
is not fully connected to its input, but it contains small banks of filters of shared
weights that traverse the different locations of the image. This introduces several
benefits: first, the number of weights to train in a CNN is drastically lower than on
a classic ANN. Considering the previous aforementioned example, a CNN with a first
layer of 100 learnable filters of size 3 × 3 has only 900 weights to train, regardless of
the image size. Moreover, the 3× 3 weights of each filter are shared across the entire
image, making the pattern learned by the filter invariant to location and translation.
Finally, the 2D or 3D arrangement of the filter weights inherently captures the spatial
information and the semantic meaning of the positions in which the intensities appear
in the images.
In addition to the kernel size, convolution operation also involves two parameters
that must be taken into account: the stride and the padding methods. The stride
controls how the filter convolves around the input image. In other words, the stride
fixes how many pixels the kernel is moved in one direction between two successive
convolutions. Therefore, a stride of 1 means that, after a convolution, the kernel must
be moved one pixel in only one direction and then perform the next convolution. The
padding controls the behavior of the convolution in terms of the size of the resulting
map after the convolution. The convolution operation, by definition, shrinks the image
into a factor related to the size of the kernel used for the operation. Additionally, pixels
in the corners and edges of the images are not visited the same number of times as
central pixels, thus, giving more importance to the latter. To compensate for this effect,
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a padding method can be employed to pad the input image so that the resulting map
after the convolution has the same size than the input image. There are different types
of padding: zero-padding, mirror-padding and reflect-padding; with zero-padding the
most widely used in CNNs.
Batch Normalization layer
Batch normalization is a technique employed to normalize the inputs of a layer, with
the main purpose of mitigating the internal covariate shift problem. The covariate
shift problem refers to the continuous shift that the internal activations of the network
undergo during the training process, due to continuous changes in the distribution of
the inputs of the layers. Since the inputs of a layer are the activations of the previous
layer, a significant change in the distribution of these activations forces the intermediate
layers to continuously adapt itself to these numerical fluctuations. This leads to a
situation where each layer in the ANN wastes training iterations in this adaptation
rather than learning the relations between the inputs and the desired target.
The batch normalization technique prevents this situation by normalizing the ac-
tivations of a layer, before feeding them as the input of the next layer. Let X =(
x1, . . . ,xN
)
a batch of N inputs of a layer, the batch normalization performs as fol-
lows:
µB =
1
N
N∑
i=1
xi
σ2B =
1
N
N∑
i=1
(
xi − µB
)2
xˆi = γ
xi − µB√
σ2B
+ β
where µB is the mean of the batch, σ2B is the variance of the batch and xˆ
i is the
ith normalized sample of the batch. Batch normalization technique introduces two
learnable parameters, γ and β, to allow the network to perform a scale and shift of the
batch if the training process requires it.
Besides mitigating the internal covariate shift, batch normalization also provides
other related benefits to the training process of an ANN. First, batch normalization
allows each layer to learn a little bit more independently of other layers. Since the
inputs are always normalized in the same numerical range, the layer can focus on
learning the relations between the inputs rather than the relations between the adjacent
layers. Second, batch normalization also significantly accelerates the training process.
Higher learning rates can be employed when using batch normalization since it ensures
that there are no a outlier activations. Finally, it reduces overfitting because it has a
slight regularization effect over the entire network.
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Pooling layer
The function of the pooling layers is to progressively reduce the size of the activation
maps in order to also reduce the number of weights and the computational cost of the
network, while retaining the most discriminant information. Additionally, pooling also
allows to increase the receptive field of the network by compressing the information in
smaller activation maps.
There are three main types of pooling layers: max pooling, average pooling and
sum pooling. Max pooling - the most frequently pooling layer used in CNNs - uses
filters to take the largest elements of the activation maps in the pooling window. Figure
2.18 shows an example of the result of a max pooling layer with filters of 2 × 2 and
stride 2.
Figure 2.18: Max pooling with filters of size 2 × 2 and stride 2. Im-
age taken with kind permission from https://towardsdatascience.com/
applied-deep-learning-part-4-convolutional-neural-networks-584bc134c1e2.
As expected, average pooling computes the average value within the pooling layer,
while sum pooling computes the summation of the values inside each pooling layer.
Pooling operation also provides benefits for preventing overfitting. In a general
sense, pooling is a feature selection method by reducing the dimensions of input.
Therefore, selecting a subset of activations from the output of the layers drop use-
less information and introduce slight variations in the new activation maps that helps
in overfitting to specific patterns.
U-Net architecture
The U-Net architecture was first proposed by Ronneberger et al (2015) as a modifi-
cation of the classic Fully convolutional network presented in (Long et al, 2015). It
consist of a contracting path similar than the fully convolutional network, followed by
and expanding path where pooling layers are replaced by up-sampling layers. This
gives the architecture a “U” shape that justifies its name.
The main innovation of this architecture was the expanding path made up of up-
sampling convolutions that allowed to reconstruct the low-dimensional activation maps
into high-dimensional maps of the same size of input image. This enabled to address
image segmentation problems through CNNs in a complete naturally manner, since
the output activation maps could directly represent the logits of each class for each
pixel of the image.
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Figure 2.19 shows the original architecture proposed in the article of Ronneberger
et al (2015). The network consisted in 5 levels of depth, with 64 activation maps
in the first level, 128 in the second, 256 in the third, 512 in the fourth and 1024 in
the final level. The contracting path was formed by blocks of two sequential 3 × 3
convolutions layers followed by max pooling layers with filters of size 2 × 2 at each
level. The expanding path performed the opposite job by gradually projecting the low-
dimensional activation maps into the space of the inputs, so that the final activation
map had as many channels as the number of classes in which each pixel could be
classified.
Figure 2.19: U-Net original architecture.
Another important contribution was the loss employed to train the network. The
work of Ronneberger et al (2015) was the first that proposed to apply a pixel-wise
softmax to the final activation map, in order to convert the activations into probabilities
that represent the degree of confidence of each pixel to belong to each class. Following
this approach, the network was finally trained by minimizing the cross-entropy loss
function between the softmax predictions and the groundthruth segmentation.
The final significant contribution of the paper was the so-called long-term skip con-
nections between same levels in the contracting and expanding paths of the U-Net
architecture (denoted as gray arrows in the figure 2.19). These connections are also
biologically inspired in the human visual cortex, where neurons of the first areas of the
cortex are directly connected with neurons in deeper regions, skipping intermediary
cortex areas. This allows to directly propagate useful signals between different regions
of the cortex to properly understand the scene. The same mechanism is mimicked in
U-Net architectures with the long-term skip connections. These connections introduce
two main benefits in the network: first, they allow to easily propagate the gradient to
the first layers, where it is more difficult to adjust weights (due to gradient vanishing
problem). Second, these connections bring the ability to directly pass useful infor-
mation captured in the first layers that is later required to reconstruct the activation
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maps during the up-sampling.
Since 2012, as a result of the breakthrough brought about by AlexNet (Krizhevsky
et al, 2012), CNNs, and specifically U-Net architectures, clearly dominate most of the
computer vision and image understanding challenges, positioning them as the de facto
standard DL classifiers for addressing these tasks.
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Chapter 3
Comparative study of unsupervised
learning algorithms for
glioblastoma segmentation
Unsupervised learning constitutes one of the most important roles in automated im-
age understanding. Specifically, it has historically played a key role in the medical
image segmentation task, as it provided the first approaches to identify tissues in MRI
acquisitions without requiring manual human intervention. However, currently, med-
ical image segmentation is often dominated by supervised learning methods because
of their superior performance over unsupervised learning methods. Nevertheless, su-
pervised learning approaches have several limitations. The performance of supervised
learning models is directly conditioned by the size and quality of the training corpus,
whose collection is often tedious, time-consuming and sometimes even unaffordable.
Though, most importantly, supervised learning can only learn tasks for which humans
already know the solution. Because of their learning scheme, supervised approaches are
only able to solve problems with well-known defined outputs. Unsupervised learning,
on the contrary, is capable of recognizing patterns within the data in completely unex-
plored and unknown tasks. Regarding the image segmentation problem, unsupervised
learning is able to delineate regions within the image with common MRI properties,
typically representing the same tissue or physiological area. However, due to the un-
guided blind learning approach of unsupervised methods, these generally do not reach
as accurate results as those of a supervised learning model in well-known tasks.
In this sense, the aim of this chapter is to demonstrate that unsupervised learning
can achieve competitive results comparable to those obtained by supervised learning
methods in a well-known task. The purpose is to ratify if unsupervised learning is capa-
ble to detect consistent patterns in MRI, discriminant enough to solve a segmentation
task. For that purpose, we performed a comparative study of several unsupervised
learning algorithms in the task of automated high grade glioma segmentation. A post-
processing stage was also developed to automatically map each label of an unsupervised
segmentations to a specific tissue of the brain. The comparative was performed with
the public reference BRAin Tumor Segmentation (BRATS) 2013 Test and Leaderboard
datasets.
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The contents of this chapter were published in the publications (Juan-Albarrac´ın
et al, 2015b,a)—thesis contributions C1, P1 and P2.
3.1 Introduction
Medical imaging plays an indisputable key role in the diagnosis and management of
brain tumors. The intracranial location of these lesions and the unspecificity of clin-
ical symptoms make medical imaging a necessary tool to diagnose and monitor the
evolution of these diseases (Wen et al, 2010). Specifically, the early identification and
delineation of the different tissues composing the tumor becomes crucial to take de-
cisions that can improve the patient survival. However, the manual segmentation of
these tissues constitutes a complex, time-consuming and biased task, which caught the
attention of the ML community (Bauer et al, 2013). Particularly, glioblastoma tumor
has received most of this attention, as it is the most common and aggressive malignant
tumor of the central nervous system (Dolecek et al, 2012; Deimling, 2009). Glioblas-
tomas are heterogeneous lesions that present different areas of active tumor, necrosis
and edema, all of them exhibiting a high variability related to the aggressiveness of
the tumor. Hence, the automated segmentation of these lesions becomes a desired
solution from the clinical standpoint and an interesting challenge to address from the
ML community.
Extensive reviews of brain tumor segmentation have been presented by Wadhwa
et al (2019); Saman and Jamjala Narayanan (2019); Gordillo et al (2013); Bauer et al
(2013). Most of these techniques fall into the supervised learning approach. Verma et al
(2008) and Ruan et al (2011) employed Support Vector Machines (SVMs) to segment
healthy and pathological tissues, and additionally subcompartiments inside these areas.
Jensen and Schmainda (2009) used neural networks to detect brain tumor invasion.
Lee et al (2008) used a combination of Conditional Random Field (CRF) and SVM to
perform tumor segmentation. Bauer et al (2011) also used SVM and Hierarchical CRF
to segment both healthy and tumor tissues including sub-compartments. Recently,
Random Forest (RF) techniques have shown high success in the supervised brain tumor
segmentation task. Meier et al (2013); Festa et al (2013); Reza and Iftekharuddin
(2013); Tustison et al (2013) proposed several approaches based on RF variants for the
BRATS challenge of Medical Image Computing and Computer Assisted Intervention
(MICCAI) 2013 Conference, reaching the first positions in the competition. Nowadays,
with the advent of novel deep learning techniques, the current state-of-the art is mostly
dominated by CNN classifiers. CNNs are a class of deep feed-forward neural networks
whose architecture is particularly well suited for computer vision recognition tasks.
CNNs have outperformed most of algorithms in many medical image segmentation
problems, arising as the winner technique in most challenges such as BRATS, ISLES
or PROMISE12 challenges. Crimi et al (2015, 2016, 2017, 2018) summarize the most
relevant contributions to the BRATS challenge from 2015 to 2018, demonstrating the
superiority of CNNs in the glioma segmentation task.
However, supervised learning performance depends directly on the quality and size
of the training dataset, which often requires an expensive, time-consuming and biased
task to collect (Gordillo et al, 2013). Moreover, changes in MRI protocols, acquisition
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routines or clinical environments may distort the data and hence affect the perfor-
mance of the supervised models (Duda et al, 2000). However, the major drawback of
supervised learning is that it is only capable to address tasks that humans have already
solved before. The mimic nature of supervised learning limits the paradigm to the set
of problems with known solution, which, without underestimating its unquestionable
usefulness, reduces the ML to an instrument for automatizing well-known tasks.
On the contrary, unsupervised learning address these limitations in a more straight-
forward manner. Unsupervised learning does not require a training corpus from which
to learn a model to solve the task, but it analyzes unlabeled data searching for hidden
patterns and inner relationships that describes their latent structure (Wittek, 2014).
Therefore, besides solving already known tasks, this approach has the innate ability to
discover new knowledge from the data by exploring the arrangement of the informa-
tion. Sticking to the glioblastoma segmentation task, unsupervised learning typically
fits a customized segmentation model to the patient’s MRI, describing their own imag-
ing patterns. This makes it possible to characterize the lesion in each case just by
discriminating its own patterns and not by reinterpreting them under the knowledge
drawn from other examples. By the opposite, the absence of manual segmentations to
guide the learning process makes segmentation more challenging and often lead to a
worse performance with respect to supervised approaches.
Some attempts for brain tissue segmentation have been made under the unsuper-
vised paradigm. Fletcher-Heath et al (2001) proposed an approach based on fuzzy
clustering and domain knowledge for multi-parametric non-enhancing tumor segmen-
tation. Domain knowledge and parenchymal tissue detection was based on heuristics
related to geometric shapes and lesion locations, which may not be robust when high
deformation is presented. Moreover, several assumptions such as prior knowledge about
the number of existing tumor foci or the minimum required thickness of the MRI slices
introduced significant limitations to the method. Nie et al (2009) used Gaussian clus-
tering with a spatial accuracy-weighted Hidden Markov Random Field (HMRF) that
allowed them to deal with images at different resolutions without interpolation. Nowa-
days, advanced reconstruction techniques such as super-resolution enables to work in
a high resolution voxel space by reconstructing the low resolution images without in-
terpolation. Moreover, no automated method was provided to differentiate between
tumor labels and normal tissue labels after the unsupervised segmentation ends. Zhu
et al (2012) developed a software based on the segmentation approach proposed by
Zhang et al (2001), which performs an GMM clustering combined whit HMRFs. Zhu
et al extended Zhang’s approach through a sequence of additionally morphological and
thresholding operations to refine the segmentation. Such operations are not fully spec-
ified and only overall commented, so the reproducibility of their results is not possible.
Vijayakumar et al (2007) proposed a method based on Self-Organizing Maps (SOMs)
to segment tumor, necrosis, cysts, edema and normal tissues using MRI. Although the
learning process of SOMs was performed in an unsupervised manner, the dataset from
which to infer the net structure was determined manually, similar than in a supervised
approach. In their work, 700 pattern observations, corresponding to 7 different tissues,
where selected manually, hence converting the process in a supervised task. Prastawa
et al (2003) proposed a similar approach than the followed in this study. They per-
75
Chapter 3. Comparative study of unsupervised learning algorithms for glioblastoma
segmentation
formed an unsupervised classification based on FMMs and also used a brain atlas to
characterize the normal tissue labels. However, they made important simplifying as-
sumptions to allow them to use the atlas without registration. Moreover, they also
simplify the segmentation task in 2 labels (tumor and edema), ignoring other impor-
tant tissues such as necrosis or non-enhancing tumor. Doyle et al (2013) also proposed
an approach based on GMM clustering and MRF priors. They defined different penal-
izations in the MRF depending on the adjacency of the labels to prevent incoherent
segmentations, however they did not clearly specify how they related the glioblastoma
tissues with these labels before running the unsupervised segmentation. Furthermore,
all the unsupervised approaches described above applied their algorithms on its own
datasets, making difficult a general comparison of the methods.
In this work, we propose a fully automated pipeline for unsupervised glioblastoma
segmentation. Our contributions concern the assessment of the performance of several
unsupervised segmentation methods, including both structured and non-structured
classification algorithms, on a real public and reference dataset; and we also provide
a generalized method to automatically identify pathological labels in an unsupervised
segmentation that represent abnormal tissues in the brain. Our aim is to demonstrate
that unsupervised segmentation algorithms can achieve competitive results, compara-
ble to supervised approaches, by detecting imaging patterns that describe the tissue’s
MRI profiles.
We evaluated our unsupervised segmentation method using the public BRATS 2013
Leaderboard and Test datasets provided for the International Image Segmentation
Challenge of MICCAI Conference. The proposed method with the GMM algorithm
improves the results obtained by most of the supervised approaches evaluated with the
Leaderboard BRATS 2013 set, reaching the 2nd position in the rank. Our variant using
the Gauss-HMRF improves the results obtained by the best unsupervised segmentation
methods evaluated with the BRATS 2013 Test set, and also reaches the 7th position
in the general Test rank, mainly against supervised approaches.
3.2 Materials
In order to make our results comparable, we have used the public multi-modal BRATS
dataset 2013 (Menze et al, 2015), provided for the international BRATS 2013 challenge
in image segmentation of MICCAI conference. We have evaluated our method with
the Test set and the Leaderboard set, and we have made a comparison between our
proposed method and the best algorithms that participated in the challenge.
The BRATS 2013 Test set consists of multi-contrast MR scans of 10 high-grade
glioma patients without the manual expert labeling. The Leaderboard set consists
of 11 + 10 multi-contrast MR scans of high-grade glioma patients, also without the
manual expert labeling. The first 11 Leaderboard patients come from to the Test set
of BRATS 2012 Challenge, while the next 10 cases refer to the new Leaderboard cases
for 2013 Challenge.
For each patient of the datasets, T1-weighted, T2-weighted, FLAIR and post-
gadolinium T1CE-weighted MR images were provided. All images were linearly co-
registered to the post-gadolinium T1CE-weighted sequence, skull stripped, and inter-
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polated to 1 mm3 isotropic resolution. No inter-patient registration was made to put
all the images in a common reference space.
Expert manual annotations of the MRI studies were performed, considering five
possible labels for the lesion:
Label 0: background, brain and everything else not corresponding to labels 1, 2, 3
and 4.
Label 1: non-brain, non-tumor, necrosis, cyst and hemorrhage.
Label 2: surrounding edema.
Label 3: non-enhancing tumor.
Label 4: enhancing tumor.
An evaluation web page was provided to assess the quality of the segmentations,
computing different metrics such as Dice coefficient, positive predictive value, sensi-
tivity and Kappa indices. Furthermore, the evaluation was made over different sub-
compartments of the lesion, to properly measure the performance of the different seg-
mentation methods. The set of labels composing each sub-compartment are described
in section 3.3.5.
3.3 Methods
This section describes the proposed pipeline for the automated unsupervised segmen-
tation of glioblastoma, including a generalized postprocessing designed to identify the
pathological classes of an unsupervised segmentation that represent abnormal tissues
in the brain.
3.3.1 MRI preprocessing
MRI preprocessing is an active field of research that attempts to enhance and cor-
rect MR images for their posterior analysis. In an unsupervised segmentation ap-
proach there is no reference nor manual labeling from which to learn tumor tissue
models. Therefore, common artifacts such as noise, NMR inhomogeneities or regis-
tration missalignments can introduce undesired patterns into images that could led
to erroneous classifications, describing MRI artifacts rather than physiological tissues.
This clearly increases the importance of an accurate and effective preprocess of the
MRI if an unsupervised segmentation is going to be performed. We propose the fol-
lowing scheme for the BRATS 2013 data: 1) Denoising, 2) Skull stripping, 3) Bias field
correction and 4) Super-resolution.
Denoising
Denoising is a standard MRI preprocessing task that aims to reduce or ideally remove
the noise from an MR image. Although MRI noise has been usually modeled as Gaus-
sian distributed, by definition MRI noise follows a Rician distribution (Gudbjartsson
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and Patz, 1995). Diaz et al (2011) presented a comprehensive analysis of different de-
noising methods, discussing their weaknesses and strengths. Recent filters such as the
NLM introduced by Buades et al (2005b) has improved the existing techniques for MR
data. Based on this approach, Manjo´n et al (2010c) introduced a variant of the NLM
filter, called Adaptive-NLM filter, which does not assume an uniform distribution of
the noise over the image, thereby adapting the strength of the filter depending on a
local estimation of the noise. The filter also deals with both correlated Gaussian and
Rician noise. We used the Adaptive-NLMfilter to remove the noise from the BRATS
images.
Brain extraction
Brain extraction, also called skull-stripping, comprises the process of removing skull,
extra-meningeal and non-brain tissues from the MRI sequences. Although BRATS
2013 dataset is already skull stripped, we detected several cases that include partial
areas of the cranium and extra-meningeal tissues. In order to improve the preprocessing
of the data, we recomputed the skull stripping masks for all patients using the Brain
Suite Software, removing the non desired tissues of the MR images. Figure 3.1 shows
an example of a patient of the BRATS 2013 dataset with the original skull stripping,
the resultant image after our new skull stripping and the remaining residual.
Figure 3.1: Example of the proposed skull stripping. From left to right column: original BRATS 2013
patient image, resultant image after the proposed skull stripping and the remaining residual.
Bias field correction
Intensity inhomogeneity is another common artifact present in MRI acquisitions. Mag-
netic field inhomogeneities are unavoidable effects consisting on low frequency sig-
nals that corrupt the images and affect their intensity levels. Typically, automated
segmentation approaches based on MRI are built upon the assumption that tissues
have the same distribution of intensity across the image. Therefore, intensity inhomo-
geneities must be corrected to ensure a correct coherent segmentation. The popular
non-parametric non-uniform intensity normalization N3 algorithm was proposed in
1998 by Sled et al (1998), becoming a reference technique for bias field correcting.
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Tustison et al (2010) proposed in 2010 a new implementation of N3, called N4, which
improves the N3 algorithm with a better B-spline fitting function and a hierarchical
optimization scheme for the bias field correction. N4 was used in our study to correct
MRI inhomogeneities.
Super-resolution
In a brain tumor lesion protocol, several MR sequences are commonly acquired nor-
mally at different resolutions, thereby introducing spatial inconsistencies when a multi-
modal MR study is performed. In these cases, an upsampling or interpolation is needed
to set a common voxel space for all sequences. Classic interpolation such as linear,
cubic or splines interpolation could rise as a solution, but at the cost of introducing ar-
tifacts such as partial volume effects or stair-case artifacts. In contrast, more powerful
and sophisticated methods such as super resolution could improve classic interpolation
by reconstructing the low resolution images recovering its high frequency components.
Several super resolution schemes for MRI are available in the literature (Plenge et al,
2013; Manjo´n et al, 2010a; Rousseau and Alzheimer’s Disease Neuroimaging Initiative,
2010; Protter et al, 2009).
BRATS 2013 dataset comes with a 1mm3 isotropic voxel size resolution achieved
through classic interpolation. In order to improve the resolution of these images, we
employed the super resolution algorithm proposed by Manjo´n et al (2010b), which
exploits the self-similarity present in MR images through a patch-based non-local re-
construction process. Such method iteratively reconstructs a high resolution image by
applying a NLM filter with different strengths, aimed to increase image regularity while
constraining intensity ranges so that they be coherent among scales through a local
back-projection approach. Figure 3.2 shows an example of a super resolved FLAIR
sequence of a patient of the BRATS 2013 dataset with a detailed zoom of an axial
slice.
Figure 3.2: Example of super resolution using Non-local Upsampling method of a FLAIR sequence
of the BRATS 2013 dataset.
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3.3.2 Feature Extraction and Dimensionality Reduction
Feature extraction comprises the process of obtaining new features from the MR images
to improve discrimination between different labels. Although MRI intensities are the
most common used features to differentiate between the brain tissues, it has been
shown that including texture features in combination with MR intensities increases
the performance of the segmentation algorithms (Kassner and Thornhill, 2010; Ahmed
et al, 2011). In this sense, we have implemented the first order statistical texture
features, also called histogram derived metrics or first order central moments.
For each patient we initially obtained an additional image, named T1Diff , which
consists on the absolute difference between the T1CE and the T1 images (Prastawa
et al, 2003). This image highlights the contrast enhanced areas of the patient, such
as the active tumor, helping in their discrimination. Next, for each MR image of the
patient (T1, T1CE, T2, FLAIR and T1Diff ), we computed their first order texture
features. Such features consist on the computation of local histograms in 3D patches
centered at each voxel of the image, and calculate the mean, skewness and kurtosis of
these histograms. We used local 3D patches of 5× 5× 5 voxels.
Thus, a set X of 20 images is obtained for each patient, consisting on the following
images:
X = (T1, T1CE, T2, FLAIR, T1Diff , µT1, ..., γT1, ..., κT1Diff )
where µ, γ, and κ prefixes refers to the mean, skewness and kurtosis features of the
corresponding image.
In order to reduce the complexity and number of parameters to estimate in the
models, a dimensionality reduction process was performed. Dimensionality reduction
seeks for an efficient representation of the original high dimensional data into a lower
dimensional space, retaining or increasing the most relevant information. In our study,
we used Principal Component Analysis (PCA) for dimensionality reduction. We run
PCA on the X set and selected the principal components, which together explained at
least the 99% of the variance of the data, reducing in most cases from 20 dimensions
to 5 dimensions. These images make up the final stack of imaging data used for the
posterior unsupervised segmentations.
An slice example of the feature extraction and PCA dimensionality reduction pro-
cess of a MR study is shown in Figure 3.3.
3.3.3 Unsupervised voxel classification
The BRATS 2013 dataset comprises 5 labels to be segmented, which in some cases
a single label encloses different brain tissues (for example 0 or 1 label). This intra-
class heterogeneity can severely affect the performance of unsupervised methods, since
heterogeneity is naturally explained in unsupervised learning through the definition
of different clusters. Hence, the same semantic class in a problem can be modeled
through a set of different clusters.
In this sense, in order to increase the expression capacity of the unsupervised models
to capture such heterogeneity, we assumed that each tissue can be initially represented
by 2 clusters. That is, we will assume that there exist 7 tissues in the brain, which
are labels 1, 2, 3 and 4 proposed in BRATS 2013 Challenge plus Grey Matter (GM),
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Figure 3.3: Example of feature extraction and dimensionality reduction of a MRI study of a patient
of the BRATS 2013 dataset.
White Matter (WM) and Cerebro-Spinal Fluid (CSF); each one of them with initially
2 clusters to represent their heterogeneity. Note that, therefore, we will estimate an
unsupervised clustering of 14 classes throughout the brain, but we do not require each
tissue to use exactly 2 classes. Hence, a tissue showing a high degree of heterogeneity
can be modeled using a set of 3 or 4 clusters, while an homogeneous tissue can be
segmented by a single cluster. Such assumption provided us a balance between the
number of parameters to estimate to the models and the degrees of freedom required
to explain the heterogeneity of the tissues.
We evaluated the most popular unsupervised classification algorithms. We divided
the algorithm comparison in two groups: structured and non-structured methods. Non-
structured algorithms classify data assuming an i.i.d. condition between the voxels of
the images. Structured prediction covers the range of algorithms that involve the clas-
sification of data with a specific structure, such as an image. Under the non-structured
paradigm, we evaluated three methods: K-means, Fuzzy K-means and GMM cluster-
ing. In the structured prediction case we evaluated the Gauss-HMRF as the archetype
of unsupervised structured learning models.
Let X =
{
x1,x2, . . . ,xN
}
the set of voxels to be classified, where xi ∈ RD repre-
sents a feature vector of D dimensions for the ith voxel. Let Y =
{
y1, y2, . . . , yN
}
the
set of labels associated to each voxel, where yi ∈ {1, . . . , K}.
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K-means
K-means (Lloyd, 1982; Macqueen, 1967) is an unsupervised non-structured iterative
partitional clustering based on a distance minimization criterion. Its aim is to divide
the data space X into K clusters Π = {Π1,Π2, . . . ,ΠK}, so that each observation of
X belongs to the cluster with nearest centroid. The distance criterion minimized by
K-means is:
arg min
Π
K∑
j=1
∑
xi∈Πj
‖ xi − µj ‖2 (3.1)
where µj represents the centroid of the j
th cluster.
The K-means algorithm performs as follow:
Initialization: Make an initial guess about the cluster centroids µj
Until there are no changes in centroids µj (or in clusters Π)
Assign yi to the cluster with nearest centroid µj:
yi = arg min
j
‖ xi − µj ‖2
Update cluster centroids µj
µj =
1
|Πj|
∑
xi∈Πj
xi
From a statistical point of view, the iterative distance minimization criterion fol-
lowed by K-means is equivalent to find the most likelihood parameters of a GMM (Duda
et al, 2000), assuming shared identity covariance matrices and uniform prior probabil-
ities for all classes. The iterative approach followed by K-means is also demonstrated
a special limit of the EM algorithm (Dempster et al, 1977; Bishop, 1995), called Hard-
EM, where each observation is uniquely assigned to a class with posterior probability
equal to 1.
Fuzzy K-means
Likewise K-means, Fuzzy K-means (Dunn, 1973; Bezdek, 1981) is a non-structured it-
erative partitional clustering base on a distance minimization criterion. Under a prob-
abilistic paradigm, it is also equivalent to a GMM assuming shared identity covariance
matrices and uniform prior probabilities for all classes. However, Fuzzy K-means differs
from K-means in which the assignment of an observation to a cluster is not hard but
fuzzy. This means that each observation keeps a degree of membership to each cluster
(equivalent to the posterior probability of a GMM) rather than a unique assignment
of the observation to a class with posterior probability equal to 1.
In the same manner as K-means, Fuzzy K-means aims to divide the data space X
into K clusters Π = {Π1,Π2, . . . ,ΠK}, but it also keeps a vector ui for each observation
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that determines the degree of membership of the ith observation to the different clusters.
The distance minimization criterion followed by Fuzzy K-means is:
arg min
Π
K∑
j=1
N∑
i=1
uij ‖ xi − µj ‖2 (3.2)
where µj represents the centroid of the j
th cluster.
The membership variable uij is typically defined as:
uij =
1∑K
k=1
(
‖xi−µj‖2
‖xi−µk‖2
) 2
m−1
(3.3)
where m controls the degree of fuzziness of the jth cluster, with 1 ≤ m < ∞ and
typically set to 2 in absence of domain knowledge.
The Fuzzy K-means algorithm performs as follow:
Initialization: Make an initial guess about the cluster centroids µj
Until there are no changes in uij greater than 
Estimate the membership coefficients uij for each observation and cluster:
uij =
1∑K
k=1
(
‖xi−µj‖2
‖xi−µk‖2
) 2
m−1
Update cluster centroids µj as the expected value of the observations given
uij:
µj =
∑N
i=1 u
i
jx
i∑N
i=1 u
i
j
Gaussian Mixture Model
A GMM is probabilistic model that model a random variable as a convex combination of
Gaussian pdfs. Thus, it provides a statistical framework to describe the heterogeneity
of a dataset trough a weighted sum of single distributions, each one representing a sub-
population within a data. An in-depth explanation of FMMs and particularly GMMs
is described in section 2.4. Please refer to this section for more details.
As a short remainder, the GMM is defined as:
p (X; Θ) =
N∏
i=1
K∑
j=1
pijN
(
xi;µj,Σj
)
(3.4)
where Θ = {µ1, . . . , µK ,Σ1, . . . ,ΣK , pi1, . . . , piK} are the parameters of the model. The
parameters {pi1, . . . , piK} are typically called mixing coefficients and can be seen as the
prior probability of each component of the mixture describing the data.
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Estimation on GMMs is performed via EM algorithm (Dempster et al, 1977) be-
cause direct MLE estimate does not yield closed-form solutions for the parameters of
the model. For a complete derivation of the MLE estimate and the EM procedure
in FMMs please refer to section 2.4. The algorithm for GMM clustering performs as
follow:
Initialization: Choose an initial setting for Θ(0).
Expectation step: Estimate p
(
Z|X; Θ(t))
p
(
zij = 1|xi; Θ(t)
)
= γij
(t)
=
pi
(t)
j N
(
xi;µ
(t)
j ,Σ
(t)
j
)
∑
k
pi
(t)
k N
(
xi;µ
(t)
k ,Σ
(t)
k
)
Maximization step: Update the parameters of the model given p
(
Z|X; Θ(t))
Θˆ
(t+1)
MLE = arg max
Θ
Ep(Z|X;Θ(t)) logL (Θ;X,Z)
where sticking to GMMs:
pi
(t+1)
j =
N∑
i=1
γij
(t)
N∑
i=1
K∑
k=1
γik
(t)
µ
(t+1)
j =
1
N∑
i=1
γij
(t)
N∑
i=1
γij
(t)
xi
Σ
(t+1)
j =
1
N∑
i=1
γij
(t)
N∑
i=1
γij
(t)
(
xi − µ(t+1)j
)(
xi − µ(t+1)j
)T
Convergence: Stop if L (Θ(t+1);X) − L (Θ(t);X) ≤ ; otherwise t = t + 1 and
go to Expectation step.
As stated above, GMM clustering can be seen as the generalization of K-means and
Fuzzy K-means algorithms, where the hard constraints related to the shared covariance
matrices and the uniform prior probabilities are dropped.
Gauss-Hidden Markov Random Field
MRFs are probabilistic undirected graphical models that define a family of joint proba-
bility distributions by means of an undirected graph (Hammersley and Clifford, 1971).
These graphs are used to introduce conditional dependencies between random vari-
ables of the model, which in the case of the image segmentation task, allows capturing
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the self-similarity and local redundancy present in the images. These dependencies
are explicitly denoted via an undirected and cyclic graph, whose vertices represent
the pixels/voxels of the images and whose edges represent the dependencies between
them. In this sense, a generative model with a given set of parameters Θ incorporating
a HMRF can be defined as:
p (X; Θ) =
∑
Y
p (X, Y ; Θ)
=
∑
Y
p (Y ) p (X|Y ; Θ)
(3.5)
MRFs are usually used to model the prior density p (Y ) of a probabilistic genera-
tive model. According to the Hammersley–Clifford theorem, assuming that the prior
density is strictly positive, a MRF can be defined in terms of local energy functions
and therefore it can be expressed as a Gibbs measure in the form:
p (Y ) =
1
Z
exp (−U (Y )) (3.6)
where U (Y ) is an energy function that defines the conditional dependencies between
the random variables via the graphical model, and Z is called the partition function
and acts as a normalizer to ensure the density to sum 1:
Z =
∑
Y ′
exp (−U (Y ′)) (3.7)
Hammersey-Clifford theorem also states that p (Y ) can be factorized over the cliques
of the undirected graphical model. A clique is defined as a subset of vertices in the
graph such that there exist an edge between all pairs of vertices in the subset. Let Q
the set of all cliques of the graph, the energy function U (Y ) is defined as:
U (Y ) =
∑
q∈Q
Ψ (Y (q)) (3.8)
Nowadays, if complexity is considered, the inference algorithms for MRFs are only
able to optimize undirected graphs with cliques of order 2 (pairwise cliques), i.e. q →
(yn, ym) ∀q ∈ Q. Hence, the most widely used graphical model is the Ising model.
The Ising model defines a graph lattice with as many vertices as pixels/voxels exist in
the image, where conditional dependencies of each variable are expressed in terms of
its orthogonal adjacent neighborhood. The clique factorization for the Ising model is
then performed in the form:
U (Y ) =
∑
(yn,ym)∈Q
Ψ(yn, ym)
=
∑
(yn,ym)∈Q
β(n,m)δ(yn, ym)
(3.9)
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where β(n,m) is a weight defined for the corresponding clique, and δ is a function
that measures the dissimilarity between the clique. Typically, in absence of domain
knowledge, β(n,m) is usually set to 1 and δ is defined as:
δ(yn, ym) =
{
0 if yn = ym
1, otherwise
(3.10)
Typically, the class conditional density p (X|Y ; Θ) is also expressed in terms of
Gibbs measures to take advantage from MRF solvers, so it is usually rewritten as:
p(X|Y ; Θ) = 1
Z
exp (−U (X|Y ; Θ)) (3.11)
where U (X|Y ; Θ) can be assumed i.i.d. and is proportional to the class conditional
p (X|Y ; Θ) density, and Z is again a partition function to ensure the distribution to
sum 1. Under a Gaussian model, U (X|Y ; Θ) can be defined as:
U (X|Y ; Θ) =
N∑
i=0
U
(
xi|yi = j; Θ) = N∑
i=0
− logN (xi;µj,Σj) (3.12)
As a results, the complete structured model is defined as:
p (X; Θ) =
∑
Y
1
Z
exp (−U (X|Y ; Θ)− U (Y )) (3.13)
Exact inference on this model is intractable due to the sum over all possible set
of labels in Z, which becomes a #P − complete problem. However, approximate
efficient algorithms to compute the best labeling Yˆ are proposed in the literature.
Iterated Conditional Modes (Birchfield and Tomasi, 1998), Monte Carlo Sampling
(Geyer and Thompson, 1992), Loopy Belief Propagation (Yedidia et al, 2003), Mean
Field Approximation (Parisi, 1998) or Graph cuts (Boykov et al, 2001) are some of
the available algorithms to solve pairwise MRFs-based models. In our study we used
the FastPD algorithm proposed by Komodakis and Tziritas (2007); Komodakis et al
(2008), which has been demonstrated to be superior to most of the aforementioned
algorithms. This algorithm is based on a combination of Graph cuts with primal-dual
strategies. Therefore the best labeling is computed as:
Yˆ = arg max−U (X|Y ; Θ)− U (Y ) (3.14)
In this sense, we can think of Yˆ as a binary one-hot encoding variable holding the
posterior probability of each label for each pixel/voxel, with yˆij = 1 for the winner class
and yˆik = 0, k 6= j for the remaining classes.
Therefore, likewise GMM, Gauss-HMRF also finds the MLE parameters of a mix-
ture of Gaussian distributions that better fits the data, but imposing the structured
MRF prior. A Hard-EM version (given that exact inference is not possible) of the EM
algorithm is employed to estimate the parameters of the model in the form:
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Initialization: Choose an initial setting for Θ(0).
Expectation step: Estimate Yˆ by using FastPD (or similar) algorithm
U (Y ) =
∑
(yn,ym)∈Q
β(n,m)δ(yn, ym)
U
(
X|Y ; Θ(t)) = N∑
i=0
− logN
(
xi;µ
(t)
j ,Σ
(t)
j
)
Yˆ = arg max−U (X|Y ; Θ(t))− U (Y )
Maximization step: Update the parameters of the model given Yˆ
Θˆ
(t+1)
MLE = arg max
Θ
EYˆ logL (Θ;X,Z)
where sticking to GMMs:
pi
(t+1)
j =
N∑
i=1
yˆij
N∑
i=1
K∑
k=1
yˆik
µ
(t+1)
j =
1
N∑
i=1
yˆij
N∑
i=1
yˆijx
i
Σ
(t+1)
j =
1
N∑
i=1
yˆij
N∑
i=1
yˆij
(
xi − µ(t+1)j
)(
xi − µ(t+1)j
)T
Convergence: Stop if L (Θ(t+1);X) − L (Θ(t);X) ≤ ; otherwise t = t + 1 and
go to Expectation step.
Algorithms initialization
A well-known requirement of unsupervised learning is the good initial seeding. Al-
though the global minima is not usually reached even if a good initialization is pro-
vided, a bad initialization can lead the model to a very sub-optimal local minimum,
thereby providing a poor segmentation. Several strategies such as multiple replications
or intelligent initial seeding are proposed to palliate this effect. In our study, we im-
plemented the K-means++ algorithm (Arthur and Vassilvitskii, 2007), which provides
an initialization that attempts to avoid local sub-optimal minimums.
We propose the following procedure to ensure a competitive unsupervised segmen-
tation: First, generate 100 different initializations using K-means++ algorithm. Next,
automatically select the 10 most promising initializations by minimizing the average
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intra-cluster sums of point-to-centroid distances of the initializations. Finally, run each
unsupervised segmentation algorithm with the 10 most promising initializations and
choose the best solution considering the following criteria:
K-means: choose the solution with lowest intra-cluster sums of point-to-centroid dis-
tances.
Fuzzy K-means: choose the solution with lowest intra-cluster sums of point-to-centroid
distances.
GMM: choose the solution with highest log-Likelihood value.
Gauss-HMRF: choose the solution with highest log-Likelihood value.
3.3.4 Automated pathological label identification
Unsupervised segmentation produces a partitioning of the data space into several
classes, each one without semantic sense. In other words, in the brain tumor unsu-
pervised approach, labels do not directly identify a specific tissue but only distinguish
between MRI data different enough from each other to be considered equal. More-
over, labelings among different patient segmentations may not always represent the
same tissue, complicating its biological interpretation. Hence, an automated patholog-
ical label identification is mandatory to provide a powerful and competitive unsuper-
vised segmentation method. We propose the following method to automatically isolate
pathological labels:
1. Identify and remove WM, GM and CSF labels.
2. Remove outlier and partial volume labels.
3. Merge labels by statistical distribution similarities.
Identify and remove WM, GM and CSF labels
Under the International Consortium of Brain Mapping (ICBM) project, an unbiased
standard MR brain atlas was provided by the McConnell Brain Imaging Centre in 2009
(Fonov et al, 2011, 2009). The ICBM atlas include a T1, T2 and Proton density MR
images, with the associated WM, GM and CSF tissue probability maps. Such tissue
probability maps indicate the probability for each voxel v of the brain to belong to a
normal tissue T = {WM,GM,CSF}, with:∑
t∈T
p(t|v) = 1 (3.15)
In our study we used these tissue probability maps to detect which labels of a
segmentation explain the WM, GM and CSF tissues. However, taking into account
that the ICBM template represents a healthy brain, it is necessary to corrected these
maps by setting to zero (or a smaller  value) the probability of any voxel v in the
area of the lesion. Therefore, we first performed a non-linear registration of the ICBM
T1 template to the T1 sequence of the patient and applied the warp transformation to
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the tissue probability maps. Following the study conducted by Klein et al (2009), we
used the SyN algorithm (Avants et al, 2008) implemented in the ANTS software with
cross-correlation similarity metric. Once we obtained the patient aligned healthy-tissue
probability maps, a roughly approximate mask of the lesion of each patient was com-
puted to correct the probability maps. The typical delineation of the lesion performed
by expert radiologists is usually based on the hyper-intensity areas in the T2 and T1CE
sequences (Bauer et al, 2013). Following a similar criteria, we computed an approxi-
mate mask of the lesion by selecting the voxels whose value in the FLAIR and T1CE
images were higher than the median plus the standard deviation of the corresponding
image. Next, we automatically filled the holes of the computed masks and removed the
voxels that fell in the perimeter of the brain (typically showing hyper-intensities due
to cranial traces). Finally, we corrected the healthy-tissue probability maps of each
patient by setting an  probability in the area determined by their corresponding le-
sion masks. Figure 3.4 shows an illustration of the algorithm to compute the corrected
tissue probability maps for a patient.
Figure 3.4: Illustration of the algorithm to compute the patient healthy-tissue probability maps and
lesion area correction.
Based on these patient healthy-tissue probability maps, we identified which classes
of an unsupervised segmentation mostly represent a normal tissue. Let S a segmen-
tation obtained through any unsupervised method, and let vl = {v : S (v) = l} the set
of voxels v of S classified with label l. Let t a normal tissue where t ∈ T . To perform
the pathological tissue identification we computed the following probability mass:
89
Chapter 3. Comparative study of unsupervised learning algorithms for glioblastoma
segmentation
p(l|t, S) =
∑
u∈vl p(t|u)∑
v p(t|v)
(3.16)
Simplifying, the p(c|t, S) determines how much of the normal tissue t is explained
by the label l in the segmentation S.
Therefore, for a given tissue t, and based on these probabilities, we constructed two
vectors: one with the p(c|t, S) values sorted in descending order, denoted as Pt, and
the other with the corresponding label codes sorted in the same manner, denoted as
Kt.
Kt = {l : p(l|t, S) ≥ p(l′|t, S)}
Pt = {p(l|t, S) : p(l|t, S) ≥ p(l′|t, S)}
(3.17)
Then, we computed the cumulative sum of Pt, denoted as St, and finally choose
the set of labels of Kt whose St value exceed a threshold τ .
Zt = {Kt (j) : St (j) > τ, 1 ≤ j < K} (3.18)
The Zt set contains the classes of S that have a very low probability of explain the
normal tissue t. Hence, we repeated the same procedure for each normal tissue t and
computed the intersection between the Zt sets to finally isolate the labels that do not
explain any normal tissue, i.e. the pathological classes:
Z = ZWM ∩ ZGM ∩ ZCSF (3.19)
Given that our aim is to evaluate the performance of each unsupervised segmenta-
tion algorithm, all of them in the same conditions, we do not carried out any particular
optimization of the τ threshold for each algorithm. Instead, we fixed a general thresh-
old for all the methods, set to τ = 0.8, as a reasonably, high confidence and compatible
value to perform the pathological labels identification. Note that τ = 1 is not possible
since this implies that all the classes of the segmentation will be required to explain
only a single normal tissue.
Remove outlier and partial volume labels
The above process of identifying and removing the healthy-tissue labels may leave some
spurious labels that must be deleted. We found that these labels frequently appear in
the perimeter of the brain or in a very low proportion compared to the other labels of
the segmentation. The labels located at the perimeter of the brain typically correspond
to remaining traces of cranium, intensity artifacts between brain and background or
partial volume effects that super resolution cannot resolve. The low proportion labels
often match to outlier voxels in terms of abnormal intensity values, usually produced
by artifacts in the MR acquisition.
In order to remove the perimeter unwanted labels, we deleted all the connected
components of all the remaining labels of the segmentation, which overlapped more
than the 50% of its area with a binary dilated mask of the perimeter of the brain. To
90
3.3. Methods
remove the smaller low proportion labels we removed those ones with a prevalence less
than the 1% the remaining segmentation after the above processes.
Merge labels by statistical distribution similarities
The heterogeneity of the pathological labels led us to assume that each tissue was ini-
tially modeled by two clusters. However, this was a general but not strict assumption,
i.e. we did not enforce to use exactly two cluster per tissue. Instead, we estimated
a general clustering of 14 components for each case. Hence, a tissue may have been
represented by two or more labels in the segmentation or, conversely, by a single label
depending on its homogeneity. Therefore, it was mandatory to design a mechanism to
find which labels were explaining the same semantic concept, i.e. the same pathological
tissue.
Based on the work proposed by Sa´ez et al (2017), we analyzed the MRI intensity
distributions of the remaining labels to find potential clusters representing the similar
information. To do so, we estimated the pdf of each label through a kernel smoothing
density estimation, and used the Jensen-Shannon divergence to measure the pairwise
distances among them. Therefore, we constructed a pairwise matrix of statistical
distribution distances and used Hierarchical Agglomerative Clustering (HAC) with
average link (Unweighted Pair Group Method with Arithmetic mean (UPGMA)) to
merge the similar labels.
Due to the BRATS 2013 labeling considers 4 pathological labels to be segmented,
we enforced the clustering to return a maximum of 4 classes. Note that the method is
able to return less than 4 classes if the HAC finds enough similarities between them,
however, in any other case the method is enforced to return a maximum of 4 labels.
Figure 3.5 shows and example of the pathological labels isolation procedure.
Figure 3.5: Automated pathological label identification process.
3.3.5 Evaluation
We evaluated our unsupervised brain tumor segmentation framework with the BRATS
2013 Leaderboard and Test datasets. Segmentations provided by the different unsu-
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pervised methods in combination with the proposed preprocessing and postprocessing
pipelines were sent to the BRATS evaluation web page. The figures of merit provided
to assess the quality of the segmentations were:
• Dice: 2(TP+TN)
P+N+Pˆ+Nˆ
• PPV: TP
TP+FP
• Sensitivity: TP
TP+FN
• Kappa: PA−PE
1−PE
where TP refers to the true positives in the segmentation, TN to the true negatives,
FP to the false positives, FN to the false negatives, P to the real positives of the
ground truth, N to the real negatives of the ground truth, Pˆ to the estimated pos-
itives of the proposed segmentation, Nˆ to the estimated negatives of the proposed
segmentation, PA to the accuracy of the segmentation and PE to a term that measures
the probability of success by chance, defined as: PE =
(
P
P+N
· Pˆ
Pˆ+Nˆ
)
+
(
N
P+N
· Nˆ
Pˆ+Nˆ
)
.
Furthermore, three different sub-compartments of the lesion were evaluated to prop-
erly assess the quality of the segmentation methods. Table 3.1 describes the labels
involved in each sub-compartment considered in the evaluation.
Table 3.1: Labels composing each sub-compartment evaluated in the BRATS 2013 challenge.
Label 0 Label 1 Label 2 Label 3 Label 4
Whole Tumor (WT) 5 5 5 5
Tumor Core (TC) 5 5 5
Enhancing Tumor (ET) 5
3.4 Results
Tables 3.2 and 3.3 show the results obtained in the Test and Leaderboard datasets
respectively, grouped by the unsupervised algorithms tested in this study.
As expected, Gauss-HMRF and GMM demonstrate their superiority with respect
the other algorithms. Almost all the metrics reveal that both algorithms obtain the
best results in all the sub-compartments segmentations. Only the enhancing tumor
sub-compartment in the Leaderboard set yielded worse results for the GaussHMRF
compared to the results obtained in the other sub-compartments and datasets. Such
effect typically occurs because of the smoothing prior of the Gauss-HMRF, which is
later discussed in the Discussion section.
Tables 3.4 and 3.5 show the published ranking of the BRATS competition grouped
by the learning paradigm adopted by each method and the metrics and sub-compartments
evaluated in the Challenge. As shown in Table 3.4, we achieved the 1st position in the
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Table 3.2: Summary of average results obtained by the different unsupervised algorithms in combi-
nation with the proposed preprocess and postprocess over the BRATS 2013 Test set.
Dice PPV Sensitiviy
Classifier
WT TC ET WT TC ET WT TC ET
Kappa
K-means 0.69 0.49 0.57 0.66 0.48 0.68 0.76 0.57 0.51 0.98
Fuzzy K-means 0.70 0.46 0.39 0.73 0.47 0.51 0.71 0.54 0.35 0.98
GMM 0.69 0.60 0.55 0.63 0.60 0.64 0.78 0.68 0.55 0.98
Gauss-HMRF 0.72 0.62 0.59 0.68 0.58 0.67 0.81 0.75 0.60 0.98
Table 3.3: Summary of average results obtained by the different unsupervised algorithms in combi-
nation with the proposed preprocess and postprocess over the BRATS 2013 Leaderboard set.
Dice PPV Sensitiviy
Classifier
WT TC ET WT TC ET WT TC ET
Kappa
K-means 0.76 0.49 0.53 0.75 0.44 0.66 0.82 0.56 0.48 0.99
Fuzzy K-means 0.77 0.46 0.25 0.81 0.46 0.27 0.77 0.51 0.27 0.99
GMM 0.74 0.59 0.60 0.71 0.55 0.60 0.81 0.71 0.66 0.99
Gauss-HMRF 0.77 0.63 0.32 0.72 0.61 0.33 0.84 0.71 0.50 0.99
ranking of the unsupervised methods of the Test set, and the 7th position in the gen-
eral ranking, mostly against supervised approaches. Table 3.5 shows the Leaderboard
ranking and the results achieved by our method. The proposed approach in combi-
nation with the GMM algorithm reaches the 2nd position of the Leaderboard ranking,
improving the results obtained by many supervised methods, mainly in the enhancing
tumor sub-compartment.
Table 3.6 shows the average time in minutes required to obtain a segmentation for
a single patient, including the preprocessing and postprocessing stages. Segmentations
were computed in an Intel Xeon E5-2620 with 64GB of RAM using multi-threading.
The preprocessing stage includes the denoising, bias field correction, skull-stripping
and super resolution steps. The unsupervised classification time involves the parallel
computation of the 10 different segmentations starting from the K-means++ initializa-
tion, and the posterior selection of the best solution. As expected, the more complex
and sophisticated the algorithm is, the longer it takes to reach the solution. The post-
processing stage consist in the automated pathological label identification method, the
outlier label removal and the merging process of similar statistical distribution labels.
Such process includes the non-linear registration of the ICBM template to the patient
T1 image, which practically covers the entire time of the postprocessing stage. It is
worth noting that the non-linear ICBM registration is performed only once for all the
unsupervised segmentation algorithms.
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Table 3.4: Ranking of the BRATS 2013 Test set and the position occupied by our proposed unsuper-
vised segmentation framework with the Gauss-HMRF algorithm.
Dice PPV Sensitiviy
User
WT TC ET WT TC ET WT TC ET
Kappa
Nick Tustison 0.87 0.78 0.74 0.85 0.74 0.69 0.89 0.88 0.83 0.99
Raphael Meier 0.82 0.73 0.69 0.76 0.78 0.71 0.92 0.72 0.73 0.99
Supervised Syed Reza 0.83 0.72 0.72 0.82 0.81 0.70 0.86 0.69 0.76 0.99
methods Liang Zhao 0.84 0.70 0.65 0.80 0.67 0.65 0.89 0.79 0.70 0.99
Nicolas Cordier 0.84 0.68 0.65 0.88 0.63 0.68 0.81 0.82 0.66 0.99
Joana Festa 0.72 0.66 0.67 0.77 0.77 0.70 0.72 0.60 0.70 0.98
Unsupervised This work 0.72 0.62 0.59 0.68 0.58 0.67 0.81 0.75 0.60 0.98
methods Senan Doyle 0.71 0.46 0.52 0.66 0.38 0.58 0.87 0.70 0.55 10.98
Table 3.5: Ranking of the BRATS 2013 Leaderboard set and the position occupied by our proposed
unsupervised segmentation framework with the GMM algorithm.
Dice PPV Sensitiviy
User
WT TC ET WT TC ET WT TC ET
Kappa
Supervised Nick Tustison 0.79 0.65 0.53 0.83 0.70 0.51 0.81 0.73 0.66 0.99
method
Unsupervised This work 0.74 0.59 0.60 0.71 0.55 0.60 0.81 0.71 0.66 0.99
method
Liang Zhao 0.79 0.59 0.47 0.77 0.55 0.50 0.85 0.77 0.53 0.99
Supervised Raphael Meier 0.72 0.60 0.53 0.65 0.62 0.48 0.88 0.69 0.64 0.99
methods Syed Reza 0.73 0.56 0.51 0.68 0.64 0.48 0.79 0.57 0.63 0.99
Nicolas Cordier 0.75 0.61 0.46 0.79 0.61 0.43 0.78 0.72 0.52 1.00
Finally, examples of segmentations achieved by the different unsupervised segmen-
tation algorithms evaluated are shown in Figure 3.6.
3.5 Discussion
In this study we have conducted an evaluation of the performance of several unsuper-
vised learning algorithms for the glioblastoma segmentation task. In addition to the
comparative, we have proposed a complete pipeline for automated brain tumor segmen-
tation, including a postprocessing stage to automatically identify labels corresponding
to pathological tissues in an unsupervised segmentation.
The proposed method is confirmed as a viable alternative for glioblastoma segmen-
tation, as it has demonstrated to achieve competitive results in a public real reference
dataset for brain tumor segmentation. The method improved the results obtained by
the other unsupervised segmentation approaches evaluated in the BRATS 2013 Chal-
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Table 3.6: Average computational times in minutes for the whole segmentation pipeline for a single
patient.
Algorithm Preprocess Unsupervised classification Postprocess Total
K-means 9 ± 5 110 ± 27
Fuzzy K-means 29 ± 3 130 ± 25
GMM 41 ± 7 142 ± 29
Gauss-HMRF
13 ± 3
39 ± 10
88 ± 19
140 ± 32
lenge, and obtained competitive results with respect to supervised methods. Moreover,
this study confirmed the capability of unsupervised learning to detect consistent pat-
terns in medical imaging data related to MRI properties of the tissue, which will serve
as basis for the next work on this thesis.
The proposed unsupervised segmentation pipeline comprises four stages: MRI pre-
processing, feature extraction and dimensionality reduction, unsupervised voxel classi-
fication and automatic pathological label identification. Concerning the preprocessing
stage, consolidated state of the art techniques that provide efficient solutions to en-
hance the information of the MR images were employed. However, some preprocessing
techniques are primarily oriented to non-pathological brains. This is the case of bias
field correction. In our experiments, we found that the estimation of the magnetic field
inhomogeneities with the N4 algorithm presented problems primarily with FLAIR se-
quences. The hyper-intensity presented in the FLAIR sequence related to the edema
was confused frequently with inhomogeneities of the magnetic field, thereby reducing
its intensity. In order to overcome this problem we reduced the number of iterations
of the algorithm to remove as much inhomogeneities as possible, while keeping the
intensities of the lesion. Such solution assumed a non optimal removal of the mag-
netic field inhomogeneities, but allowed to save the information contained in the lesion
area, which becomes more important to the segmentation task. We empirically set a
maximum of 10 iterations at each scale of the multi-scale approach of the N4 algorithm.
Several unsupervised classification algorithms were evaluated to assess its pros and
cons, ranging from the most restrictive algorithms in terms of class-conditional prob-
abilistic models (K-means and Fuzzy K-means) to more sophisticated models with
more degrees of freedom such as GMM or Gauss-HMRF. The last one, also introduces
statistical dependencies between adjacent variables of the model, that penalizes neigh-
boring voxels with different labels. Hence, this structured prior aims to model the self
similarity of the images, leading the algorithm to a more homogeneous segmentation
than the non-structured classification techniques.
Therefore, the less restrictive algorithms were expected to achieve better results
based on the hypothesis that these algorithms learn a more flexible model that best fits
the data to be classified. Moreover, structured algorithms were also expected to obtain
better results based on the hypothesis that these algorithms introduce mechanisms to
model the self similarity of the images. Tables 3.2 and 3.3 confirm such hypotheses.
Both GMM and Gauss-HMRF rose as the best algorithm tested in almost all the
95
Chapter 3. Comparative study of unsupervised learning algorithms for glioblastoma
segmentation
Figure 3.6: Examples of final segmentations of 3 patients of BRATS 2013 dataset computed by the
different unsupervised algorithms.
metrics returned by the evaluation web page. Only the results obtained by the Gauss-
HMRF model in the enhancing tumor sub-compartment of the Leaderboard set were
not comparable with the other sub-compartments and datasets results. This effect
was due to the smoothing prior imposed by the Gauss-HMRF, which was too strong
in some cases. We revised the cases that achieved low results in the enhancing tumor
sub-compartment and realized that most of them had a large necrotic core with a thin
low-brightness enhancing tumor ring. We also revised the K-means++ initializations
and realized that the enhancing tumor was partially segmented in some cases but finally
lost in the final segmentation due to the hard smoothing prior in the necrotic class.
We are currently working on the introduction of different penalizations for the labels,
depending on their statistical distribution similarities to avoid this over-smoothing.
It is worth noting that we obtained better results on the Leaderboard set (Table
3.5) than in the Test set (Table 3.4), in contrast with the rest of participants. This
effect may have been produced by the fact that the Leaderboard set may include
more heterogeneities and differences with respect to the Training set than to the Test
set, thereby directly affecting the supervised approaches performance. Unsupervised
paradigm avoids this possible overfitting by building a particular model for each patient
considering only its own data, therefore achieving better results in the Leaderboard
set against most of the supervised approaches evaluated.
In future work, we plan to improve our feature extraction process by analyzing
the influence of the texture images in the final segmentations and including more
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sophisticated textures such as the Haralick texture features. Furthermore, we plan
to extend our unsupervised methodology to the analysis and segmentation of PWI
in combination with anatomical images. The biomarkers obtained from PWI might
discover relevant segmentations by adding additional valuable functional information
about the tissues. We consider that research efforts should be aligned with quantitative
MRI by providing powerful systems that leverage the information contained in these
images.
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Chapter 4
Non Local Spatially Varying Finite
Mixture Models for unsupervised
image segmentation
As stated in the previous chapter, image segmentation is one of the most important
core problems in computer vision. It constitutes one of the basic and fundamental
steps for automated image understanding since its purpose is to delineate objects in
the image with semantic meaning. Innumerable approaches have been proposed in
the literature to address this problem, ranging from supervised to unsupervised ML
approaches. The latter are indispensable to the image understanding and segmentation
task as they provide a robust and reliable solution to all the problems that do not have
manually annotated datasets, which ultimately represent the vast majority of real-life
image segmentation problems.
Images are structured arrangements of data in which, in addition to the pixel inten-
sities, the location of the pixels provides important information to properly understand
its content. Structured learning models capable to properly capture the patterns of
local regularity and spatial redundancy of the images have demonstrated their superi-
ority in the image segmentation task.
In this chapter a Bayesian model for unsupervised image segmentation based on a
combination of the SVFMMs and the NLM framework is presented. Such model suc-
cessfully integrates a gauss-markov random field into a classic FMM, to simultaneously
codify the idea that neighboring pixels tend to belong to the same semantic object,
but preserving the edges and structure of the image. The chapter introduces the math-
ematical foundations of the model and their estimation via a MAP-EM scheme. We
present an evaluation of the performance of the model in a synthetic medical imaging
corpus and with a reference dataset of real-world images.
The contents of this chapter were published in the journal publication (Juan-Albarrac´ın
et al, 2019b)—thesis contributions C2 and P3.
99
Chapter 4. Non Local Spatially Varying Finite Mixture Models for unsupervised image
segmentation
4.1 Introduction
Unsupervised learning has historically played a key role in the image segmentation task,
constituting one of the first paradigms to automatically identify objects and structures
in an image (Zhang et al, 2008). Specifically, clustering has gathered most of the efforts
in unsupervised image segmentation research. Clustering is the task of finding natural
groupings of data within a population, sharing a similar set of properties (Rokach
and Maimon, 2005). Many clustering techniques have been proposed in the literature
during the past decades (Saxena et al, 2017), ranging from distance based techniques
such as partitional clustering or hierarchical clustering; density-based techniques such
as DBSCAN (Ester et al, 1996) or Mean Shift (Cheng, 1995); graph based algorithms
such as graph-cuts (Boykov et al, 2001); or probabilistic models such as Finite Mixture
Models (FMMs)(Pal and Pal, 1993).
Specifically, probabilistic models intend to learn the pdf of an image by means
of fitting a multi-parametric statistical model to the data. In particular, FMMs fit
a weighted sum of probabilistic distributions, each one representing a component of
the image, to capture the heterogeneity nature of the image information. GMMs are
the most extended FMMs, being widely employed for image segmentation, as they
have proven to successfully capture the complexity of an image (Juan-Albarrac´ın et al,
2015b). Moreover, GMMs can be efficiently estimated by means of MLE via the
Expectation-Maximization (EM) algorithm (Dempster et al, 1977).
However, learning from an image has several particularities that must be taken
into account. Images are structured arrangements of data in which, in addition to
the pixel intensities, the location of these intensities provide important information to
properly understand its content. Images show patterns of local regularity and spatial
intensity redundancy that enclose the idea that adjacent pixels tend to belong to the
same semantic object. Conventional FMMs, by the opposite, do not inherently take
into account this information. FMMs make the heavy assumption that data in an
image is i.i.d., ignoring the spatial information that has demonstrated to be useful to
generate more accurate and realistic models.
To overcome this limitation, several solutions have been proposed in the literature
(Blake and Rother, 2011). Most of them rely on the inclusion of a MRF to model
the local dependencies between pixels in an image. Specifically, a variant to the FMM
called SVFMM was proposed by Sanjay-Gopal and Hebert (1998), which replaces the
classics mixing coefficients of the FMM by contextual mixing coefficients for each pixel
of the image. This approximation allows to introduce a continuous MRF over these
contextual mixing coefficients to incorporate the idea that neighboring pixels tends to
share the same intensity properties.
Many variants of MRFs have been proposed in the literature to capture the local in-
formation contained in an image. Nikou et al (2007) proposed a family of Gauss-MRFs,
successfully achieving better results than the classic FMMs. However, such approxi-
mation introduces a local isotropic smoothing over the contextual mixing coefficients,
that ignores the presence of edges in the image. Therefore, the contextual mixing
coefficients estimated under the Gauss-MRF approximation are iteratively smoothed,
yielding prior probability maps that lose the information of image edges. Sfikas et al
(2008) proposed a t-Student MRF that allowed to regulate the smoothing between pix-
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els in an edge. However, this approximation introduces new parameters to be estimated
in the model, yielding a non closed-form analytic solution for it.
In this chapter a fully Bayesian SVFMM model, called NLSVFMM, that combines
the SVFMM framework with the NLM filtering schema is proposed. The model has
2 variants: the pixel-wise version (NLv-SVFMM) and the patch-wise version (NLp-
SVFMM). The proposed model introduces a Gauss-MRF weighted by the proba-
bilistic NLM function proposed by Wu et al (2013) to adaptively adjust the spatial
regularization depending on the structure of the image. Such approximation avoids
the introduction of new parameters, reducing the degrees of freedom of the model and
the number of samples required for a reliable estimation of the parameters.
4.2 Background on Spatially Varying Finite Mix-
ture Models
The SVFMM is a modification of the classic FMM, focused mainly on imaging data,
in which the coefficients of the mixture are related to each other through a structured
graph that defines the statistical dependencies between them. SVFMMs are thoroughly
introduced in section 2.4, however, in order for this chapter to be self-contained, a short
remainder will be made.
Let X =
(
x1, . . . ,xN
)
a set of observations corresponding to the pixels of an image,
where xi ∈ RD and represents a vector of D features for the ith pixel. The SVFMM is
defined as:
p (X|Θ,Π) =
N∏
i=1
K∑
j=1
piijφ
(
xi; Θj
)
(4.1)
where φ (xi|Θj) is a pdf used to model the data (typically a Normal or t-Student
distribution) and Θ =
{
Θ1, . . . ,ΘK , pi
1, . . . , piN
}
the set of parameters of the model,
with Π =
{
pi1, . . . , piN
}
called the contextual mixing coefficients, which must comply
with:
∀pii, 0 ≤ piij ≤ 1,
K∑
j=1
piij = 1 (4.2)
A MAP estimate of (Θ,Π) is typically conducted to impose a proper prior over Π
to introduce the idea that neighboring pixels in an image tend to belong to the same
semantic object. (
Θˆ, Πˆ
)
MAP
= arg max
(Θ,Π)
log p (X|Θ,Π) + log p (Π) (4.3)
Several variants of p (Π) have been proposed in the literature. Specifically, the
DCAGMRF, introduced in equation 2.65, has proven to successfully capture the lo-
cal redundancy and spatial regularity inherent in images, regularizing many ill-posed
inverse problems with successful results (please refer to section 2.4.2 for a detailed
description of the DCAGMRF prior).
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As stated in section 2.4.2, inference on SVFMMs is not analytically tractable. Nu-
merical optimization methods are therefore required to estimate (Θ,Π) in a tractable
manner. Typically, a MAP-EM algorithm is used to iteratively find the updates of the
model parameters, based on the conditional expectation of the log-likelihood function,
used to guide the estimation procedure. Nevertheless, no closed-form solution can be
obtained for pii when considering the restriction stated in 4.2. To overcome this lim-
itation, an alternative solution is to consider Π as a random variable governed by a
DCM distribution. Nikou et al (2010) demonstrated that, following such approach, piij
can be computed as:
piij =
αij
K∑
k=1
αik
(4.4)
with αi the parameters of the Dirichlet distribution. It is easy to see that such approach
always guarantees that
∑
j pi
i
j = 1 ∀i, hence satisfying the condition settled in 4.2.
In addition, αi parameters only require to satisfy αij > 0 ∀i, j, making easier their
optimization.
Therefore, following this DCM-SVFMM approach, the DCAGMRF density can
be imposed over A =
{
α1, . . . , αN
}
(instead of over Π), to enforce the desired local
regularity:
p (A) =
N∏
i=1
K∏
j=1
D∏
d=1
∏
m∈Mid
1√
2piβ2j,d
exp
(
−
(
αi − αmj
)2
2β2j,d
)
(4.5)
where sub-index d refers to the different spatial adjacency directions (i.e. horizontals,
verticals or diagonals), and Mid indicates the set of neighbors of the ith pixel that lies
in the dth spatial direction.
The complete step-by-step estimation of the parameters of the DCM-SVFMM via
the EM algorithm is described in section 2.4.3. We encourage the reader to review this
section for an in-depth explanation of the estimation procedure of the DCM-SVFMMs.
4.3 Background on Probabilistic Non Local Means
The NLM filter (Buades et al, 2005a) proposes a schema for image filtering where
pixels are restored by a weighted sum of similar neighbor patches.
The core of NLM schema is the weight function that relates neighboring patches,
which has taken a lot of variants in the literature. Specially, Wu et al (2013) derived the
probabilistic version of the NLM algorithm and its associated probabilistic weighting
function.
In order to relate the description of the probabilistic NLM with the SVFMM back-
ground, let’s consider di,mj,d as the distance between a pair of adjacent Dirichlet param-
eters in the form:
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di,mj,d =
(
αij − αmj
)2
2β2j,d
(4.6)
Assuming that local differences are i.i.d., we have di,mj,d ∼ χ2 (1). For a patch-based
version of the algorithm, the distance between two patches centered at ith and mth
locations is defined as:
Di,mj,d =
∑
k∈P
di+k,m+kj,d (4.7)
where P is the set of offsets that define a local patch around a given pixel. If patches
are completely disjoint, then Di,mj,d ∼ χ2 (|P|), however, in most cases, overlapping
occurs between patches, so the i.i.d. assumption does not hold. In such cases, an
approximation to the sum of a set of correlated χ2 distributions can be computed as:
Di,mj,d ∼ γmχ2 (ηm) (4.8)
where
γm = var
[
Di,mj,d
]
/2E
[
Di,mj,d
]
ηm = E
[
Di,mj,d
]
/γm
(4.9)
and
E
[
Di,mj,d
]
= |P|
var
[
Di,mj,d
]
= 2 |P|+ ∣∣Oi,m∣∣ (4.10)
with Oi,m the set of overlapping pixels between the patches centered at ith and mth
pixels.
Hence, the weight function ui,mj,d proposed in the probabilistic NLM approach, as-
sociated to the SVFMM framework, is defined as
ui,mj,d = χ
2
(
Di,mj,d /γm|ηm
)
=
(
Di,mj,d /γm
)(ηm/2)−1
exp
(−Di,mj,d /2γm)
2ηm/2Γ (ηm/2)
(4.11)
4.4 The Non Local Spatially Variant Finite Mix-
ture Model
One of the main drawbacks of the SVFMM-based models is that they enforce a local
smoothness on the contextual mixing coefficients (or Dirichlet parameters) without
taking into account the structure of the image. In other words, the SVFMM iteratively
applies an isotropic local Gaussian smoothing to these parameters, leading to a over-
smoothed prior probability map that losses the information of the edges and structures
in the image.
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To overcome this limitation, Sfikas et al (2008) proposed a variant of the SVFMM
where local differences between Dirichlet parameters follow a t-Student distribution.
Such an approach was intended to exploit the heavy-tailed nature of the t-Student
distribution, to perform a robust estimation of the Dirichlet coefficients when edges
and structures are present in their local neighborhoods.
αij − αmj ∼ St
(
0, β2j,d, νj
)
(4.12)
Following the Bishop’s development in (Bishop, 2006), a St distribution can be
expressed as:
αij − αmj ∼ N
(
0, β2j,d/g
i,m
j,d
)
gi,mj,d ∼ G (νj,d/2, νj,d/2)
(4.13)
This model introduces a new set of latent variables gi,mj,d , whose posterior density
should be estimated at the E-step, and a new set of parameters νj,d, with non closed-
form analytic estimation. Therefore, numerical optimization methods such as Newton-
Raphson or Brent’s methods should be employed to estimate νj,d.
In this sense, and similar in spirits than the t-Student model, in this chapter we
propose the NLSVFMM as a modification of the Sfikas’ t-Student model, by replacing
the gi,mj,d random variable by the probabilistic NLM u
i,m
j,d weight. Therefore, we propose
to reformulate the local differences between contextual Dirichlet parameters to follow
a NLM-related distribution, denoted by:
αij − αmj ∼ N
(
0, β2j,d/χ
2
(
Di,mj,d /γm|ηm
))
Di,mj,d ∼ γmχ2 (ηm)
(4.14)
with Di,mj,d being latent variables of the model.
Following the conventional EM scheme, the posterior densities of Di,mj,d should be
calculated at the E-step. However, this leads to a different calculation of Di,mj,d than
the proposed by Wu et al (2013) (see Section 4.3). Therefore, in order to preserve the
use of the original NLM weights, we will follow a Variational EM approach (Neal and
Hinton, 1999; Bishop, 2006). The Variational EM framework introduces the concept
of partial E-step, in which a functor of the latent variables can be used when the
posterior densities of these variables cannot be calculated, or when it is desirable to
calculate them differently for reasons of efficiency or performance. As demonstrated by
Neal and Hinton (1999), such functor can take any form as long as the log-likelihood
function is increased at each iteration, effectively driving the model to a local optimum
of the function, and hence to an optimum of the parameters of the model. Therefore,
following this framework, the Di,mj,d latent variables are estimated at the E-step as the
standard quantitative Chi-squared test proposed by Wu et al (2013):
Di,mj,d =
∑
k∈P
(
αi+kj − αm+kj
)2
2β2j,d
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Figure 4.1: Graphical model for the non-local spatially varying finite mixture model. Superscripts
i,m ∈ [1, N ] denote pixel indexes, subscript j ∈ [1,K] denotes mixture component and subscript
d ∈ [1, D] denotes neighborhood direction.
Once these latent variables are estimated, the ui,mj,d weights are calculated at the
M-step following ui,mj,d = χ
2
(
Di,mj,d /γm|ηm
)
. Since ui,mj,d depends on both the i
th and
mth observations, this model specifies a different instance of a Gaussian distribution
for each
(
αij − αmj
)
pair of contextual Dirichlet coefficients in the MRF. This allows
ui,mj,d to regulate the variance of the corresponding Gaussian between the i
th and mth
observations, if an edge or an homogeneous area is detected at this location. Thus,
as ui,mj,d increases, the Gaussian distribution for the corresponding pair shrinks around
zero imposing a hard smoothing between the observations. On the contrary, as ui,mj,d
decreases, the variance of the Gaussian distributions increases producing a lower pdf
value that prevents the smooth.
This approximation avoids the introduction of new parameters since ηm and γm
are completely known once i and m are fixed. Therefore, no numerical approximate
methods are required, simplifying the model and reducing its degrees of freedom and
the number of samples required for its statistically reliable estimation.
The graphical model of the NL-SVFMM is shown in Figure 4.1.
Imposing the DCAGMRF prior to the proposed NLSVFMM model, the new density
for p (A) becomes
p (A) =
N∏
i=1
K∏
j=1
D∏
d=1
∏
m∈Mid
1√
2piβ2j,d/u
i,m
j,d
exp
(
−
(
αi − αmj
)2
ui,mj,d
2β2j,d
)
(4.15)
which setting ∂Q/∂αij yields a third degree equation of the form:
(
α
i(t+1)
j
)3
+
(
α
i(t+1)
j
)2(
Ai−j −
Ĉij
B̂ij
)
−
(
α
i(t+1)
j
)(Ai−jĈij
B̂ij
)
− z
i
jA
i
−j
2B̂ij
= 0 (4.16)
where
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Ai−j =
K∑
k=1
k 6=j
αik
(t)
B̂ij =
D∑
d=1
∑
m∈Mid
ui,mj,d
(t)
β2j,d
(t)
Ĉij =
D∑
d=1
∑
m∈Mid
αmj
(t)ui,mj,d
(t)
β2j,d
(t)
(4.17)
Likewise the conventional DCM-SVFMM, it can be demonstrated that, under poly-
nomial theory, there is always a real non negative solution that satisfies αij ≥ 0. The
Vieta’s method is used to algebraically obtain the roots of the proposed third degree
equation.
Finally, β2j,d is estimated as:
β2j,d
(t+1)
=
1
N
N∑
i=1
∑
m∈Mid
(
αij
(t+1) − αmj (t+1)
)2
ui,mj,d
(t)
|Mid|
(4.18)
Hereafter, the pixel-wise χ2 (1) version of the proposed NLSVFMM will be referred
as NLv-SVFMM, while the patch-wise χ2 (ηm) will be referred as NLp-SVFMM.
4.5 Experimental results
Both variants of the proposed NLSVFMM algorithm have been evaluated in a simu-
lated and a real-world scenario. First an evaluation on a synthetic high grade glioma
dataset of the BRATS 2013 Challenge was conducted (Menze et al, 2015). Next, and
evaluation over the 300 real-world images of the Berkeley Segmentation dataset was
performed (Martin et al, 2001). We have compared our proposed NLv- and NLp-
SVFMM model with the conventional FMM, the SVFMM and the St-SVFMM. For
the spatially varying algorithms we have employed the DCM Bayesian approximation
and the DCAGMRF prior specified in 4.15. All algorithms in all experiments were
initialized with a deterministic version of K-means++ (Arthur and Vassilvitskii, 2007)
to ensure a fair comparative. In addition, results on the behavior of the weighting
functions and weighting maps of the NLSVFMM and t-Student model are shown. The
evaluation is presented below.
4.5.1 Evaluation on the synthetic BRATS 2013 high grade
glioma dataset
The BRATS 2013 high grade glioma synthetic dataset is composed of 25 cases, each
one segmented into 7 labels: 1) WM, 2) GM, 3) CSF, 4) peripheral edema (ED),
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5) tumor core (split into enhancing tumor (5.1) and necrotic core (5.2)) (TC) and
6) vessels (VS). For each voxel, intensities on pre- and post-gadolinium T1-weighted,
T2-weighted and FLAIR MRI sequences were employed for the segmentation.
Figure 4.2 compares the behavior of the weighting functions G =
{
gi,mj,d
}
for the St-
SVFMM model and U =
{
ui,mj,d
}
for the NLv-SVFMM model (NLp-SVFMM weighting
function is not depicted because is not numerically comparable to the St and NLv-
SVFMM models).
As figure shows, U function behaves more aggressive for differences between ob-
servations than the St-SVFMM, hence yielding more dichotomous weighting maps
(see Figure 4.3). For the shake of simplicity, each pixel of each picture of Figure 4.3
represent
∑D
d=1
∑
m∈Mi λ
i,m
j,d , with λ = g for St-SVFMM and λ = u for NLv- or NLp-
SVFMM models respectively. The weighting maps of Figure 4.3 demonstrates that
the NLSVFMM-based algorithms better differentiates among tissues than than the
St-SVFMM.
Figure 4.2: Comparison between the behavior of the weighting functions G =
{
gi,mj,d
}
for the St-
SVFMM model and U =
{
ui,mj,d
}
for the NLv-SVFMM (NLp-SVFMM weighting function is not
depicted because is not numerically comparable to the St and NLv-SVFMM functions).
Table 4.1 and Figure 4.4 show the superiority of the proposed NL-SVFMM (in both
variants) to generate higher confidence prior probability maps for each component. An
example of the contextual mixing coefficient maps for the HG0014 case of the BRATS
2013 dataset and its associated mixing coefficient values for different pixels obtained
by each method is shown. In almost all evaluations, the NLp-SVFMM version achieves
the best results, indicating that the patch-based probabilistic NLM weighting function
better captures the local similarities in the images.
Table 4.2 shows the Dice coefficients obtained for the evaluation based on the
BRATS 2013 dataset. Consistently with previous results, the NLp-SVFMM variant
achieves the best results in terms of segmentations based on the maximization of
the posterior probabilities (Bayes minimum classification error). An improvement of
107
Chapter 4. Non Local Spatially Varying Finite Mixture Models for unsupervised image
segmentation
Figure 4.3: Comparison between G maps of the St-SVFMM and U maps for the NLv- and NLp-
SVFMM models for a case of the BRATS 2013 dataset. Each pixel i of the images represent∑D
d=1
∑
m∈Mi λ
i,m
j,d , with λ = g or λ = u for St-SVFMM and NLv- or NLp-SVFMM models re-
spectively.
about 3 points in Dice is obtained when comparing the NLp-SVFMM with the stan-
dard SVFMM and more than 1 point in Dice with respect to the St-SVFMM, thanks
to the proposed prior density. Moreover, in order to explore the capabilities of the
proposed prior densities to yield accurate segmentations, we have also computed the
Dice coefficients for the segmentations based only on the maximization of the prior
probability maps generated by each method. As Table 4.2 shows, the NLv-SVFMM
method, followed by the NLp-SVFMM, achieves the best results. Of course the Dice
coefficients are significantly low because the segmentations do not take into account
the pixel intensities. However, the aim is to evaluate which method better captures
the local similarities in the images, hence producing more accurate prior information
about the different segments in the image.
4.5.2 Evaluation on the Berkeley Segmentation Dataset
In addition to the synthetic evaluation, we have assessed the performance of the pro-
posed model with the 300 real-world images of the Berkeley Segmentation dataset. In
our experimentation, we have employed a 3-dimensional feature vector to represent
each each pixel of the images, comprising the 3 channels of the L*a*b color space. We
also applied a local median smoothing to each channel using a 5× 5 window centered
at each pixel. We have evaluated the performance of each algorithm for different values
of K = {3, 5, 7, 10, 15, 20}.
Table 4.3 shows the results for the evaluation of the 300 images of the Berkeley
dataset. Rand Index (RI) is employed to measure the degree of concordance between
the automated segmentation and the manual segmentations. Our experiments show
that the proposed methods perform favorably in terms of RI to the other approaches
in almost all situations. The NLv-SVFMM performs comparable to the St variant in
most of cases, achieving very similar results. However, the NLv-SVFMM requires less
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Table 4.1: Contextual mixing coefficients for different voxels of the HG0014 case of the BRATS
2013 challenge. Voxels correspond to coordinates a = (151, 127, 85) , b = (167, 75, 85) , c =
(151, 152, 85) , d = (97, 89, 85) , e = (117, 62, 85) , f = (110, 71, 85) and f = (128, 99, 85)
SVFMM St-SVFMM NLv-SVFMM NLp-SVFMM
piaWM 0.457 0.486 0.481 0.499
pibGM 0.296 0.429 0.497 0.606
picCSF 0.253 0.426 0.446 0.447
pidED 0.294 0.374 0.394 0.411
pieET 0.248 0.442 0.453 0.381
pifNC 0.267 0.291 0.285 0.361
pigV S 0.118 0.305 0.355 0.265
Table 4.2: Results on the Dice coefficient over the 25 synthetic high-grade gliomas of the BRATS
2013 dataset for each algorithm evaluated. Segmentations based on the maximization of the posterior
and prior probabilities are shown.
SVFMM St-SVFMM NLv-SVFMM NLp-SVFMM
Segmentation
Mean Median Std. Mean Median Std. Mean Median Std. Mean Median Std.
Posterior 0.7766 0.7680 0.0368 0.7912 0.7817 0.0384 0.7988 0.7833 0.0397 0.8044 0.7936 0.0351
Prior 0.2231 0.2247 0.0092 0.2467 0.2461 0.0103 0.2576 0.2578 0.0113 0.2494 0.2495 0.0106
parameters, hence reducing the degrees of freedom of the model. Nevertheless, the
NLp-SVFMM method achieves, both in average and median cases, the best results in
most cases. Only in the K = 3 case (the simplest segmentation), the SVFMM method
outperforms the rest of the models. However, as segmentation complexity increases,
the models including edge preserving priors performs better in all cases.
Table 4.3: Results on the RI over the 300 images of the Berkeley dataset for each algorithm evaluated.
SVFMM St-SVFMM NLv-SVFMM NLp-SVFMM
K Mean Median Std. K Mean Median Std. K Mean Median Std. K Mean Median Std.
3 0.6952 0.6915 0.0986 3 0.6941 0.6891 0.0988 3 0.6940 0.6891 0.0988 3 0.6944 0.6897 0.0987
5 0.7274 0.7478 0.1086 5 0.7284 0.7482 0.1086 5 0.7284 0.7482 0.1085 5 0.7288 0.7480 0.1086
7 0.7283 0.7585 0.1208 7 0.7312 0.7596 0.1207 7 0.7313 0.7597 0.1206 7 0.7316 0.7599 0.1207
10 0.7250 0.7618 0.1335 10 0.7281 0.7632 0.1333 10 0.7283 0.7634 0.1334 10 0.7288 0.7639 0.1334
15 0.7184 0.7585 0.1431 15 0.7215 0.7594 0.1428 15 0.7214 0.7595 0.1428 15 0.7221 0.7612 0.1429
20 0.7136 0.7495 0.1479 20 0.7161 0.7538 0.1478 20 0.7162 0.7538 0.1478 20 0.7166 0.7545 0.1479
Figure 4.5 shows several examples of segmentations of images of the Berkeley
dataset obtained with the NLp-SVFMM method.
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Figure 4.4: Example of contextual mixing coefficient maps for a case of BRATS 2013, for each label
of the segmentation.
4.5.3 Evaluation of computational time requirements
Additionally, a comparison in terms of the computational time required by each method
has been performed. Table 4.4 shows the average times (in seconds) and the std.
deviation of each method evaluated in the Berkeley 300 dataset for different number
of segments calculated in the images.
Table 4.4: Average and std. deviation time comparison (in seconds) for each algorithm evaluated in
the study on the Berkeley 300 dataset for each number of segments computed in the images.
K SVFMM St-SVFMM NLv-SVFMM NLp-SVFMM
3 0.91± 0.04 1.48± 0.06 1.73± 0.06 2.01± 0.09
5 1.39± 0.08 2.27± 0.12 2.56± 0.13 2.99± 0.13
7 1.87± 0.08 3.05± 0.15 3.37± 0.14 3.98± 0.16
10 2.69± 0.14 4.40± 0.20 4.92± 0.21 5.75± 0.17
15 3.91± 0.17 6.32± 0.22 6.96± 0.26 8.23± 0.30
20 5.18± 0.47 8.39± 0.75 9.27± 0.82 10.92± 0.96
As expected, the SVFMM is the fastest method since it doesn’t carry the extra
computation of the weights for constrain the β2j,d variances. It should be noted that
only the NLv-SVFMM and the St-SVFMM are directly comparable since both perform
the calculation of the u and g weights respectively, and those weights are computed
pixel-wise. It can be seen that both methods perform very similar, with no signifi-
cant difference between them. Although the St-SVFMM model requires a numerical
iterative approximation of the νj,d parameters, which is often a slow procedure, the
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Figure 4.5: Example of segmentation maps forK ∈ {3, 5, 7, 10, 15, 20} obtained with the NLp-SVFMM
for 4 images of the Berkeley dataset.
complexity in the computation of the gi,mj,d weights is lighter than the u
i,m
j,d weights.
That is the reason why the NLv-SVFMM is a bit slower than the St-SVFMM. The
calculation of ui,mj,d weights requires the computation of NKD |Md| χ2 (ηm) pdf values,
which ultimately equals or even slightly increases the computational time with respect
the g weights. The NLp-SVFMM performs the best in terms of Dice and RI scores,
but also requires more time to compute the segmentation since it carries the extra
computation of the patch-based similarity.
4.6 Discussion
In this study we have proposed a new unsupervised image clustering algorithm that
successfully merges the SVFMM framework with the well-known NLM filtering scheme.
The main advantage of this algorithm is the proposed new MRF density over the
contextual mixing proportions, which enforces local smoothness while preserving edges
and the structure of the image. This MRF improves the previously proposed St-
MRF both in performance and in complexity of the model by reducing the number of
parameters to be estimated. Experimental results demonstrated the superiority of the
proposed method with respect to previous state-of-the-art algorithms proposed in the
literature when evaluated in a public reference dataset.
As figure 4.2 shows, the proposed probabilistic NLM weighting function behaves
more aggressive in the NLSVFMM than its analogous in the St-SVFMM. This shrinks
or widens the covariance matrices more dramatically when there are differences (even
small ones) between adjacent contextual mixing coefficients, leading to a sharper prior
density. This behavior tends to estimate more radical prior maps, which hypothetically
should provide stronger information during the learning and inference of the model.
On the contrary, uniform flat prior probability maps rapidly fade into an uninformative
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element in the model. Figure 4.4 and table 4.1 corroborates this hypothesis. In figure
4.4, it can be seen that the prior probability maps obtained by the NLSVFMM variants
achieve the highest degrees of confidence for the different labels among all models
compared. Table 4.1 compares the contextual mixing coefficient values obtained by
each method for different voxels corresponding to different tissues of a BRATS case.
As it can be seen, the highest values are always obtained by the proposed NLSVFMM
variants, leading to a highest degree of confidence about the presence of a specific
tissue.
Results on the BRATS synthetic dataset allowed to evaluate the performance of the
methods in a controlled environment where the number of labels existing in the data
is known. This enabled us to directly measure the impact of the proposed NLM-based
prior density in the results. Table 4.2 compares the Dice scores of the segmentations
obtained by each method, based on the posterior probabilities (Bayes decision rule) and
only on the contextual mixing coefficient maps estimated by each method. Regarding
the posterior probabilities case, which is the optimal decision rule, an improvement
of about 3 points in Dice with respect to the SVFMM and about 1 point with re-
spect to the St-SVFMM was obtained only by changing the prior density. Considering
that the prior density acts as a guide during the learning and segmentation process,
this improvement in final results is highly valuable given its limited impact. Simi-
larly, results obtained by the NLSVFMM variants only based on the prior probability
maps (contextual mixing coefficient maps) outperform the other methods in a similar
manner. Obviously, Dice results are significantly lower than those obtained based on
the posterior probability (which takes into account also the intensities of the images),
however the comparison among them demonstrates the superiority of the NLSVFMM
approach.
The evaluation performed on the Berkeley dataset also yielded favorably results in
terms of RI for the NLSVFMMs methods. In almost all cases, the NLSVFMMs variants
performed superior or comparable to the St model, with the advantage that they
introduce less parameters that must be estimated. Moreover, as expected, the patch-
based NLp-SVFMM method achieved the best results, confirming that the probabilistic
NLM weighting function better captures the local redundancy of the images. Only in
the K = 3 case (the simplest segmentation), the SVFMM method outperforms the rest
of the models. However, as segmentation complexity increases, the models including
edge preserving priors perform better in all cases.
It is worth noting that standard deviations are high and similar for all methods.
This is due to several images that are intrinsically difficult to segment and present
poor RI results across all methods uniformly, rather than to a high variability in the
methods themselves. To corroborate it, we measured the percentage of cases of the
Berkeley300 dataset that showed RI improvement when segmented by our methods
with respect to the SVFMM and the St-SVFMM. For most of the K states, our NLp-
SVFMM approach showed RI improvement in approximately more than the 85% of
cases compared with the SVFMM, and more than the 80% of cases compared with the
St-SVFMM. This behavior indicates that there is a systematic improvement of our
algorithms with respect to the previous approaches in the literature, which is not a
product of random fluctuations due to the high standard deviations.
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On the other side, it is also worth noting that differences in RI are not significantly
large between methods, which is a reasonably behavior. Under the Bayes’ decision rule,
the prior probability p (Π) (or p (A)) acts as an initial degree of belief of each label at
each location of the image before observing the image, which ultimately represents a
less informative distribution compared to the class conditional p (X|Θ,Π). Therefore,
the impact on the final results of changing the prior distributions is limited, and thus
the segmentation results are less affected. In addition, prior distributions become
weaker as the number of observations in a problem increase, which is the case of pixel
classification in an image. In those cases, variations in the prior densities also have a
lesser impact in final results, which is observed in our experimentation.
In future work, we plan to study the inclusion of prior distributions for other
parameters of the model, i.e. µj and Σj, ∀j, to introduce prior knowledge and
constraints that can help in the estimation of more accurate and realistic models.
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Chapter 5
Vascular heterogeneity assessment
of glioblastoma through the
Hemodynamic Tissue Signature
Understanding glioblastoma intra- and inter-tumoral heterogeneity represents one of
the most important challenges in advancing the fight against this lethal cancer. Over
the years, much evidence has accumulated to suggest that this heterogeneity is highly
responsible for the poor prognosis of the tumor and its resistance to effective therapies.
Specifically, vascular heterogeneity has been identified as one of the most important
pathological hallmarks of glioblastoma. The study of the aberrant vasculature of this
lethal tumor, its hemodynamic local behavior and its angiogenesis mechanism is crucial
to design new effective therapies that improve patient prognosis. However, to date,
determining the extent and characteristics of this intra-tumor heterogeneity is still
poorly understood.
In this chapter we present the Hemodynamic Tissue Signature (HTS), an unsuper-
vised machine learning method to describe the vascular heterogeneity of glioblastoma
by means of perfusion MRI analysis. The method analyzes the perfusion markers to
automatically draw four reproducible habitats that describe the tumor vascular hetero-
geneity: the High Angiogenic Tumor (HAT) and Low Angiogenic Tumor (LAT) habi-
tats of the enhancing tumor, the potentially tumor Infiltrated Peripheral Edema (IPE)
and the Vasogenic Peripheral Edema (VPE).
The purpose of the work presented in this chapter was to assess if preoperative
vascular heterogeneity of glioblastoma predicts OS of patients undergoing standard
of care treatment by using the HTS method. To do so we conducted Kaplan-Meier
and Cox proportional hazard analyses to study the prognostic potential of the HTS
habitats on a cohort of 50 retrospective patients from a local hospital. Additionally,
we explored the ability of the HTS habitats to improve the conventional prognostic
models based on clinical, morphological, and demographic features.
The contents of this chapter were published in the journal publications (Juan-
Albarrac´ın et al, 2018; Fuster-Garcia et al, 2018)—thesis contributions C3, C4, P5
and P6.
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5.1 Introduction
Glioblastoma heterogeneity has been identified as one of the factors responsible for
the high aggressiveness of these neoplasms (Leme´e et al, 2015) and as a key hallmark
to understanding their resistance to effective therapies (Soeda et al, 2015). Molecular
characterization of glioblastomas has advanced the understanding of the biology and
heterogeneity of these tumors, improving routine diagnosis, prognosis, and response to
therapy (Parsons et al, 2008; Verhaak et al, 2010). However, significant interest has
been placed in the past years in the analysis of glioblastoma heterogeneity based on
medical imaging, to discover non-invasive tumor features related to different clinical
outcomes such as OS, tumor grading or molecular sub-typing Wangaryattawanich et al
(2015).
Glioblastoma is characterized by highly infiltrative and deeply invasive behavior
(Dang et al, 2010). Strong vascular proliferation, robust angiogenesis, and exten-
sive microvasculature heterogeneity are major pathological features that differentiate
glioblastomas from low-grade gliomas (Alves et al, 2011; Hardee and Zagzag, 2012;
Kargiotis et al, 2006). Such factors have been shown to have a direct effect on prog-
nosis (Hardee and Zagzag, 2012). Therefore, the early assessment of the highly het-
erogeneous vascular architecture of glioblastomas could provide powerful information
to improve therapeutic decision making.
Dynamic Susceptibility Contrast (DSC) MRI has been used widely to retrieve phys-
iologic information on glioblastoma vasculature (Shah et al, 2010; Knopp et al, 1999;
Lupo et al, 2005). DSC quantification involves the computation of the hemodynamic
indexes obtained from the kinetic analysis of the T2∗ concentration time curves re-
trieved from the first pass of an intravenously injected paramagnetic contrast agent
(Østergaard, 2005). Section 2.2.2 performs an in depth description of the techniques
employed in this thesis to estimate the perfusion parametric maps from the DSC se-
quence. Such perfusion indexes have demonstrated powerful capabilities for a wide
range of applications such as tumor grading (Law et al, 2003; Emblem et al, 2008),
neovascularization assessment (Thompson et al, 2011; Tykocinski et al, 2012), early re-
sponse to treatment assessment (Vidiri et al, 2012; Elmghirbi et al, 2017), recurrence
versus radionecrosis (Hu et al, 2009; Barajas et al, 2009) and prediction of clinical
outcome (Mangla et al, 2010; Jain et al, 2014).
Numerous studies have been focused on the analysis of pretreatment perfusion
indexes to assess tumor heterogeneity (Jackson et al, 2007; Liu et al, 2017a; Sanz-
Requena et al, 2013; Ulyte et al, 2016). The most common practice is the manual
definition of Region Of Interests (ROIs) within the tumor to study vascular properties
that correlate with clinical outcomes. However, these manual approaches impair the
reproducibility studies and the analysis of high-dimensional multiparametric MRI data
(Young et al, 2007).
An alternative novel approach to describe the heterogeneity of glioblastomas is
by means of the definition of lesion sub-compartments or radiological habitats that
express a specific biological behavior observable from MRI. Several attempts have
been made in the literature to describe the glioblastoma heterogeneity through this
technique (Dextraze et al, 2017; Zhou et al, 2014; Lee et al, 2015; Zhou et al, 2017).
However most of them are based on morphological MRI and classical image processing
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techniques such as histogram analysis, intensity thresholding, texture measurements
or histogram derived features. The preoperative characterization of the vascular het-
erogeneity of glioblastomas through a multiparametric search of habitats drawn from
an unsupervised machine learning process has not previously been well established in
the literature.
In this sense, we hypothesize that vascular-related habitats obtained in the preoper-
ative evaluation of glioblastoma are early predictors of OS in patients who subsequently
undergo standard-of-care treatment. In this work, we present the Hemodynamic Tis-
sue Signature (HTS) method: an unsupervised machine learning-based algorithm that
delineates a set of vascular habitats within the glioblastoma obtained through a multi-
parametric structured clustering of morphologic and DSC MRI features. HTS includes
consideration of four habitats: the High Angiogenic Tumor (HAT) (the more perfused
area of the enhancing tumor), the Low Angiogenic Tumor (LAT) (the area of the en-
hancing tumor with a lower angiogenic profile), the potentially Infiltrated Peripheral
Edema (IPE) (the surrounding non-enhancing region adjacent to the tumor with ele-
vated perfusion indexes), and the Vasogenic Peripheral Edema (VPE) (the remaining
edema with a lower perfusion profile).
To determine whether the preoperative vascular heterogeneity of glioblastoma al-
lows early prediction of OS of patients who undergo standard-of-care treatment, we
conducted a survival analysis on the basis of perfusion measures obtained from the
HTS habitats. In addition, we also studied the contribution of the HTS habitats to
improve the estimation of OS with respect to models based solely on clinical, morpho-
logical and demographic variables; and models including perfusion markers measured
from the conventional enhancing tumor and edema ROIs instead of HTS habitats.
5.2 Materials
5.2.1 Patient selection
Our institutional review board approved this retrospective study, and the requirement
for patient informed consent was waived. Eighty-four patients from January 2012
to December 2016 with suspected glioblastoma were included. The inclusion criteria
were: (a) confirmation of glioblastoma through biopsy; (b) access to preoperative MRI
examinations, including unenhanced and GBCA–enhanced T1-weighted, T2-weighted,
FLAIR, and DSC sequences; and (c) patients who underwent standard Stupp treat-
ment (Stupp et al, 2005).
Of the 84 initial patients, six were excluded because of an incomplete MRI study,
three were excluded because of motion or spike artifacts on the DSC images that pre-
vented the quantification (gamma variate R2 goodness of fit < 0.95), 10 patients were
excluded because of unconfirmed or unconventional glioblastomas (giant cell glioblas-
toma and glioblastoma with oligodendroglioma component), and 10 patients were ex-
cluded because they did not undergo resection because of their tumor location (only
biopsy results available) or they did not undergo radiation therapy and chemotherapy
treatment. In addition, five patients who presented with glioblastomas with contigu-
ous leptomeningeal extensions were excluded from the study because of the inability
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to accurately differentiate the tumor vascularity from the reactive meningeal enhance-
ment in the perfusion signal intensity. Finally, 50 patients constituted the study group,
including 33 men with an average age of 60.94 years (range, 25–80 years); 17 women
with an average age of 62.53 years (range, 36–75 years); and an overall mean age of
60.08 years (range, 25–80 years).
5.2.2 Magnetic Resonance Imaging
Standard-of-care examinations were obtained with 1.5-T or 3-T imagers (Signa HDxt;
GE Healthcare, Waukesha, Wisconsin) with an eight-channel-array head coil. MRI ex-
aminations included unenhanced and GBCA–enhanced T1-weighted three-dimensional
spoiled gradient-echo sequences with inversion recovery (repetition times msec/echo
times msec, 6–10/2–4; matrix, 256 × 256; section thickness, 1.5 mm; field of view,
24× 24 cm; inversion time, 400 msec; flip angle, 70◦–80◦), fast spin-echo T2-weighted
imaging (3000–4000/100–110; matrix, 256×256; section thickness, 5 mm; field of view,
21.9 × 21.9 cm; one signal acquired; intersection gap, 2 mm) and a FLAIR sequence
(8000–9000/140–165; matrix, 256×192; section thickness, 5 mm; field of view, 22×22
cm; one signal acquired; intersection gap, 2 mm; inversion time, 2200 msec).
Table 5.1: Summary of the most relevant parameters of the MR studies employed in the study.
T1 T1CE T2 FLAIR DSC
MR techinque
Spoiled
gradient-echo
Spoiled
gradient-echo
Fast
spin-echo
Fluid Attenuated
Inversion Recovery
Gradient-echo
TE (msec) 6− 10 6− 10 3000− 4000 8000− 9000 25
TR (msec) 2− 4 2− 4 100− 110 140− 165 2000
Matrix (mm) 256× 256 256× 256 256× 256 256× 192 128× 128
Sect. thickness (mm) 1.5 1.5 5 5 7
Field of view (cm) 24× 24 24× 24 21.9× 21.9 22× 22 14× 14
Flip angle 70◦ − 80◦ 70◦ − 80◦ 90◦ 90◦ 60◦
Inv. time (msec) 400 400 2200
Bolus-conct. (mmol/kg) 0.1
Bolus-speed (mL/sec) 5
Number of dynamics 40
The DSC T2∗-weighted gradient-echo perfusion study was performed during the in-
jection of GBCA (Multihance; Bracco, Milan, Italy). A bolus injection of 0.1 mmol/kg
of GBCA was administered at 5 mL/sec by using a power injector (no pre-bolus ad-
ministration). Saline solution was injected after the bolus injection. The study was
performed with the following parameters: 2000/25; matrix, 128 × 128 (1.8 × 1.8 mm
in-plane resolution); section thickness, 7 mm; flip angle, 60◦; 14 cm full-coverage cranio-
caudal (20 sections), 40 sequential temporally equidistant volumes, each one with an
acquisition time of 2 seconds. The baseline before injection of the bolus was five
dynamics. Table 5.1 summarizes the aforementioned parameters.
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5.3 Methods
5.3.1 Quantification of DSC parametric maps
DSC T2∗-weighted quantification involves the computation of the hemodynamic indices
obtained from a kinetic analysis of the first pass of a intravenously injected paramag-
netic contrast agent (Østergaard, 2005). A detailed explanation of the calculation of
perfusion parametric maps is performed in section 2.2.2. In order for this chapter to
be self-contained, a short remainder will be made.
Previous to DSC T2∗-weighted quantification, registration of the sequence was per-
formed to the morphologic T2-weighted image of the patient. Next, signal intensity
curves were converted to concentration time curves by using the following equation 2.1.
Contrast material leakage correction was performed by using the technique proposed
by Boxerman et al (2006) and recirculation was corrected by means of gamma-variate
curve fitting (please refer to section 2.2.2 for more details).
rCBV and rCBF maps were obtained using standard algorithms previously de-
scribed (Knutsson et al, 2010). rCBV was computed according to numerical integra-
tion of the area under the curve of the gamma-variate fittings (Knutsson et al, 2010);
while rCBF was calculated by means of the block-circulant SVD deconvolution tech-
nique proposed by Wu et al (2003). Both perfusion maps were normalized against the
contra-lateral unaffected white matter value.
The AIF was automatically selected by following a divide-and-conquer approach.
The method recursively dichotomizes the set of concentration time curves of the perfu-
sion study into two groups, selecting those curves with higher peak height, earliest time
to peak, and lowest full-width at half maximum. We used the median as a threshold
to split the groups. The process is repeated until 10 or fewer curves are conserved,
finally fixing the AIF as the average of those curves.
5.3.2 Enhancing tumor and edema segmentation
In this work the enhancing tumor and edema ROI delineation was performed by us-
ing an unsupervised segmentation method based on a variant of the work proposed in
a study by Juan-Albarrac´ın et al (2015b). This method is based on DCM-SVFMM
(Nikou et al, 2007), which consists of a clustering algorithm that combines GMM with
continuous DCAGMRFs to take advantage of the self-similarity and local redundancy
of the images. The method includes the unenhanced and GBCA–enhanced T1-weighted
sequences, the T2-weighted sequence, and the FLAIR sequence in combination with
atlas-based prior knowledge of healthy tissues to perform the segmentation. The au-
tomated enhancing tumor and edema ROIs obtained with the method were manually
revised and validated by two experienced radiologists in consensus (F.A., with 14 years
of experience; L.M.B., with 25 years of experience).
Nowadays, this method has been replaced by a more robust and powerful approach
based on CNNs (Juan-Albarrac´ın et al, 2019a) (to be presented in the next chapter),
which has proven to be comparable and competitive with manual segmentations per-
formed by expert radiologists. The new method achieves a Dice score index of 0.89 on
a large public real glioblastomas dataset, of more than 300 cases manually annotated
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by more than 3 expert radiologist each case.
5.3.3 Hemodynamic Tissue Signature habitats
The HTS consists of a set of vascular habitats detected in glioblastomas and obtained
by means of a multiparametric unsupervised analysis of DSC MRI patterns within
the tumor. The technology used to compute the HTS of the glioblastoma is publicly
accessible for non-commercial research purposes at https://www.oncohabitats.upv.es.
The HTS defines four habitats within the glioblastoma: the High Angiogenic Tu-
mor (HAT) and Low Angiogenic Tumor (LAT) habitats, and the Infiltrated Peripheral
Edema (IPE) and Vasogenic Peripheral Edema (VPE) habitats. Table 5.2 summa-
rizes the relationships among HTS habitats, glioblastoma tissue, and DSC observed
vascularity.
Table 5.2: Glioblastoma habitats considered by the HTS an their relation with the degree of vascularity
and the pathological tissue.
HTS habitat Vascularity Glioblastoma-related tissue
HAT Highest High-angiogenic enhancing tumor
LAT High Low-angiogenic enhancing tumor
IPE Low Potentially tumor infiltrated peripheral edema
VPE Lowest Vasogenic peripheral edema
HTS habitats are obtained by means of a DCM-SVFMM structured clustering
(with the DCAGMRF prior) of rCBV and rCBF maps. The clustering consists of two
stages (see figure 5.1): (a) a two-class clustering of the rCBV and rCBF data at the
whole enhancing tumor and edema ROIs defined morphologically; and (b) a two-class
clustering also of the rCBV and rCBF data within each ROI obtained in stage a). To
ensure the reproducibility of the HTS, both stages are initialized with a deterministic
seed method. We fix the seeds of every two-class clustering to the extremes of the
rCBV and rCBV distributions (5% and 95% percentiles, respectively, for each class).
The aim of the first stage is to refine the enhancing tumor and the edema ROIs,
previously delineated through the anatomical MRI segmentation, but introducing the
perfusion information. Therefore, a spatially varying mixture of two components is fit
to the distributions of rCBV and rCBF observed in the regions previously labeled as
enhancing tumor and edema. We named these two components: enhancing tumor at
DSC (ETDSC) and edema at DSC (EDDSC). During the fitting process, we introduce
several constraints to avoid misclassifications of nearby healthy vascular structures
ETDSC . Thus, we constrained the apparition of the ETDSC class to a neighborhood
of less than 1 cm around the enhancing tumor observed on the GBCA–enhanced T1-
weighted MRI (Guo et al, 2016). This constraint allows the correction of misalignments
during the DSC registration and the removal of healthy vascular structures far from the
enhancing area of the tumor, which may distort the HTS. Moreover, the also enforce
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Figure 5.1: Schema of the methodology used to compute the HTS of the glioblastoma. HAT =
high-angiogenic tumor; LAT = low-angiogenic tumor, IPE = inflitrated peripheral edema, VPE =
vasogenic peripheral edema
the ETDSC class to explain at least the 80% of the enhancing tumor ROI obtained
from the anatomical segmentation.
The second stage includes DCM-SVFMM clustering within the ETDSC and EDDSC
ROIs, to delineate the two potential hemodynamic habitats inside each tissue. Like-
wise, the first stage, a spatially varying mixture of two components is fit to the dis-
tributions of rCBV and rCBF for both the ETDSC and EDDSC ROIs. In this stage,
several constraints are also introduced. First, we force a minimum size of the habitats
of at least 10% of the whole lesion ROI to avoid habitat vanishing. Second, infil-
trated peripheral edema habitat is also constrained to a nearby region around the
ETDSC class. Following the definition of the clinical target volume proposed by Guo
et al (2016), we fix a 2 cm margin around the enhancing tumor observed at GBCA-
enhanced T1-weighted MRI as the maximum distance where the infiltrated peripheral
edema habitat could appear. Voxels classified as infiltrated peripheral edema outside
this region are automatically removed from the HTS, since they have a similar vascu-
lar pattern to that of infiltrated peripheral edema but far from the plausible region of
tumor infiltration.
5.3.4 Statistical analysis
All analyses were performed with software (Matlab R2015a; MathWorks, Natick, Mas-
sachusetts) on a personal workstation.
First, an evaluation of the statistical differences between habitats was conducted
to assess the degree of separability of the rCBV and rCBF distributions within each
habitat to confirm their different hemodynamic activity. To do so, global probabilistic
deviation (Sa´ez et al, 2017) was used as a metric to control the degree of concor-
dance among several statistical distributions. Such a metric is bounded to a [0, 1]
range, with 0 referring to absolute overlapping between distributions, and 1 indicating
non-overlapped, completely separated distributions. Therefore, for each perfusion pa-
rameter, the distributions of the four proposed habitats and their global probabilistic
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deviation metric were calculated.
Second, Cox proportional hazards modeling was conducted to investigate the rela-
tionship between patient survival and the rCBVmax and rCBFmax at the HTS habitats.
We used the maximum of the perfusion parameters because it has been reported to be
the most reliable measure for inter-observer and intra-observer reproducibility (Wetzel
et al, 2002). Proportional hazard ratios with 95% confidence intervals were reported,
while the Wald test was used to determine the significance of the Cox regression model
results.
Finally, Kaplan-Meier survival analyses between populations dichotomized accord-
ing to the median value of each perfusion biomarker at each HTS habitat were also
conducted. A log-rank test was used to determine the statistical significance of the
differences in observed population survival. Average survival for each population was
also reported. Benjamini-Hochberg false discovery rate correction at an α level of .05
was used to correct for multiple hypothesis testing (Benjamini and Hochberg, 1995) in
all analyses.
On the other side, we also conducted a study to determine the added value of HTS
habitats for predicting patient OS when these are added to classical models based
on clinical, demographic and morphological variables. To do so, first we conducted
an analysis to measure the importance of each clinical, demographic or MRI-related
variable independently to predict OS. For the categorical variables we conducted
Kaplan-Meier survival analysis, while for the continuous variables Cox proportional
hazards modeling was used.
Next, we studied the added value of the HTS habitats by adding its information
to the models built with the variables that showed significant association with OS in
the aforementioned independent study. To do so we constructed three models:
Model 1: Clinical variables + demographic variables
Model 2: Clinical variables + demographic variables + rCBVmax and rCBFmax at
enhancing tumor
Model 3: Clinical variables + demographic variables + rCBVmax and rCBFmax at
HTS habitats
Cox proportional hazard regression models were fit for each model and a comparison
between the predicted OS and the real patient’s OS was performed. A Kaplan-Meier
survival study was next performed by using Cox the predicted OS of each model to
split the population in two groups: long-survivors, whose Cox predicted OS was greater
than the real average OS of the population (402 days); and short-survivors, whose Cox
predicted survival was less or equal than the real average OS of the population (402
days). Root Mean Squared Error (RMSE) was employed to measure the deviance
between the predicted OS and the real OS of the population. Single-tailed Wilcoxon
paired signed rank test was used to determine if there are stastistically significant
differences between predicted RMSEs among models.
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5.4 Results
Figure 5.2 shows examples of HTS maps. GBCA-enhanced T1-weighted and T2-
weighted images, as well as rCBV and rCBF maps are shown with the HTS map of
the patient. The global probabilistic deviation analysis of the different hemodynamic
activity among habitats yielded the following average results: 0.88±0.03 for rCBV and
0.86±0.05 for rCBF. These results indicate separated perfusion distributions between
habitats of the patients. Figure 5.3 shows an example of the rCBV distributions for
each HTS habitat. The Cox proportional hazard analysis is presented in Table 5.3.
Figure 5.2: Examples of the HTS habitat’s map placed over the GBCA-enhanced T1-weighted MR
image for six patients. In addition, for each patient, GBCA-enhanced T1-weighted MR image, T2-
weighted MR image, rCBV map, rCBF map, are also shown in small images (left to right, top to
bottom).
Significant results were obtained for rCBVmax and rCBFmax in the high-angiogenic
habitat (hazard ratios, 1.22 [P = .0004] and 1.20 [P = .0004], respectively), rCBVmax
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Table 5.3: Cox proportional hazard analysis for maximum perfusion indexes at the HTS habitats to
predict patient’s OS.
Habitat and perfusion parameter Hazard ratio P-value*
High-angiogenic tumor
rCBVmax 1.22 (1.10, 1.35) .0004
†
rCBFmax 1.20 (1.09, 1.32) .0004
†
Low-angiogenic tumor
rCBVmax 1.62 (1.31, 2.01) .0001
†
rCBFmax 1.89 (1.35, 2.66) .0005
†
Infiltrated peripheral edema
rCBVmax 1.67 (1.05, 2.66) .0498
†
rCBFmax 2.07 (1.02, 4.20) .0579
Vasogenic peripheral edema
rCBVmax 1.59 (0.94, 2.70) .0962
rCBFmax 1.58 (0.71, 3.54) .2657
Data in parentheses are 95% confidence intervals.
* False discovery rate corrected.
† Indicates a significant difference.
Figure 5.3: Example of the rCBV distributions at each HTS habitat for a 62-year-old man and the
global probabilistic deviation score obtained in the assessment of the separability of the distributions.
HAT = high-angiogenic tumor, LAT = low-angiogenic tumor, IPE = infiltrated peripheral edema,
VPE = vasogenic peripheral edema.
and rCBFmax in the low-angiogenic habitat (hazard ratios, 1.62 [P = .0001] and 1.89
[P = .0005], respectively) and rCBVmax in the infiltrated peripheral edema habitat
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(hazard ratio, 1.67 [P = .498]). Non-significant results were obtained for rCBFmax in
the infiltrated peripheral edema (hazard ratio, 2.07 [P = .0579]), and rCBVmax in the
vasogenic peripheral edema habitat (hazard ratio, 1.59 [P = .0962]) and rCBFmax at
vasogenic peripheral edema (hazard ratio, 1.58 [P = .2657]). Figure 5.4 shows the scat-
terplots of the combinations of perfusion biomarkers and HTS habitats that yielded
significant correlation in the Cox survival analysis. Total versus partial maximum safe
resection, complete versus incomplete concomitant radiation therapy and chemother-
apy and adjuvant temozolomide plus bevacizumab administration are also shown.
Kaplan-Meier survival analysis yielded significant differences for the survival times
observed for the populations dichotomized by low and high rCBVmax in the high-
angiogenic habitat (log-rank test P = .0104), rCBFmax in the high-angiogenic habitat
(log-rank test P = .0003), rCBVmax at low-angiogenic habitat (log-rank test P =
.0048) and rCBFmax in the low-angiogenic habitat (log-rank test P = .0128). An
average difference of 230 days in overall survival between populations was observed.
Mean survival of the population was 459 days ± 286.15 (range, 121–1656 days). Table
5.4 shows the average observed survival times for each population and the corrected
P-values for the log-rank survival test. Figure 5.5 demonstrates the Kaplan-Meier
estimated survival functions for the different populations dichotomized according to
the rCBVmax and rCBFmax at different HTS habitats.
Table 5.4: Kaplan-Meier survival analysis for populations with high versus low maximum perfusion
parameters at the different habitats.
Average survival (days)
Habitat and perfusion parameter Low High P-value*
High-angiogenic tumor
rCBVmax 550.33 351.78 .0104
†
rCBFmax 594.73 311.96 .0003
†
Low-angiogenic tumor
rCBVmax 571.62 337 .0048
†
rCBFmax 554.96 355.04 .0128
†
Infiltrated peripheral edema
rCBVmax 500.52 423.63 .7986
rCBFmax 557.17 368.38 .0641
Vasogenic peripheral edema
rCBVmax 532.56 385.44 .1300
rCBFmax 500.92 420.31 .8992
* False discovery rate corrected.
† Indicates a significant difference.
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Figure 5.4: Scatterplots of the relation between patient survival and perfusion biomarkers in High
Angiogenic Tumor (HAT), Low Angiogenic Tumor (LAT) and Infiltrated Peripheral Edema (IPE)
habitats. Treatment undergone by each patient is also shown, to allow differentiation between total
versus partial resection, complete versus incomplete concomitant radiation therapy and chemotherapy,
adjuvant temozolomide and bevacizumab administration. BVZ = bevacizumab, RT-QT = radiation
therapy-chemotherapy, TMZ = temozolomide.
Tables 5.5 and 5.6 show the log-rank test and the Cox-Wald test to measure the
potential of each categorical and additional continuous variable to independently cor-
relate with patient OS.
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Figure 5.5: Kaplan-Meier estimated survival functions for the populations divided by the median
rCBVmax or rCBFmax in High Angiogenic Tumor (HAT), Low Angiogenic Tumor (LAT) and Infil-
trated Peripheral Edema (IPE) habitats.
Figure 5.6 shows the OS predictions generated by Models 1, 2 and 3 during the
leave-one-out evaluation. Model 1, based solely on clinical and demographic variables,
obtained a RMSE = 219.33; Model 2, based on clinical, demographic and perfusion
markers at enhancing tumor region, obtained a RMSE = 202.39; while Model 3,
which was based on clinical, demographic and perfusion markers measured from the
HTS habitats, obtained a RMSE = 183.57.
The improvement achieved in the prognostic estimation obtained by the Model 2
with respect the Model 1 was 7.7%, while the improvement obtained by the Model
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Table 5.5: Kaplan-Meier survival analysis for clinical and demographic variables included in the study.
Variable # Population Average survival P-value*
Gender [36, 24] [437, 349] 0.522
Laterality [24, 33] [487, 371] 0.525
Resection
Total [20, 40] [562, 322] .025†
Subtotal [34, 26] [356, 462] .262
Biopsy [6, 54] [129, 432] .001†
Distance to ventricles
Long [20, 40] [575, 316] .002†
Mid [21, 39] [391, 408] .957
Short [19, 41] [233, 481] 3e−5†
Location
Frontal [14, 46] [299, 433] .028†
Parietal [14, 46] [465, 383] .217
Temporal [27, 33] [391, 411] .962
Occipital [5, 55] [573, 386] .525
Radiochemotherapy
Complete [49, 11] [465, 122] 3e−11†
Incomplete [5, 55] [173, 423] .006†
Note that this study was carried out with 10 patients more than the
previous studies.
* False discovery rate corrected.
† Indicates a significant difference.
3, which incorporates the HTS habitats, reached 16.3% in terms of RMSE. Wilcoxon
paired signed test yielded no significant differences between Model 1 and Model 2,
however it did obtained statistically significant differences between Model 3 and Model
1 (P < .05).
5.5 Discussion
In this study, we investigated whether the perfusion heterogeneity in the four vas-
cular habitats of the HTS is predictive of survival in untreated glioblastomas. Our
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Table 5.6: Cox proportional hazard analysis for continuous variables included in the study.
Variable Hazard ratio P-value*
Age 1.08 (1.01, 1.07) .007†
Enhancing tumor
rCBVmax 1.23 (1.10, 1.37) .0004
†
rCBFmax 1.24 (1.11, 1.37) 8e−5†
Volumetry 1.02 (1.00, 1.03) .012†
Edema
rCBVmax 1.20 (0.94, 1.54) .134
rCBFmax 1.28 (0.93, 1.75) .127
Volumetry 1.00 (0.99, 1.01) .979
HAT
rCBVmax 1.14 (1.06, 1.23) 6e−4†
rCBFmax 1.16 (1.08, 1.39) 4e−5†
Volumetry 1.06 (1.01, 1.11) .011†
LAT
rCBVmax 1.28 (1.07, 1.52) .007
†
rCBFmax 1.44 (1.07, 1.93) .015
†
Volumetry 1.03 (1.01, 1.06) .006†
IPE
rCBVmax 1.89 (1.07, 3.34) .027
†
rCBFmax 2.57 (1.12, 5.91) .027
†
Volumetry 1.01 (0.98, 1.05) .401
VPE
rCBVmax 1.84 (0.99, 3.42) .052
rCBFmax 2.31 (0.95, 5.64) .065
Volumetry 1.00 (0.99, 1.01) .917
Note that this study was carried out with 10
patients more than the previous studies.
Data in parentheses are 95% confidence inter-
vals.
* False discovery rate corrected.
† Indicates a significant difference.
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Figure 5.6: Scatter plot for predicted versus real OS (top) and Bland-Altman plot (bottom) for the
proposed aforementioned models: Model 1 (left), Model 2 (middle), and Model 3 (right). Red dashed
line indicates the hypothetical perfect prediction, while shadow blue bands indicate the confidence
intervals of the prediction.
results demonstrate that the preoperative perfusion heterogeneity contains relevant
information about patient survival, even considering the effect of other known rele-
vant factors such as standard-of-care treatment. Gradually longer survival times were
found for patients who presented with lower preoperative perfusion indexes in different
HTS habitats. The influence of standard-of-care treatment on patient survival was
also directly observed. As expected, patients who underwent maximal safe resection
plus concomitant adjuvant chemotherapy and radiation therapy showed better sur-
vival times. However, a tendency of longer survival times within subgroups of patients
who underwent the same specific treatment and had lower perfusion indexes at several
habitats was also observed. This indicates that preoperative perfusion heterogeneity
contains early important information about patient survival.
Cox proportional hazard analysis substantiated these conclusions. High- and low-
angiogenic habitats arose as those with the highest prognostic abilities, yielding sig-
nificant correlations between survival and rCBVmax and rCBFmax (with multiple-test
false discovery rate correction). rCBVmax in the infiltrated peripheral edema habitat
also was significantly correlated with survival, while rCBFmax in the infiltrated periph-
eral edema was significantly correlated without multiple-test correction (P = .0434).
These results suggest that relevant information about patient survival is also contained
in the peripheral edema (Jain et al, 2014; Akbari et al, 2014; Artzi et al, 2014).
Significant differences also were observed in the Kaplan-Meier estimated survival
functions for populations divided according to the median rCBVmax and rCBFmax at
several HTS habitats. An improvement of approximately 230 days in overall survival
was observed for patients who had lower rCBVmax and rCBFmax in the high- and low-
angiogenic habitats. These results support the potential of HTS to accurately describe
the preoperative vascular heterogeneity of glioblastomas and its prognostic abilities at
early stages.
Regarding the added value provided by the HTS to predict OS in combination with
clinical and demographic variables, we found that, in agreement with the literature,
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variables such as age, biopsy instead of resection, long or short distance of the lesion
to the ventricles, frontal tumor location, complete vs incomplete radiochemotherapy
or enhancing tumor volumetry presented strong association with patient OS.
The comparison of the prognostic capabilities of the three proposed regression mod-
els also confirmed the added value of the HTS markers in the prognosis estimation of
the patient. As expected, the models including perfusion MRI performed better than
those based solely on clinical and demographic variables. However, it is worth noting
that the inclusion of perfusion related measurements from the enhancing tumor ROI
improved the prognosis estimation by 7.7% in terms of RMSE, however, the improve-
ment obtained when including the HTS perfusion-based measurements outperformed
the previous model by 16.3%. Additionally, only this latter improvement proved to be
statistically significant. These results reinforce the evidence of the need for a better
characterization of the heterogeneity of glioblastoma in order to improve the current
management of the disease.
Several studies have been conducted to analyze the vascular heterogeneity of the
glioblastoma, many of them focusing on the enhancing tumor region. Law et al (2008)
found that patients who presented with an rCBVmax of less than 1.75 in the enhancing
tumor had longer progression-free survival times; however, they did not find a signif-
icant correlation with overall survival. Sawlani et al (2010) also correlated time to
progression with several hyper-perfused regions delineated in the rCBV . However,
they also observed no significant correlation between patients’ overall survival and
rCBVmax in the enhancing tumor. Hirai et al (2008) and Jain et al (2013), studied
the potential for prediction of survival of rCBV in the enhancing tumor of high-grade
gliomas. They showed that patients who presented with an rCBVmax of greater than
2.3 had significantly shorter survival times. These results are consistent with our
findings, hence aligning HTS with the results of previous studies in the literature.
However, these studies were only based on the rCBVmax; other perfusion indexes such
as rCBFmax, which may also add important information about instantaneous capillary
flow in the tissues to the analysis, were not considered. Moreover, manual delineation
of ROIs based on rCBVmax was used, which may affect reproducibility and may not
fully capture the tumor information available in a multiparametric study.
Authors of other studies focused on peripheral edema of glioblastoma. Akbari et al
(2014), Jain et al (2014) and Artzi et al (2014) studied the peritumoral region of the
glioblastoma to account for heterogeneity and possible tumor infiltration in the periph-
eral edema. Akbari et al used ROIs to train a support vector machine, which was then
used to generate heterogeneity maps. Jain et al analyzed the association of Visually
Accessible Rembrandt Images, or VASARI, features and molecular data with overall
survival and progression-free survival, while Artzi et al used diffusion, perfusion, and
morphologic MR imaging with an unsupervised segmentation algorithm to analyze the
edema region. Their results correlate with our findings in the infiltrated peripheral
edema habitat, because they also found that vascular heterogeneity in the peripheral
edema correlate with overall patient survival. However, ROIs to describe tumor het-
erogeneity in these studies were also delineated manually. Moreover, statistical tests
were conducted without multiple comparison correction, which decreases the statistical
power of the conclusions.
131
Chapter 5. Vascular heterogeneity assessment of glioblastoma through the Hemodynamic
Tissue Signature
One of the main limitations of our study and similar studies in which authors at-
tempted to describe the vascular heterogeneity of glioblastoma by means of discovery
of new habitats was the unavailability of a ground truth for validating the habitat’s
segmentation (Akbari et al, 2014; Hirai et al, 2008; Jain et al, 2013). Multiple biopsy or
pathological sampling could confirm the accuracy of the habitats; however, such tech-
niques cannot always be performed in clinical practice. To overcome this limitation,
alternative validation should be conducted to demonstrate the clinical relevance of the
habitats. In this study, we have analyzed the relationship between the preoperative
vascular heterogeneity of glioblastomas described through HTS and patient survival.
Another important limitation was the lack of molecular markers in the population
of our study. Molecular markers are currently considered a standard of care for WHO
glioblastoma classification and are also known to affect prognosis of patients with
glioblastoma. Positive correlation of genetic markers with the HTS habitats would
strengthen the study and the predictive potential of the proposed method and should
be performed in the future.
Finally, a limitation of the HTS arises in the presence of highly vascularized healthy
structures close to the glioblastoma, such as nearby vessels or arteries. In such cases,
these structures can be misidentified as high- and low-angiogenic or infiltrated pe-
ripheral edema habitats depending on their degree of vascularity. Although HTS im-
plements several constraints to remove these healthy structures, nearby vessels may
influence the HTS, modifying measures obtained from the habitats. Results of future
studies should improve vessel detection by using a vascular probability atlas to weight
the HTS inference process.
In conclusion, preoperative vascular heterogeneity of glioblastomas demonstrated
by the habitats of HTS is associated with patient survival. HTS separates glioblas-
tomas into four vascular habitats with early prognostic capabilities, offering an oppor-
tunity to define refined imaging biomarkers surrogated to clinical outcomes.
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In the previous chapter it was shown that early-stage vascular heterogeneity of glioblas-
toma has a direct effect on prognosis and a strong association with tumor aggres-
siveness. The proposed Hemodynamic Tissue Signature (HTS) method provides an
unsupervised ML solution to study the vascular heterogeneity of glioblastomas by an-
alyzing patterns of local hemodynamic activity in perfusion MRI. The four habitats
delineated by the HTS method have demonstrated strong associations with patient
OS and early prognostic capabilities. However, the validation of the method was con-
ducted on a single-center cohort of patients, thus avoiding the variability inherent in
real-life multi-center heterogeneous scenarios.
In this chapter we present a multi-center retrospective international validation of
the HTS method. The validation was performed under the umbrella of the clinical
study NCT03439332, which involved seven international centers with more than 180
patients. The purpose of this chapter is to validate the association between the hemo-
dynamic markers obtained from the HTS habitats and the patient OS, considering the
inter-center variability of MRI acquisition protocols, patient demographics and lesion
heterogeneity. Kaplan-Meier and Cox proportional hazard analyses were conducted to
study the prognostic potential of the HTS habitats under the proposed environment.
The contents of this chapter were published in the journal publications (Juan-
Albarrac´ın et al, 2018; A´lvarez Torres et al, 2019)—thesis contributions C4, C5, P5,
P6 and P7.
6.1 Introduction
Glioblastoma is the most aggressive malignant primary brain tumor in adults with a
median survival rate of 12-15 months (Louis et al, 2016; Gately et al, 2017). It still
carries a poor prognosis despite aggressive treatment, which includes tumor resection
followed by chemo-radiotherapy (Bae et al, 2018; Akbari et al, 2014). One of the
main factors thought to be responsible of glioblastoma aggressiveness is its vascular
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heterogeneity (Akbari et al, 2014; Soeda et al, 2015), mainly defined by a strong
angiogenesis that supplies the glioblastoma metabolic requirements and accounts for its
rapid progression (Weis and Cheresh, 2011; De Palma et al, 2017). The early-vascular
profile of the tumor is strongly associated with molecular characteristics of the lesion
(De Palma et al, 2017), which in combination with the local micro-environment are
both directly related to the glioblastoma progression (Weis and Cheresh, 2011).
The negative association between patient survival rates and vascular markers ex-
tracted from perfusion MRI has been widely demonstrated in the literature (Akbari
et al, 2014; Jain et al, 2014; Jensen et al, 2014). Perfusion indexes such as rCBV or
capillary heterogeneity were found to be associated with prognosis and patient survival
rates. Dozens of methodologies are proposed in the literature to assess these perfu-
sion indexes, ranging from manually defined ROIs, which introduce high uncertainty
and lack of repeatability; to more up-to-date techniques based on artificial intelligence
methods able to analyze imaging patterns to describe tumor heterogeneity (Demerath
et al, 2017; Jena et al, 2016; Price et al, 2016; Chang et al, 2017; Cui et al, 2016).
In 2018, Juan-Albarrac´ın et al (2018) proposed the Hemodynamic Tissue Signature
(HTS) method able to characterize the vascular heterogeneity of glioblastomas by
means of delineating vascular habitats obtained from perfusion MRI. The HTS method
draws four habitats within the lesion related to: the High Angiogenic Tumor (HAT)
region, the Low Angiogenic Tumor (LAT) region, the potentially Infiltrated Peripheral
Edema (IPE) and the Vasogenic Peripheral Edema (VPE) habitats. The HTS method
is publicly accessible at ONCOhabitats website https://www.oncohabitats.upv.es for
non-commercial research purposes.
The study conducted by Juan-Albarrac´ın et al (2018) found statistically significant
correlations between OS and several measures obtained from the HTS markers. In
2018, Fuster-Garcia et al (2018) demonstrated the ability of these imaging markers
to improve the prognosis of conventional models based on clinical, morphological and
demographic features. Both studies were conducted on a single-center cohort of 50
patients from a local institution.
However, the current road map to validate an imaging marker into clinical routine
requires to overcome two translational gaps (Abramson et al, 2015; O’Connor et al,
2017): the marker validation with pre-clinical or clinical datasets from a single or a
few expert centers, and the subsequent extension of the evaluation to multiple centers,
along with the biological validation of the biomarkers. The aforementioned studies
of Juan-Albarrac´ın et al (2018) and Fuster-Garcia et al (2018) addressed the first
translational gap, however it is still necessary to validate the HTS markers in a multi-
center heterogeneous cohort with the purpose of demonstrating their robustness and
stability under highly variable clinical conditions.
The purpose of this work is to determine if the habitats obtained by the HTS
method are predictive of the OS of glioblastoma patients undergoing standard-of-care
treatment. To this end, we have involved the HTS technology in an international multi-
center observational retrospective clinical study registered at the ClinicalTrial.gov of-
ficial platform with name “Multicentre Validation of How Vascular Biomarkers From
Tumor Can Predict the Survival of the Patient With Glioblastoma (ONCOhabitats)”
and identifier NCT03439332. We have analyzed the possible association between the
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HTS markers and patients OS, as well as their capability to stratify groups of patients
according to these markers, in a large heterogeneous international cohort. Addition-
ally, we also have assessed the robustness of the HTS method operating under a highly
variable MRI acquisition protocols from multiple centers.
6.2 Materials
6.2.1 Patient selection
Seven European clinical centers participated in the clinical study NCT03439332: the
Hospital Universitario de La Ribera, Alzira, Spain; Hospital de Manises, Manises,
Spain; Hospital Clinic, Barcelona, Spain; Hospital Universitario Vall d’Hebron, Barcelona,
Spain; Azienda Ospedaliero-Universitaria di Parma, Parma, Italy; Centre Hospitalier
Universitaire de Liege, Liege, Belgium and the Oslo University Hospital, Oslo, Norway.
A material transfer agreement document was approved by all the participating
centers and an acceptance report was issued by the ethical committee of each center.
The institution review board of each center also approved this retrospective study and
the requirement for patient-informed consent was waived.
The inclusion criteria for patients participating in the study were: (a) adult patients
(age > 18 y.o.) with histopathological confirmation of glioblastoma diagnosed between
January 1, 2012 and January 1, 2018; (b) access to preoperative MRI studies, including:
pre- and post-gadolinium T1-weighted, T2-weighted, FLAIR and DSC T2∗-weighted
perfusion sequences; and (c) patients who underwent standard Stupp treatment (Stupp
et al, 2005) with a minimum survival of 30 days.
From the initial cohort consisting of 196 patients, two cases were excluded due to
incomplete DSC perfusion acquisitions; five cases were excluded due to excessive noise
in DSC concentration curves that prevented quantification (gamma variate goodness
of fit R2 < 0.95); four cases were excluded due to MRI processing errors; and one
case was excluded due to inability to differentiate between tumor vascularity and re-
active meningeal enhancement. Table 6.1 summarizes the number of patients initially
contributed by each center and the number of patients finally excluded due to non-
compliance with the inclusion criteria.
Table 6.1: Number of patients contributed by each center with their corresponding excluded due to
noncompliance of the inclusion criteria.
H. Ribera H. Manises C. Barcelona H. Vall d’Hebron AO Parma CH Liege Oslo UH Total
Initial 10 14 28 34 42 34 34 196
Excluded 3 0 3 1 2 1 2 15
Enrolled 7 14 25 33 40 33 32 184
The final cohort enrolled in the study was of 184 patients. Those who were still
alive during the study were considered as censored observations. The date of censorship
was the last date of contact with the patient or, if was not available, the date of the
last MRI exam. Table 6.2 summarizes the most important demographic and clinical
characteristics of the population.
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Table 6.2: Summary of demographic and clinical variables of the cohort of 184 patients enrolled in
the study.
H. Ribera H. Manises C. Barcelona H. Vall d’Hebron AO Parma CH Liege Oslo UH Total
Gender (F/M)
# of patients 6/1 5/9 10/15 14/19 12/28 11/22 8/24 66/118
Age at diagnosis (years)
Mean 49 65 56 60 61 58 63 60
Range [24, 67] [39, 79] [35, 74] [30, 81] [35, 76] [32, 77] [40, 81] [24, 81]
Survival (months)
Mean 14.6 14.4 10.3 15.2 11.7 15.3 15.4 13.7
Median 9.1 12.8 9.6 13.0 12.9 14.5 12.6 12.6
Range [3.4, 52.6] [3.4, 38.4] [1.3, 26.9] [4.1, 40.0] [1.1, 30.7] [2.5, 41.0] [3.0, 36.9] [1.1, 52.6]
Resection (# of patients)
Total 3 3 0 12 19 22 11 70
Sub-total 1 4 1 10 15 6 21 67
Biopsy 1 7 6 11 2 5 0 32
Unknown 2 0 9 0 4 0 0 15
Tumor location (# of patients)
Frontal 2 4 7 10 18 11 12 64
Parietal 2 0 5 7 4 9 3 30
Temporal 3 7 11 13 12 9 14 69
Occipital 0 2 1 2 2 0 1 8
Other/Unknown 0 1 1 1 4 4 2 13
IDH1 (# of patients)
Mutated 2 0 4 0 0 0 1 6
Wild type 2 0 4 32 30 34 31 99
Unknown 3 14 17 1 10 0 1 79
6.2.2 Magnetic Resonance Imaging
Standard-of-care MR examinations were obtained with 1.5-T or 3-T imagers. Pre- and
post-GBCA T1-weighted MRI, as well as T2-weighted, FLAIR and DSC perfusion MRI
sequences were collected from each center. Table 6.3 summarizes the MRI acquisition
protocol employed by each center.
6.3 Methods
6.3.1 Vascular heterogeneity assessment of glioblastoma based
on HTS habitats
The HTS method, available at ONCOhabitats (https://www.oncohabitats.upv.es), was
used to describe the vascular heterogeneity of the glioblastomas enrolled in the multi-
center study. The methodology comprises the following stages:
1. MRI preprocessing: including denoising, magnetic field inhomogeneity correc-
tion, multi-modal registration, brain extraction, motion correction and intensity
standardization.
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Table 6.3: Summary of the most relevant parameters of the MRI studies collected by each center.
(MFS: Magnetic Field Strength)
Center MFS Sequence TR (msec) TE (msec) Matrix (mm) Sect. thickness (mm) FOV (cm2) # Dynamics
T1 25 4.6 268× 268 0.9 24× 24 -
T2 2000 120 320× 199 5.0 23× 18.3 -
FLAIR 11000 140 256× 164 6.0 23× 18.3 -
H. Ribera 1.5T
DSC 1650 40 116× 116 2.2 24× 24 80
T1 500 20 304× 241 5.0 24× 24 -
T2 2000 120 304× 228 5.0 24× 24 -
FLAIR 11000 140 256× 209 6.0 24× 24 -
H. Manises 1.5T
DSC 836 30 128× 128 5.0 24× 24 40
T1 12 4.68 256× 256 1.0 24× 24 -
T2 3000 80 256× 256 5.0 24× 24 -
FLAIR 9000 164 256× 256 5.0 24× 24 -
C. Barcelona 3.0T
DSC 1550 32 128× 128 5.0 24× 24 50
T1 253 2.64 320× 180 4.0 22× 16.5 -
H. Vall T2 6100 91 512× 326 4.0 22× 17.5 -
d’Hebron FLAIR 9000 68 320× 288 4.0 22× 19.8 -
3.0T
DSC 1450 45 128× 128 5.0 23× 23 60
T1 8.18 8.18 256× 256 1.0 24× 24 -
T2 6500 65.90 160× 160 4.0 24× 24 -
FLAIR 12000 96.72 384× 224 4.0 24× 24 -
AO. Parma 3.0T
DSC 1500 30 128× 128 4.0 24× 24 60
T1 13 4.76 256× 218 1.0 25× 25 -
T2 5000 109 384× 384 5.0 23× 23 -
FLAIR 9000 90 256× 173 5.0 23× 23 -
CH. Liege 1.5T
DSC 1460 47 128× 128 5.0 23× 25 50
T1 5.2 2.3 512× 512 1.0 25.6× 25.6 -
T2 3800 84 896× 896 3.0 22× 22 -
FLAIR 4800 325 512× 512 0.9 25.6× 25.6 -
Oslo UH 3.0T
DSC 1500 25 128× 128 5.0 25.6× 25.6 100
2. Glioblastoma segmentation: implementing a state-of-the-art deep learning
3D CNN that delineates the enhancing tumor, edema and necrotic tissues.
3. Perfusion quantification: to calculate the parametric rCBV, rCBF, MTT and
K2 maps derived from the DSC perfusion sequence.
4. HTS habitats: in which an unsupervised segmentation algorithm performs the
detection of the HAT, LAT, IPE and VPE habitats to describe the vascular
heterogeneity within the lesion.
According to Wetzel et al (2002), for each habitat we defined the HTS marker as the
maximum rCBV (rCBVmax), computed as the 95
th percentile of the rCBV distribution
within the region defined by the corresponding habitat.
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6.3.2 Association among OS and HTS markers - whole cohort
study
Cox proportional hazard regression analysis was used to quantify the associations be-
tween patient OS and HTS markers. The proportional Hazard Ratios (HRs) with their
95% confidence intervals were reported, as well as the associated P-values corrected
for multiple-test with Benjamini-Hochberg false discovery rate correction at an α level
of .05.
Kaplan-Meier analyses were also conducted to study the survival evolution of the
population stratified into two groups according to HTS markers: the high-vascular and
the low-vascular groups. We defined the high-vascular and low-vascular groups as the
set of patients with a rCBVmax higher or lower than an optimal cut-off threshold cal-
culated with the C-index method. Log-rank test was used to determine the statistical
differences between the estimated survival functions of the aforementioned groups.
6.3.3 Association among OS and HTS markers - inter-center
study
In order to determine the degree of agreement in describing the vascular heterogeneity
of glioblastomas, we conducted an study measuring the similarities of the HTS marker
distributions among the clinical centers enrolled in the study. To this end we conducted
a pair-wise Mann-Whitney U-test (α = .05), followed by a post-hoc Tukey’s honest
significant difference criterion test.
Cox regression analyses were also conducted to assess whether the association be-
tween patient OS and HTS markers differed among the centers. Kaplan-Meier analy-
ses were conducted after dividing the population of each center using the same cut-off
thresholds previously calculated for the whole cohort study.
All the statistical analyses were performed on Matlab R2017b (MathWorks, Natick,
MA).
6.4 Results
6.4.1 Association among OS and HTS markers - whole cohort
study
Table 6.4 summarizes the Cox proportional hazard analysis between HTS markers and
patient OS. Statistically significant negative associations were found for rCBVmax at
HAT, LAT and IPE habitats and patient OS, with the IPE marker showing the highest
HR (1.28). Kaplan-Meier results are presented in Table 6.5, including estimated opti-
mal cut-off thresholds, the number of patients assigned to each group, the estimated
C-index area under the curve, the median OS calculated per group, and the log-rank
P-values.
Significant differences in OS between low and high vascular groups divided by HTS
marker values were found. Consistently with previous results in the literature (Juan-
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Albarrac´ın et al, 2018), patients with a low rCBVmax at HAT, LAT and IPE habitats
presented a higher median survival rate.
Table 6.4: Cox regression analysis for rCBVmax at each vascular habitat and patient OS.
95% confidence FDR-corrected
Hazard Ratio
interval
P-value
P-value
rCBVmax
HAT 1.05 [1.01, 1.09] 0.0115† 0.0174†
LAT 1.11 [1.02, 1.20] 0.0131† 0.0174†
IPE 1.28 [1.05, 1.55] 0.0122† 0.0174†
VPE 1.19 [0.89, 1.60] 0.2502† 0.2502
† Indicates a significant difference.
Table 6.5: Kaplan Meier and log-rank test results for patient stratification in low- and high-vascular
groups according to rCBVmax value at the HTS habitats.
Cut-off # Patients per group AUC OS per group
threshold [low, high] C-Index [low, high]
P-value
rCBVmax
HAT 11.06 [97, 87] 0.606 [14.3, 11.3] 0.0014†
LAT 5.31 [91, 93] 0.605 [13.9, 11.3] 0.0085†
IPE 1.92 [59, 125] 0.634 [14.3, 11.4] 0.0101†
VPE 1.67 [100, 84] 0.599 [13.8, 11.2] 0.1356
AUC: Area under the curve.
† Indicates a significant difference.
Figure 6.1 shows the Kaplan-Meier estimated survival functions for the popula-
tions divided in high-vascular and low-vascular groups according to the optimal-cutoff
threshold for the rCBVmax estimated with the C-Index method.
6.4.2 Association among OS and HTS markers - inter-center
study
No statistical differences were found between the rCBVmax values at the different HTS
habitats among most of the centers, specially for the IPE habitat, which was the most
correlated with OS in the whole cohort study of section 6.4.2 (see tables 6.6, 6.7, 6.8,
6.9; † indicates statistical significant difference).
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Figure 6.1: Kaplan-Meier estimated survival functions for the populations stratified into groups ac-
cording to high and low rCBVmax at HAT (top left), LAT (top right), IPE (bottom left) and VPE
(bottom right) HTS habitats.
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Table 6.6: Pair-wise Mann Whitney U-test results for rCBVmax at HAT habitat.
H. Manises C. Barcelona H. Vall d’Hebron AO Parma CH Liege Oslo UH
H. Ribera 0.3139 0.6816 0.1762 0.1937 0.4765 0.0959
H. Manises 0.0363† 0.6170 0.7899 0.1111 0.7292
C. Barcelona 0.0258† 0.0124† 0.2091 0.0017†
H. Vall d’Hebron 0.6063 0.1302 0.1584
AO Parma 0.0504 0.3557
CH Liege 0.0085
Table 6.7: Pair-wise Mann Whitney U-test results for rCBVmax at LAT habitat.
H. Manises C. Barcelona H. Vall d’Hebron AO Parma CH Liege Oslo UH
H. Ribera 0.0932 0.3384 0.1445 0.0914 0.2401 0.0135†
H. Manises 0.1243 0.6170 0.7003 0.2794 0.5586
C. Barcelona 0.1317 0.932 0.5300 0.0103†
H. Vall d’Hebron 0.7690 0.3832 0.0844
AO Parma 0.2423 0.1392
CH Liege 0.0228
Table 6.8: Pair-wise Mann Whitney U-test results for rCBVmax at IPE habitat.
H. Manises C. Barcelona H. Vall d’Hebron AO Parma CH Liege Oslo UH
H. Ribera 0.0932 0.0917 0.1016 0.2500 0.1349 0.1383
H. Manises 0.8262 0.6170 0.2910 0.7011 0.3457
C. Barcelona 0.8752 0.3771 0.9624 0.5253
H. Vall d’Hebron 0.2949 0.9387 0.6227
AO Parma 0.2848 0.7296
CH Liege 0.6698
Table 6.9: Pair-wise Mann Whitney U-test results for rCBVmax at VPE habitat.
H. Manises C. Barcelona H. Vall d’Hebron AO Parma CH Liege Oslo UH
H. Ribera 0.0676 0.0754 0.0299† 0.1937 0.0462† 0.4103
H. Manises 1.0000 0.8615 0.2030 0.8433 0.0678
C. Barcelona 0.8260 0.2275 0.9374 0.0546
H. Vall d’Hebron 0.0931 0.8174 0.0160†
AO Parma 0.1117 0.5595
CH Liege 0.0280†
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Box-whisker plot shown in Figure 6.2 summarizes the information contained in
tables 6.6, 6.7, 6.8, 6.9. Significant overlapping among the distributions of rCBVmax of
each hospital can be observed, indicating no statistical differences in the HTS markers
among centers.
Figure 6.2: Box-whisker plots per center of the rCBVmax distributions at HAT, LAT, IPE and VPE
habitats.
Table 6.10 shows the results of the Cox regression analysis grouped per hospital,
to investigate the association of the HTS markers with patient OS at each center. Due
to the small sample sizes of some centers, confidence intervals are wider, so the results
of this analysis are more uncertain. However, overall, results are consistent with those
obtained in the whole cohort study, consolidating the significant association between
HTS habitats and patient OS in highly heterogeneous scenarios.
Figure 6.3 shows a diagram of the HRs and confidence intervals of the HAT, LAT
and IPE habitats per center, and using all the data together in the analysis. The figure
shows a significant overlap between confidence intervals for most of the centers, sug-
gesting no significant differences among them, and consolidating the results obtained
in the whole cohort study.
Figure 6.4 show the Kaplan-Meier estimated survival functions per center, dividing
the population of each center in high and low rCBVmax values at HAT, LAT and IPE
habitats according to the optimal thresholds obtained with the C-index method.
6.5 Discussion
In this work we have conducted an international multi-center validation of the HTS
method published in (Juan-Albarrac´ın et al, 2018). Using data from seven European
centers, significant negative associations have been found between patient OS and the
142
6.5. Discussion
Table 6.10: Cox regression analysis for rCBVmax at each HTS habitat and patient OS per center.
H. Ribera H. Manises C. Barcelona H. Vall d’Hebron AO Parma CH Liege Oslo UH
rCBVmax
HR 1.00 1.04 1.10 1.10 1.07 0.98 1.09
HAT
CI [0.84, 1.20] [0.96, 1.13] [0.96, 1.28] [0.98, 1.23] [0.98, 1.18] [0.86, 1.12] [1.00, 1.20]
HR 1.08 1.11 1.07 1.33 1.11 0.96 1.15
LAT
CI [0.64, 1.81] [0.89, 1.37] [0.79, 1.44] [0.98, 1.80] [0.95, 1.30] [0.77, 1.28] [0.97, 1.36]
HR 1.95 1.76 1.01 1.73 1.40 1.10 1.54
IPE
CI [0.5, 7.65] [0.80, 3.89] [0.61, 1.65] [0.65, 4.61] [0.97, 2.01] [0.64, 1.90] [0.92, 2.57]
HR 2.13 1.83 0.92 1.20 1.31 1.11 1.67
VPE
CI [0.12, 35.9] [0.42, 7.89] [0.39, 2.18] [0.39, 3.68] [0.81, 2.13] [0.45, 2.67] [0.80, 3.48]
# patients 7 14 25 33 40 33 32
CI Indicates a Confidence Interval.
Figure 6.3: Diagram with the HRs and 95% confidence intervals per center, to investigate the associ-
ation between OS and HTS markers at HAT, LAT and IPE habitats. The continuous black lines and
the grey bands correspond to the HRs and their associated confidence intervals using the data from
all centers. Black diamond markers and colored bars represent the HR with its confidence interval
for each respective center.
HTS markers at HAT, LAT and IPE habitats, consolidating the results obtained in
the aforementioned single-center study conducted by Juan-Albarrac´ın et al (2018).
Addressing heterogeneity between centers in the estimation of MRI markers is not
an easy task. Several authors in the bibliography have pointed out the uncertainty
and low reproducibility of MRI markers, especially across multiple centers (Abramson
et al, 2015; O’Connor et al, 2017; Schnack et al, 2004; De Guio et al, 2016). The non-
quantitative nature of several MRI acquisitions and the manual procedure for obtaining
MR-based biomarkers introduce important sources of variability, making it difficult to
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Figure 6.4: Kaplan-Meier estimated survival functions for the populations of each center stratified
into groups according to high or low rCBVmax at HAT (top left), LAT (top right) and IPE (bottom
left), using the optimal thresholds calculated with the C-index method.
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validate new robust and stable MRI markers (Schnack et al, 2004).
The HTS method focuses its efforts on the automated delineation of habitats re-
lated to perfusion patterns within the lesion in a robust and reliable manner. In the
current study, a cohort with large variations in terms of patient demographics as well
as MRI acquisition protocols was used to measure the robustness of the method. The
experiments conducted in our study did not show relevant differences among the dis-
tributions of the HTS markers obtained from MRI studies acquired at the different
centers. Only for a small number of cases, significant differences were found for the
HAT and LAT markers among centers. These results strongly suggest that the HTS
method is robust against inter-center variability in the task of describing the vascular
heterogeneity of the glioblastoma. Furthermore, the results of the Cox and Kaplan-
Meier analyses per center showed robust associations between patient OS and the HTS
markers, regardless of the center of origin. The proposed thresholds were also effec-
tive in stratifying patients from different centers into low- and high-vascular groups,
presenting different OS tendencies.
Consistently with the literature, the HTS method strongly correlates with patient
OS when observing the rCBVmax values at HAT habitat. Such values represent the
most hyper-perfused measures of the glioblastoma, which aligns with the measurements
proposed in previous studies in the literature (Jain et al, 2014; Liu et al, 2017a; Hirai
et al, 2008). As expected, shorter OS survival rates were found for patients with higher
rCBVmax values at the HAT habitat. Similarly, we also found that LAT habitat present
strong association with OS and high stratification abilities. Both results have been
replicated under highly variable conditions of MRI acquisition protocols and patient
demographics, hence demonstrating the robustness of the HTS method in describing
the vascular arrangement of the glioblastoma.
One of the most important finding presented in Juan-Albarrac´ın et al (2018) was
the correlation between long-term OSs and lower rCBVmax values in the IPE habitat.
The peritumoral region of the glioblastoma is the most heterogeneous area of the
tumor, in which uncontrolled infiltration occurs. Moreover, the inter-patient variability
and the inter-center heterogeneity significantly increases the uncertainty in this region,
obscuring the important information that it contains. However, in the present study we
found statistical association between perfusion markers at this region and patient OS,
even under the large heterogeneous nature of the proposed cohort. Moreover, effective
stratification capabilities were also found when employing this marker as indicator to
divide the population between high- and low-vascular glioblastomas.
Having demonstrated the influence of early-stage vascularity on the prognosis of
glioblastoma, we suggest the use of this factor in any clinical study that includes
population randomization. Authors consider that the HTS method will help overcome
current limitations and improve patient recruitment and randomization by initiating a
route map to avoid the second translational gap cited previously in (Abramson et al,
2015).
One of the most important limitations of our study is the imbalance between the
number of patients in each center. Although the whole cohort size is large enough for a
powerful statistical study, some of the participating centers provided a low number of
patients (less than 15 patients), which introduces limitations and uncertainties into the
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studies conducted per center. On the other hand, since the influence of the molecular
markers in patient prognosis has been clearly demonstrated (Louis et al, 2016; Verhaak
et al, 2010), it may be of interest to add them as co-factors in the regression survival
models. In future studies we plan to analyze the possible association between molecular
and imaging markers and their prognostic possibilities.
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ONCOhabitats: A system for
glioblastoma heterogeneity
assessment through Magnetic
Resonance Imaging
Neuroimaging analysis is currently crucial for an early assessment of glioblastoma, to
help improving treatment and tumor follow-up. To this end, multiple quantitative
and morphological MRI sequences are usually employed, requiring the development of
automated tools capable to extract the relevant information contained in these sources.
Despite major advances in MRI brain tumor technology, the latter is generally private
and inaccessible to the research community. This significantly slows down the advances
in tumor understanding, as many researchers continually have to re-implement many
software pieces for the typical MRI analysis pipeline to conduct their investigation.
This task is often arduous or even unreachable to many research groups specialized
on the clinical aspects of the tumor, and with less knowledge about state-of-the-art
technology for MRI analysis. As a result, many efforts are lost in developing this
necessary technology before research begins.
In this thesis, several methods have been developed to analyze glioblastoma through
MRI. One of the aspects significantly taken into consideration since the beginning of
this thesis was to, parallel to the academic and theoretical research, develop the re-
quired infrastructure to facilitate public access to the technology developed in the
thesis. In this sense, this chapter presents ONCOhabitats (https://www.oncohabitats.
upv.es): an online open access system for glioblastoma heterogeneity assessment by
MRI data. ONCOhabitats provides two services for untreated glioblastomas: 1) malig-
nant tissue segmentation, and 2) vascular heterogeneity assessment of the tumor. The
segmentation service was validated against the BRATS 2017 reference dataset, show-
ing comparable results with current state-of-the-art methods (WT Dice score: 0.89).
The vascular heterogeneity assessment service was validated in a retrospective cohort
of 50 patients, in a study focused on predicting patient OS. Cox proportional hazard
regression analysis and Kaplan-Meier survival study showed significant positive cor-
relations (p-value < .05) between the HTS habitats and patient OS. ONCOhabitats
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system also generates radiological reports for each service, including volumetries and
perfusion measurements of the different regions of the lesion. Additionally, ONCO-
habitats gives access to the scientific community to a computational cluster capable to
process about 300 cases per day.
The contents of this chapter were published in the journal publication (Juan-Albarrac´ın
et al, 2019b)—thesis contributions C6 and P4, P8, P9 and P10.
7.1 Introduction
Glioblastoma is a primary brain tumor presumed to arise from neuroglial cells. It is
the most malignant and frequent astrocytoma, accounting for more than 60% of all
brain tumors in adults. Glioblastoma has a global incidence of 4.67 to 5.73 per 100,000
people, and presents a poor prognosis of 14-15 months under the best treatment (Stupp
et al, 2005).
Heterogeneity is a hallmark that has been identified as crucial to understand the
tumor aggressiveness and its resistance against therapies (Leme´e et al, 2015; Soeda
et al, 2015). Specifically, glioblastoma is characterized by a high heterogeneity both
at macroscopic tissue level, with co-existence of different malignant tissues within
the neoplasm (Liu et al, 2017b); as well as at microscopic cellular level, with different
molecular sub-types and genetic alterations (Inda et al, 2014). Such heterogeneity rises
this tumor as one of the deadliest malignant primary brain tumor in adults (Ostrom
et al, 2015).
Molecular analysis of glioblastoma has largely improved the understanding of the
biological heterogeneity of these tumors. Molecular profiling of glioblastoma has al-
lowed the identification of different tumor sub-types, helping in the development of
more efficient drugs (Parsons et al, 2008; Verhaak et al, 2010). However, in the past
years, significant interest has been placed in the analysis of glioblastoma heterogeneity
based on medical imaging, to discover non-invasive tumor features related to different
outcomes such as overall survival, tumor grading or glioblastoma molecular sub-typing
(Wangaryattawanich et al, 2015).
Characterization of glioblastoma heterogeneity based on MRI has been addressed
from a wide range of approaches. Glioblastoma tissue segmentation has gathered
most of these efforts. Automated identification of the different tissues that co-exist
in the lesion, such as enhancing tumor, non-enhancing tumor, edema and necrosis,
has been largely addressed by the scientific community. This has lead to initiatives
such as the BRATS challenge, which was born in 2012 and has become the reference
benchmark (Menze et al, 2015) to evaluate the state-of-the-art of automated high-grade
and low-grade glioma segmentation algorithms. Nowadays, with the advent of novel
deep learning techniques, the current state-of-the art is mostly dominated by CNN
classifiers. CNNs are a class of deep feed-forward neural networks whose architecture
is particularly well suited for computer vision recognition tasks. In medical image
analysis field, CNNs have outperformed most of algorithms in many problems, arising
as the winner technique in most challenges such as BRATS, ISLES or PROMISE12
challenges (Crimi et al, 2016, 2017, 2018).
148
7.2. Materials
In addition to glioblastoma tissue segmentation, PWI has played a key role in the
advanced characterization of the tumor heterogeneity based on MRI (Shah et al, 2010;
Lupo et al, 2005; Knopp et al, 1999). Glioblastoma is characterized by a robust an-
giogenesis, strong vascular proliferation and an aberrant microvasculature (Alves et al,
2011; Hardee and Zagzag, 2012; Kargiotis et al, 2006). Numerous studies have fo-
cused on the analysis of perfusion indices to assess tumor grading (Law et al, 2003;
Emblem et al, 2008), early response to treatment assessment (Elmghirbi et al, 2017;
Vidiri et al, 2012), recurrence vs radionecrosis (Hu et al, 2009; Barajas et al, 2009) or
clinical outcome prediction (Mangla et al, 2010; Jain et al, 2014). More recent studies
addressed the local characterization of sub-regions within the glioblastoma using DSC,
DCE or Magnetic Resonance Spectroscopy Imaging (MRSI) (Artzi et al, 2014; Akbari
et al, 2014; Sawlani et al, 2010; Raschke et al, 2019). Specifically, in (Juan-Albarrac´ın
et al, 2018) an unsupervised method called HTS was proposed to characterize the
vascular heterogeneity of glioblastoma based on DSC. This method combined perfu-
sion biomarkers and glioblastoma tissue segmentation to discover habitats within the
neoplasm, showing significant correlation with patient overall survival.
However, despite the great advances in novel methods to describe glioblastoma
heterogeneity, most of them are based on private algorithms and in-house technology
developed by the authors, non-accessible for the scientific community. MRI-dedicated
libraries such as Advanced Normalization Tools (ANTs) (Avants et al, 2011; Tustison
et al, 2014), FSL (Jenkinson et al, 2012) or ITK (Avants et al, 2014), as well as modern
toolkits for deep learning such as Tensorflow™ or PyTorch, are provided to develop such
technologies. However, these libraries are just the pieces to build the complex state-
of-the-art models to analyze glioblastoma, whose development requires considerable
efforts, resources and arduous learning curves, which are not often accessible to many
researchers or institutions. In this regard, open-access public platforms that implement
state-of-the-art techniques in a user-transparent manner are highly desirable to bring to
the scientific community the possibility to conduct advanced multiparametric analysis
of glioblastoma.
In this work we present ONCOhabitats: an online system aimed to provide state-of-
the-art analysis services for glioblastoma. ONCOhabitats provides two main services
for untreated glioblastoma: 1) High-grade glioma tissue segmentation based on CNN;
and 2) glioblastoma vascular heterogeneity assessment by means of the HTS method
proposed in (Juan-Albarrac´ın et al, 2018). For each service, ONCOhabitats returns the
preprocessed images, the tissue segmentation and habitats maps, and automatically
generates a radiological report summarizing all the findings of the study.
7.2 Materials
To validate ONCOhabitats technology several datasets were employed for the different
services.
ONCOhabitats high-grade glioma segmentation service was evaluated with the pub-
lic BRATS 2017 challenge dataset, provided for the international MICCAI 2017 con-
ference. The training corpus of the BRATS 2017 dataset consists of multi-parametric
MR scans of 210 high-grade gliomas: 20 patients from the BRATS 2013 dataset, 88
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from the Center for Biomedical Image Computing and Analytics (CBICA) and 102
from the The Cancer Imaging Archive (TCIA) corpus. The validation corpus consists
of 46 multi-contrast MR scans of high-grade glioma patients distributed in 16 cases
from the CBICA institution, 24 cases from the TCIA corpus and 6 cases from the
University of Alabama at Birmingham (UAB) department.
For each patient, pre- and post-gadolinium T1-weighted, T2-weighted and FLAIR
MR exams were provided. All images were linearly co-registered to the post-gadolinium
T1-weighted exam, skull stripped, and interpolated to 1mm
3 isotropic resolution.
Manual expert annotations of this dataset comprise 4 classes: Class 1) necrosis,
cyst, hemorrhage and non-enhancing tumor; class 2) surrounding edema; class 4) en-
hancing tumor core; and class 0) for everything else. Evaluation is assessed for 3
different compartments, whose composition is shown in table 7.1.
Table 7.1: Labels composing each sub-compartment evaluated in the BRATS 2013 challenge.
Label 0 Label 1 Label 2 Label 4
WT 5 5 5
TC 5 5
ET 5
The glioblastoma vascular heterogeneity service was validated with a retrospective
local dataset of 50 patients, including 33 men with an average age of 60.94 years (range,
25–80 years) and 17 women with an average age of 62.53 years. MRI included pre-
and post-gadolinium T1-weighted, T2-weighted and FLAIR MR exams, and DSC T2∗-
weighted perfusion study. The institutional review board approved this retrospective
study, and the requirement for patient informed consent was waived. The patient
inclusion criteria and MRI protocol are extensively detailed in section 5.2.
7.3 Methods
ONCOhabitats provides two main services: 1) High-grade glioma segmentation, and
2) glioblastoma vascular heterogeneity assessment.
Figure 7.1 shows an outline of the different sub-processes involved in each service.
The first pipeline performs a morphological segmentation of high-grade glioma tumors
by first pre-processing the MRI and then using a 3D U-Net CNN classifier. The
second pipeline extends the morphological segmentation pipeline by incorporating DSC
perfusion pre-processing and quantification, and the HTS method to detect regions
within the glioblastoma with different hemodynamic activity.
We will first describe both services and then the ONCOhabitats on-line system will
be presented.
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Figure 7.1: Diagram of the different modules comprising the high-grade glioma segmentation and
glioblastoma vascular heterogeneity assessment services of ONCOhabitats.
7.3.1 High-grade glioma segmentation service
ONCOhabitats considers three tissues to morphologically describe high-grade gliomas:
1) enhancing tumor, 2) edema and 3) necrotic and non-enhancing regions of the tumor.
The service is composed of two stages: 1) MRI preprocessing and 2) Segmentation
based on CNNs.
MRI preprocessing
Our preprocessing module includes the following steps: (1) voxel isotropic resampling
of all MR images, (2) denoising, (3) rigid intra-patient MRI registration, (4) affine
registration of all sequences to Montreal Neurological Institute (MNI) ICBM space,
(5) skull-stripping and (6) magnetic field inhomogeneity correction. Voxel resampling
is performed at 1mm3 by means of linear interpolation. Denoising is carried out using
the adaptive non local means filter (Manjo´n et al, 2010c) with a search window of
7 × 7 × 7 voxels and a patch window of 3 × 3 × 3 voxels. Registration is conducted
with the ANTs software (Avants et al, 2008), taking the T1CE sequence as reference
and using Mutual Information metric. In a previous version of ONCOhabitats, skull-
stripping was performed with an in-house pipeline based on a non-linear registration
of the T1CE sequence to a template with a known intra-cranial mask. Nowadays, skull-
stripping if performed with a patch-based U-net CNN working with T1CE patches of
32 × 32 × 32 trained on 120 manually segmented glioblastomas. The network has a
performance of 0.94 Dice score on an independent test set. Finally, magnetic field
inhomogeneities are corrected with the N4 software using the previously computed
intra-cranial mask (Tustison et al, 2010).
High-grade glioma segmentation
ONCOhabitats CNN takes as input the T1CE, T2 and FLAIR MRI and works with
3D patches of size 32 × 32 × 32. We followed a U-net architecture (Ronneberger
et al, 2015; Soltaninejad et al, 2018; Dong et al, 2017) of 5 levels, with a contracting
and expanding paths of 4 residual-blocks preceded of 4 simple-blocks. A simple-block
consists of the following sequence of operations: convolution + batch normalization +
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ReLu activation function, while a residual-block implements the proposal of He et al
(He et al, 2016): convolution + batch normalization + ReLu + convolution + batch
normalization + residual connection + ReLu activation function. Max-pooling of size
2 is employed to down-sample patches at each level, while transpose convolutions are
employed to up-sample patches in the expanding path. The number of filters per level
are: 16 at first level (native patch resolution of 32× 32× 32), 32 filters at second level
(patch resolution of 16×16×16), 64 filters at third level (patch resolution of 8×8×8),
128 filters at fourth level (patch resolution of 4 × 4 × 4) and 256 filters at fifth level
(patch resolution of 2×2×2). Long-term concatenations are also employed to connect
blocks at each level.
Isotropic kernels of 3× 3× 3 were employed for all convolutions. The network was
trained using Adam Optimizer with an initial learning rate of 1e−3 and cross-entropy
was used as loss function. L2 regularization with penalty 1e − 3 was employed to
avoid for over-fitting. We employed a batch size of 64 individuals, forcing an equal
representation of enhancing tumor, edema, necrosis and healthy patches to compensate
for class imbalance. The network was trained for 50k iterations.
Figure 7.2 summarizes the network architecture and the internal design of the
simple and residual blocks.
Figure 7.2: High-grade glioma Convolutional Neural Network architecture for the ONCOhabitats
morphological segmentation service.
7.3.2 Glioblastoma vascular heterogeneity assessment service
This service extends the morphological segmentation service by introducing perfusion
information into the study. The service implements the HTS method presented in
(Juan-Albarrac´ın et al, 2018), which aims to describe the vascular heterogeneity of
glioblastoma. The HTS combines the glioblastoma morphological segmentation with
perfusion indexes such as rCBV and rCBF to discover habitats within each tissue
with different patterns of vascularity. We found that these habitats provide relevant
information to early predict patient survival, even taking into account the variations
in treatment.
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The service includes four stages: 1) MRI preprocessing, 2) Segmentation based
on CNNs, 3) Perfusion quantification and 4) Vascular habitats detection. The MRI
preprocessing and glioblastoma segmentation are inherited from the high-grade glioma
segmentation service.
Perfusion quantification
ONCOhabitats rCBV and rCBF maps are quantified by means of standard techniques
proposed in the literature (Knutsson et al, 2010). For a detailed explanation of the
calculation of perfusion parametric maps, please refer to section 2.2.2. In order for this
chapter to be self-contained, a short remainder will be made.
T1-weighted leakage effects are automatically corrected using the Boxerman method
(Boxerman et al, 2006), while gamma-variate curve fitting is employed to correct for
T2 extravasation phase. rCBV is computed by numerical integration of the area under
the gamma-variate curve (Knutsson et al, 2010), while rCBF is calculated based on
the block-circulant SVD devolution technique proposed in (Wu et al, 2003). The AIF
is automatically calculated using a divide and conquer algorithm, which recursively
dichotomizes the gadolinium concentration-time curves into two groups, selecting those
curves with higher peak height, earliest time to peak and quickest wash-out (i.e. lowest
full width at half maximum). The AIF is finally computed as the average of the curves
of the final group that contains 10 or fewer curves.
Vascular habitats detection
The HTS method (Juan-Albarrac´ın et al, 2018) describes the vascular heterogeneity
of the glioblastoma by means of an unsupervised analysis of the perfusion patterns
detected within the lesion. Such analysis is designed to yield four habitats: the HAT,
the LAT, the potentially IPE and the VPE.
The unsupervised analysis of perfusion patterns is carried out through the DCM-
SVFMM algorithm (Sfikas et al, 2008) (with DCAGMRF prior (Nikou et al, 2007)).
Such algorithm is an extension of the classic FMM specially focused on image data,
which incorporates a continuous MRF on the spatial coefficients of the model to capture
the self-similarity and local redundancy of the images. The HTS method consists
of two stages: (a) an initial re-definition of the enhancing tumor and edema ROIs
obtained by the morphological segmentation using perfusion information, and (b) a
cluster analysis of the perfusion heterogeneity within each previously mentioned ROI
to detect the different vascular behaviors expressed by the neoplasm. A comprehensive
detailed explanation of the HTS method is performed in section 5.3.3.
7.3.3 Clinical report
Clinical reports are automatically generated after the finalization of each ONCOhabi-
tats job. The reports summarize all the findings of the studies, including morphological
and functional measurements of each glioblastoma tissue and habitat. Regarding the
morphological segmentation service jobs, absolute tissue volumetry in cm3, as well
as relative volumetry with respect to the intra-cranial cavity are calculated for the
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enhancing tumor, necrosis and edema tissues. Concerning the vascular heterogeneity
assessment service jobs, in addition to the tissue volumetries, habitat’s absolute and
relative volumetries are also calculated. Moreover, a tendency analysis of the perfusion
biomarkers confined within each tissue and habitat is also included in the report. Me-
dian perfusion values of each ROI as well as Median Absolute Deviations are calculated
to robustly determine the vascular tendency of each sub-comparment of the lesion. Fi-
nally, perfusion prototypical curves in combination with a radar chart of the perfusion
biomarkers at each region are also included in the report for a visual representation
of the functional behavior of the glioblastoma. Figures 7.3, 7.4, 7.5, 7.6, 7.7 show an
example of a vascular heterogeneity assessment report.
7.3.4 ONCOhabitats system
ONCOhabitats is a web service solution to carry out the previously presented analy-
ses. The platform implements a Software as a Service (SaaS) model to automatically
analyze glioblastoma cases. Figure 7.8 shows the diagram scheme of ONCOhabitats
system.
The system implements a Wordpress® landing web-page as front-end for the user.
Before applying for a job, user must be registered in ONCOhabitats system. Regis-
tration requires a username, the first and last names, the institution of provenance
and a valid email only used to inform the user about the status of their jobs. After
registration, the user can upload the MR images to a data storage secure server to
launch the jobs.
The system implements secure encrypted communication via HTTPS protocol with
a trusted certificate to enhance data protection and privacy. The data storage includes
file encryption and secure transfer protocol via SFTP. ONCOhabitats currently sup-
ports DICOM and NIfTI (compressed and uncompressed) medical imaging formats.
An automated de-identification is carried out for all DICOM files using the gdcmanon
tool from the Grassroots DICOM library. Once DICOM files are de-identified, they
are converted to compressed NIfTI format and automatically removed from the server.
The de-identified NIfTI files are stored in a secure server, non-accessible through the
ONCOhabitats website, to enhance security and data protection. Once the analysis is
complete, the pre-processed images as well as the resulting segmentation masks and
biomarker maps are stored in a separated data storage, only accessible for 15 days
by the user owner of the job. After this period, all the data is completely removed
from the ONCOhabitats servers, unless the user explicitly specifies through his account
web-page that his data can be used for research purposes, in which case the data is
kept on a private server. This procedure follows the guidelines recommended by the
Data Protection Officer (DPO) of the Universitat Polite`cnica de Valencia (UPV) and
has been approved by the ethical committee of our institution.
ONCOhabitats system equips 7 DELL PowerEdge R720® dedicated servers, each
one shipping two Intel Xeon E5-2620 CPUs with a total of 12 cores and 64 GB of
RAM. Two NVidia Titan Xp with 3840 CUDA® cores and 12 GB of RAM supports
the cluster for the deep learning tasks.
The ONCOhabitats pipelines are mostly implemented in C++ using ITK and Eigen
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ONCOhabitats
Vascular	
heterogeneity	
assessment	report
www.oncohabitats.upv.es	
Biomedical	Informatics	Group
ITACA	Institute,	Universitat	Politècnica	de	València
Report	Number	5d202f80c30ee781982602b88bec859549bface7
Figure 7.3: Example of the first page of a report for a vascular heterogeneity assessment analysis of
a glioblastoma.
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STUDY	INFORMATION
GBM	MORPHOLOGICAL	SEGMENTATION
ii
ONCOhabitats	-	Vascular	Heterogeneity	Assessment	Report
Report	ID Report	Date
5d202f80c30ee781982602b88bec859549bface7 20-Nov-2019
User	Name Institution E-mail
ONCOhabitats	ONCOhabitats ONCOhabitats javij1@gmail.com
Patient	ID Patient	Gender Patient	Age
W30	Ivy	Gap Male 60
-	Volumetry	(cm3)
Intra-cranial	cavity Enhancing	Tumor Edema Necrosis
Abs. Rel. Abs. Rel. Abs. Rel. Abs. Rel.
1602.17 100.00	% 37.38 2.33% 35.75 2.23	% 18.77 1.17	%
-	Intra-cranial	cavity	mask	(axial	/	sagittal	/	coronal)	
-	GBM	anatomical	segmentation	maps	(axial	/	sagittal	/	coronal)	
1The	results	contained	in	this	report	are	only	certified	for	research	purposes.
-	www.oncohabitats.upv.es	-
Figure 7.4: Example of the second page of a report for a vascular heterogeneity assessment analysis
of a glioblastoma.
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DSC	QUANTIFICATION
iii
ONCOhabitats	-	Vascular	Heterogeneity	Assessment	Report
-	Median	and	MAD	deviation	of	DSC	biomarkers	per	tissue	(enhancing	tumor,	edema	and	necrosis)
rCBV rCBF MTT
Enh.Tumor 4.71±1.78 3.64±1.30 0.14±0.01
Edema 1.74±1.04 1.56±0.80 0.12±0.01
-	Biomarker	maps:	1)	rCBV	map,	2)	rCBF	map,	and	3)	MTT	map	
-	K2	leakage	correction	map	(Boxerman	et.	al	2006)	
1The	results	contained	in	this	report	are	only	certified	for	research	purposes.
-	www.oncohabitats.upv.es	-
Figure 7.5: Example of the third page of a report for a vascular heterogeneity assessment analysis of
a glioblastoma.
157
Chapter 7. ONCOhabitats: A system for glioblastoma heterogeneity assessment through
Magnetic Resonance Imaging
HEMODYNAMIC	DSC	TISSUE	SIGNATURE
iv
ONCOhabitats	-	Vascular	Heterogeneity	Assessment	Report
-	Volumetry	per	vascular	habitat	(cm3)
HAT LAT IPE VPE
Abs. Rel. Abs. Rel. Abs. Rel. Abs. Rel.
21.86 1.36	% 32.10 2.00	% 8.76 0.55	% 9.75 0.61	%
-	Median	and	MAD	deviation	of	DSC	biomarkers	per	vascular	habitat	
rCBV rCBF MTT
HAT 6.84±1.04 5.29±0.83 0.14±0.00
LAT 3.46±0.90 2.73±0.65 0.14±0.01
IPE 1.20±0.16 1.16±0.13 0.12±0.00
VPE 0.64±0.15 0.70±0.13 0.10±0.00
-	Hemodynamic	DSC	tissue	signature	nosological	map	
-	Hemodynamic	DSC	tissue	signature	chart	and	prototype	concentration-time	perfusion	curves	
1The	results	contained	in	this	report	are	only	certified	for	research	purposes.
-	www.oncohabitats.upv.es	-
Figure 7.6: Example of the fourth page of a report for a vascular heterogeneity assessment analysis
of a glioblastoma.
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v
ONCOhabitats	-	Vascular	Heterogeneity	Assessment	Report
 DISCLAIMER	
 All	calculations,	measurements	and	images	provided	by	this	software	are	intended	only	for	scientific
research.	Any	other	use	is	entirely	at	the	discretion	and	risk	of	the	user.	If	you	do	use	this	software	for
scientific	research	please	give	appropriate	credit	 in	publications.	The	results	of	the	HTS	may	not	be
commercially	used	in	any	other	way	without	prior	approval	of	the	author.	
 DEFINITION	OF	THE	SERVICES	
 Pre-Processing:	 Pre-processing	module	 attempts	 to	 enhance	 and	 correct	 the	 MR	 images	 for	 its
posterior	analysis.	Several	common	artefacts	are	corrected	in	this	module	such	as	magnetic	bias	field
inhomogeneities,	noise	or	spike	artefacts.	Additionally,	automated	 registration	and	skull-stripping	 is
conducted	to	generate	a	consistent	multi-parametric	high	quality	imaging	space	of	the	brain.	
 Segmentation:	The	anatomical	analysis	of	 the	glioblastoma	requires	the	delineation	of	 the	tumor
tissues,	which	encompass	the	enhancing	tumor,	the	edema	and	the	necrotic	tissues.	In	this	module,
we	implemented	a	deep	learning	approach	to	provides	such	tissue	identification.	Convolutional	Neural
Networks	 are	 employed	 in	 combination	 with	 a	 morphological	 component	 analysis	 to	 identify	 the
pathological	structures.	
 DSC	perfusion	quantification:	DSC	quantification	involves	the	computation	of	the	hemodynamic
indices	 obtained	 from	 a	 kinetic	 analysis	 of	 the	 first	 pass	 of	 a	 intravenously	 injected	 paramagnetic
contrast	agent.	T1	and	T2	 leakge	effects	are	also	corrected	to	not	miss-estimate	the	hemodynamic
biomarkers.	 The	 quantified	 maps	 computed	 by	 this	 module	 are:	 relative	 Cerebral	 Blood	 Volume
(rCBV),	relative	Cerebral	Blood	Flow	(rCBF),	Mean	Transit	Time	(MTT)	and	K2	maps.	
 Hemodynamic	Tissue	Signature	(HTS):	HTS	consist	on	an	automated	unsupervised	method	able
to	describe	the	vascular	heterogeneity	of	 the	enhancing	tumour	and	edema	tissues	 in	 terms	of	 the
angiogenic	process	located	at	these	regions.	The	HTS	provides	a	characterization	of	the	GBM,	whose
output	is	a	nosologic	map	of	the	tumoral	tissues	grouped	in	different	vascular	sub-comparmtents	with
their	 associated	 MRI	 fingerprint.	We	 consider	 4	 vascular	 sub-compartments	 for	 the	 GBM:	 the	 high
angiogenic	enhancing	tumour	region	(HAT),	 the	 low	angiogenic	enhancing	tumour	region	(LAT),	 the
potentially	tumour	infilatrated	peripheral	edema	(IPE)	and	the	pure	vasogenic	edema	(VPE).	The	HTS
is	able	to	capture	the	local	heterogeneity	of	the	tumour,	hence	providing	relevant	information	about
its	behaviour.	
rCBV				relative	Cerebral	Blood	Volume	
rCBF				relative	Cerebral	Blood	Flow	
MTT				Mean	Transit	Time	
DSC				Dynamic	Susceptibility	Contrast	
HTS				Hemodynamic	Tissue	Signature
-	www.oncohabitats.upv.es	-
Figure 7.7: Example of the fifth page of a report for a vascular heterogeneity assessment analysis of
a glioblastoma.
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Figure 7.8: ONCOhabitats system architecture.
Figure 7.9: ONCOhabitats system security rating evaluated by SSL Labs by Qualy.
libraries. MATLAB© and PHP are also employed as scripting languages for different
tasks. Tensorflow™ is used to develop the deep learning segmentation models.
ONCOhabitats has been designed to deal with up to 14 concurrent jobs, each
job taking approximately one hour, which yields a theoretical limit of 336 processed
cases per day. The terms of use of the system are available in the landing web page,
paying particular attention to the GDPR compliance and the non-commercial research
purpose of the system.
7.4 Results
Since each ONCOhabitats service performs a different task, they have been evaluated
separately with different datasets and methodologies. The results of the evaluations
are presented below.
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7.4.1 High-grade glioma segmentation service
High-grade glioma tissue segmentation performance was evaluated according to BRATS
evaluation guidelines. Such evaluation comprises the assessment of the segmentation
quality of the WT region, the TC region and the ET area. Dice metric, as well as sen-
sitivity and specificity of each region was computed to compare ONCOhabitats results
with several state-of-the-art methods.
Table 7.2: Segmentation results obtained by the ONCOhabitats high-grade glioma segmentation
service for the BRATS 2017 validation set. ET : Enhancing Tumor, WT : Whole Tumor, TC : Tumor
Core
ET WT TC
Dice 0.73 0.89 0.73
Sensitivity 0.77 0.87 0.72
Specificity 0.99 0.99 0.99
The results of our high-grade glioma segmentation service are presented in Table
7.2. A comparison between the results obtained by ONCOhabitats system and the
ones obtained by each participant of the challenge for the BRATS 2017 validation
set are presented in Figure 7.10. As the figure shows, ONCOhabitats offers competi-
tive comparable segmentations with the state-of-the-art algorithms, always achieving
results above the median of the participants and in most cases close to the third quar-
tile. Moreover, CNN yield segmentations of high specificity, which is a highly desirable
property for a medical tool, ensuring a very low false positive rate.
7.4.2 Glioblastoma vascular heterogeneity assessment service
An extensive evaluation of the HTS method at different levels is presented in section
5.4.
First, a statistical evaluation to assess the degree of similarity among the rCBV and
rCBF distributions for the HAT, LAT, IPE and VPE habitats was conducted. Global
probabilistic deviation metric (Sa´ez et al, 2017) was employed as a multi-dimensional
extension of Jensen-Shannon divergence to measure distances between distributions.
The analysis yielded the following average results for the population: 0.88 ± 0.03 for
rCBV and 0.86±0.05 for rCBF. Such results indicated that the perfusion distributions
of the habitats for each patient of the study were statistically significantly separated,
hence corroborating that the HTS habitats describe regions within the glioblastoma
with different hemodynamic behavior.
Second, the prognostic capabilities of the HTS habitats were studied. Cox propor-
tional hazard regression analysis and a Kaplan-Meier study were conducted to measure
the degree of correlation of the HTS habitats with patient OS. The maximum rCBV
and rCBF value at each habitat (computed as the 95% percentile of the distribution)
was the marker with better results in concordance with previous studies in the liter-
ature (Wetzel et al, 2002). HAT and LAT habitats, as well as IPE yielded positive
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Figure 7.10: Distributions of Dice scores, sensitivities and specificities for the BRATS 2017 validation
set results obtained by the participants of the challenge. ONCOhabitats results are indicated with a
* marker. ET : Enhancing Tumor, WT : Whole Tumor, TC : Tumor Core
correlations with overall survival for both Cox and Kaplan-Meier studies. Benjamini-
Hochberg false discovery rate at α level of 0.05 was employed to correct for multiple
hypothesis testing, increasing confidence of the statistical results.
7.5 Discussion
In this work we presented ONCOhabitats: an on-line open-access system to study
different aspects of glioblastoma such as the tumor morphology and the vascular tumor
heterogeneity patterns. ONCOhabitats provides the user with consolidated state-of-
the-art techniques based on both deep learning and unsupervised structured learning
algorithms previously published in the literature. The system also generates automated
radiological reports summarizing the findings of the analysis, in a formal document
easily integrable in clinical routine.
The ONCOhabitats high-grade glioma segmentation was compared against the cur-
rent state-of-the-art methods presented at BRATS 2017 challenge. Our system yields
comparable results with these approaches, demonstrating competitive comparable re-
sults with no significant differences between them. Our method is completely determin-
istic and reproducible, which is a highly desirable property to conduct large population
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studies or clinical trials. The higher reproducibility of a system, the greater the like-
lihood to detect changes in the disease. Additionally, ONCOhabitats implements the
Hemodynamic Tissue Signature method presented in (Juan-Albarrac´ın et al, 2018), to
study the vascular heterogeneity of the tumor. Glioblastoma vascular heterogeneity
has been demonstrated to be a key hallmark to understand the behavior of this masses.
The HTS analysis allows to study the different vascular patterns of the lesion, detecting
functional habitats within the tissues that have been demonstrated to contain relevant
information about patient’s survival at a very early stage of the disease.
ONCOhabitats offers these analyses by means of a free web-based solution. We
give access to the scientific community not only to our software services but also to
our computational resources, avoiding the requirement for medical imaging experts,
expensive computational labs and arduous learning curves to develop the technology.
We provide a system capable to process about 300 cases per day including MRI pre-
processing and standardization, tissue segmentation, DSC perfusion quantification and
vascular heterogeneity assessment of the lesion. The system is designed to be imme-
diately scalable by adding new computing machines and also cloud-based services as
the workload increases.
The major limitation of our system is the time to process a case. Glioblastoma
study involves the analysis of a considerable amount of MRI to capture all the infor-
mation contained in the lesion, requiring to process a huge amount of data. Currently,
MRI preprocessing accounts for the most part of the processing time, so we are cur-
rently developing new approaches to optimize this module.
Currently, ONCOhabitats system is participating in the international clinical trial
NCT03439332, aimed to validate the ONCOhabitats technology in a multi-centre ob-
servational study with 300 patients from hospitals from Spain, Italy, Belgium and
Norway. In future work, we plan to extend ONCOhabitats system to handle DWI
and Diffusion Tensor Imaging (DTI) sequences, as well as post-surgery and follow-up
studies for a longitudinal assessment of the glioblastoma.
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Chapter 8
Concluding remarks and
recommendations
This chapter finalizes the work conducted in this thesis and summarizes the main
concluding remarks and recommendations derived from it. Additionally, in this chapter
we provide the guidelines for continuing the scientific research and development based
on this work.
8.1 Concluding remarks
AI medical image analysis is a cornerstone in the future of modern precision medicine.
The ability to non-invasively measure morphological and quantitative characteristics
of complicated diseases such as glioblastoma is an invaluable aid in successfully com-
bating these lethal lesions. In the particular case of glioblastoma, to date, this tumor
still remains a major challenge, as there is no satisfactory therapy for it. Understand-
ing its high heterogeneity, and in particular its vascular heterogeneity, constitutes a
key element in advancing the design of effective therapies. Therefore, it is essential
to continue the study and research of this neoplasm from different perspectives: its
pathology, its molecular and genetic processes, its immunology and, of course, through
neuroimaging. The latter is rapidly evolving towards richer and more complex mul-
tiparametric acquisitions that require increasingly advanced computational models to
harness the raw information they contain. In this sense, this thesis has contributed
to the assessment and characterization of the vascular heterogeneity of the glioblas-
toma by means of unsupervised ML techniques applied to MRI data, able to discover
habitats within the lesion with early prognostic capabilities.
This thesis has contributed to the state-of-the-art in the fields of Medical Informat-
ics, Statistics and Probability, Radiology and Nuclear Medicine, Machine Learning and
Data Mining and Biomedical Engineering. The scientific publications in top-ranked
journals and international conferences derived from this thesis endorse the research
carried out in these fields. Furthermore, the methods and technology developed in this
thesis have been integrated in a public open-access platform for its use by the medical
and research community, or for its posterior industrialization.
The specific concluding remarks of this thesis are listed as follows.
165
Chapter 8. Concluding remarks and recommendations
CR1 Unsupervised learning is confirmed as a viable tool for MRI analysis and patho-
logical pattern detection. We found that, although supervised learning normally
achieves better results in well-known tasks such as image segmentation, unsu-
pervised learning is also able to accurately capture MRI patterns related to mor-
phological and physiological characteristics of the lesion. The study conducted
in chapter 3 demonstrated the potential of unsupervised learning approaches,
showing a consistent behavior across the different datasets, which is a highly
desirable property when dealing with heterogeneous data.
This settled the basis for the subsequent contributions carried out in the the-
sis, where no ground-truth exist from where to learn supervised methods. The
performance obtained in this preliminary study in segmenting well-known tissues
based on MR intensity patterns gave us evidences and confidence in the following
studies conducted in the thesis.
This concluding remark responds to the research question RQ1, covers the ob-
jectives O1 and O2 and was derived from the works in publications P1, P2 and
P3.
CR2 The SVFMM is a powerful and robust state-of-the-art framework for unsuper-
vised learning of imaging data. The Bayesian nature of this model provides great
flexibility to inject existing knowledge into the learning process, to successfully
capture spatial redundancy of the images and introduce local regularization.
Moreover, it also provides mechanisms to guide the learning process towards
plausible solutions aligned with task-specific constraints.
The SVFMM has been the basis for the HTS method presented in this thesis to
describe the vascular heterogeneity of glioblastomas. Particularly, we have pro-
posed a variant of the SVFMM combined with the probabilistic NLM scheme that
achieves better results compared to the alternative approaches in their family.
The proposed approach also simplifies the previous models since the probabilistic
NLM weighting function does not introduce additional parameters to the model.
This concluding remark responds to the research question RQ2, covers the objec-
tive O3 and was derived from the work in publication P3.
CR3 Early-stage vascular heterogeneity provide crucial information about expected
survival of patients with glioblastoma undergoing standard-of-care treatment.
The HTS habitats successfully capture this heterogeneity by analyzing the per-
fusion patterns within the lesion, showing improved association with OS with re-
spect to alternative approaches. Consistently with the literature, habitats related
to the enhancing tumor presented strong correlation with patient OS. However,
the most important finding is the positive association of the rCBVmax in the IPE
habitat with OS. The infiltrated edema today catches all the attention since it
is identified as the critical region for many decisive treatments such as surgical
resection or radiotherapy, thus increasing the importance of this finding.
Moreover, the HTS relies on a conceptual framework to describe the heterogeneity
of a lesion by means of detecting habitats with differentiated MRI functional
profiles. This enables a new perspective in the characterization of complex lesions
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under the medical imaging paradigm. This approach introduces a concept-shift
in the segmentation of lesions towards the delineation of regions sharing a similar
physiological behavior rather than a common morphological appearance.
This concluding remark responds to the research questions RQ3 and RQ4, covers
the objectives O4 and O5 and was derived from the works in publications P5, P6
and P7.
CR4 ONCOhabitats (https://www.oncohabitats.upv.es) platform encapsulates all the
original methods and algorithms developed in this thesis, and several state-of-
the-art algorithms for medical image analysis, in a public open-access system
free for the medical and research community. ONCOhabitats is a reliable system
for the study of glioblastoma that provides an end-to-end analysis of the lesion,
from the preprocessing of the raw MRI obtained from the scanner to the final
measurement of volumetries and quantitative biomarkers of habitats representing
regions with a specific physiological behavior.
ONCOhabitats is designed modularly to allow an easy reuse of the technology, a
sustainable development cycle and a high scalability. It is mainly written using
open-access state-of-the-art libraries with the aim to positioning the system as
a reference platform for the analysis of brain tumors through medical imaging.
In this sense, ONCOhabitats not only offers cutting edge technology, but also
provides access to their computational resources, allowing a case-analysis-rate of
about 300 cases per day.
The software is registered in the technological offer of the UPV and is pro-
tected under the patents ES201431289A in Spain, EP3190542A1 in Europe and
US20170287133A1 in United States.
This concluding remark responds to the research question RQ5, covers the objec-
tive O6 and was derived from the works in publications P4, P8 and P9.
8.2 Recommendations
Glioblastoma tumor still remains a lethal disease that requires a tireless multi-disciplinary
effort to understand its behavior, evolution, proliferation and survival mechanisms that
grant its uncontrollable aggressiveness. Under this scenario, the future of the analysis
of such lethal diseases lies in the inclusion of ML techniques, capable of analyzing the
vast amount of complex multi-disciplinary medical information available to a patient,
with the aim of developing personalized therapies that exploit the particularities of
each individual.
The developed methods and research findings performed in this thesis points to the
aforementioned direction and can serve as a starting point for further research. In this
sense, the following recommendations are suggested.
R1 Despite the unquestionable power, utility and performance that supervised learn-
ing is demonstrating nowadays, its ability to discover new knowledge from biomed-
ical data is severely limited by its learning mechanism. This task is, by the oppo-
site, perfectly suited for unsupervised learning. The exploratory nature inherent
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in unsupervised learning provides it with the ability to detect hidden patterns
within the data, often imperceptible to the human.
In this regard, we encourage the use of unsupervised learning for medical image
analysis and biomedical data mining in general, to build descriptive models of the
data capable of capturing subtle patterns that lead to undetectable important
findings for the human being. Therefore, unsupervised learning must assume a
relevant role in modern medicine to situate ML as an essential tool for the future
of personalized therapies.
R2 Learning from structured data, such as MR images, requires ML models capa-
ble to exploit the conditional dependencies and spatial correlations associated to
these data. Historically, MRFs have proven to be powerful mathematical models
to capture the local dependencies encoded in the images. Specifically, SVFMMs
constitute a versatile statistical framework to describe heterogeneous structured
imaging data under a strong mathematical foundation. On the other hand, the
NLM image processing scheme has also proven to achieve state-of-the-art results
in many image-related tasks such as denoising, super-resolution, in-painting or
patch-based segmentation. We encourage the use of the NLSVFMM algorithm,
as it brings together the potential of both approaches in a fully Bayesian statis-
tical model that has demonstrated comparable state-of-the-art performance in a
model mathematically less complex than those of its family.
Nevertheless, the current trend in ML focuses on the use of CNNs, since they
have demonstrated to be the state-of-the-art models for most of image analysis
related tasks. CNNs, however, are mathematical models mainly oriented to the
supervised learning paradigm. Therefore, we advocate the need to investigate
new architectures and learning schemes to exploit the potential of CNNs in an
unsupervised learning scheme. Nowadays, Convolutional AutoEnconders (CAEs)
with latent space clustering losses are being raised as the most powerful alter-
natives for performing unsupervised learning segmentation in images based on
CNNs.
R3 The HTS method settles an innovative approach to characterize the vascular
heterogeneity of glioblastomas by means of detecting functional habitats within
the lesion with differentiated MRI profile. We consider that this conceptual
framework provides a powerful tool to explore the internal behavior of a tumor
in an objective non-biased data-driven manner. The underlying unsupervised
ML approach behind the method allows the heterogeneity of the lesion to be
easily explored from different points of view, ranging from varying the number
of habitats to find within the lesion, to adding additional MRI sequences, such
DWI or NMR relaxometry maps, to enrich the imaging profile of the tumor.
R4 Enhancing tumor vascularity has historically demonstrated strong association
with OS of patients affected by glioblastoma. However, there is a lack of consen-
sus in the literature on the rCBVmax quantities that correlate with this outcome.
This is probably due to the large variability in the perfusion MRI protocols and
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quantification methods employed, in addition to the manual ROI selection for
tumor measurements and perfusion relative normalization techniques.
In this sense, we encourage the use of the HTS method, as it has proven to be
robust to highly variable MRI acquisition protocols and manufacturers from dif-
ferent international centers, yielding rCBVmax distributions for the different HTS
habitats with no statistically significant differences among most of the centers.
This is a highly desirable property to conduct large cross-sectional population
studies, where the conclusions of the experiments must be extrapolable to the
entire population.
R5 Diffuse infiltration is one of the most crucial aspects of the glioblastoma, as it
renders total resection impossible and, therefore, progression after surgery is al-
most inevitable. Thus, detecting the areas of potentially infiltrated tumor cells is
of clinical significance for many targeted interventions such as surgery or radio-
therapy. The findings of this thesis related to the IPE habitat strongly positions
the HTS method as a primary tool to study the morphology, distribution, profile
and characteristics of the infiltration region. The positive association of the IPE
habitat with patient OS confirms the importance of this habitat and enhances
the HTS as a method to study the heterogeneity of the glioblastoma.
R6 Glioblastoma heterogeneity is evidenced at multiple levels, ranging from macro-
scopic co-existence of malignant tissues, to genetic alterations that derive in
different glioblastoma molecular sub-types and to longitudinal evolution of mu-
tant glioblastomas. Molecular analysis is nowadays crucial to investigate the
response of the tumor to different therapies and its mechanisms of proliferation.
Nevertheless, multi-parametric medical image analysis of the tumor has gained
a lot of attention in the past years since it is demonstrating strong associations
with relevant clinical outcomes such as OS, tumor grading or genetic mutations.
In this sense, we recommend that further research on glioblastoma using medical
imaging takes into account molecular and genetic alterations to enhance and
complement the imaging information, with the goal of designing more accurate
models capable of predicting clinical outcomes more reliably.
R7 Multi-disciplinary cross-sectional research is nowadays necessary to find effective
therapies for such a lethal disease as the glioblastoma. From the technological
point of view, it is almost impossible for each research group to develop from
scratch all the necessary state-of-the-art technology needed to analyze the differ-
ent sources of information available for glioblastoma, i.e. MRI, genetic profiling,
monitoring events, electronic health records, etc.
In this regard, we encourage research groups specialized in particular topics must
make an effort to provide open access to their methods to facilitate the cross-
sectional research between different disciplines, since it will accelerate and im-
prove the research on these complex and lethal diseases.
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